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INNOVATIVE SELF-ASSEMBLED AND MICROFABRICATED STRUCTURES TO BE USED 
IN DISTINCT BIOMEDICAL APPLICATIONS 
 
ABSTRACT 
Advances in self-assembly offer new opportunities in molecular design of biomaterials. A major 
advantage of these systems is their ability to generate similar fibrillar structures to those found in 
the natural extracellular matrix (ECM) of tissues and to integrate directly into their structure 
biomolecular ligands for cell signalling. On the other hand, the integration of self-assembly into 
existing microtechnologies could offer new possibilities to fabricate hierarchical materials with 
high levels of precision and reproducibility. Therefore, the overall goal of the work presented in 
this thesis was to develop novel biomaterial systems (microcapsules and membranes) for 
encapsulation and culture of cells by exploring self-assembly and microfabrication techniques. 
Towards this goal, this PhD work investigated the application of xanthan gum, an anionic 
extracellular polysaccharide produced by the bacterium Xanthomonas campestris, as potential 
cell encapsulation matrix, as this polysaccharide remains largely unexplored in this regard. In 
one first attempt, xanthan was carboxymethylated and the microcapsules were generated by 
simple ionic crosslinking. To generate stable microcapsules by self-assembly, efforts were made 
to synthesize xanthan derivatives by conjugation with hydrophobic molecules (palmitoyl and 
phospholipid) or by combination with multidomain peptides of opposite charge. 
A second objective of this PhD work was to produce microcapsules with homogeneous size 
distribution and micrometer size favorable for mass transfer and easy injects for cell therapy. 
Different devices (microdroplet generator and microfluidics) and methods (ionic crosslinking, 
self-assembly) were developed to prepare xanthan-based microcapsules. The microstructure 
(morphology, molecular organization) and properties (size, membrane thickness, permeability, 
stability) of the developed microcapsules were investigated in detail. 
Using a new microdroplet generator, microcapsules of ionic crosslinked carboxymethylated 
xanthan (chapter III) and self-assembled palmitoyl xanthan (chapter IV) were generated with an 
average diameter of 500 and 576 µm, respectively. The self-assembly of phospholipid-xanthan 
(chapter V) and native xanthan with a positively charged multidomain peptide (chapter VI) was 
guided in microfluidic device to obtain stable capsular structures with regular spherical shape 
and controlled size at the microscale. The results of these studies showed that the properties of 
the developed microcapsules could be easily controlled by manipulating the concentration of 
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building blocks and assembling conditions. Moreover, capsule forming devices were successful 
used to guide the formation of capsular structures. 
Cell encapsulation experiments were also conducted to corroborate the initial hypothesis. 
ATDC5 cells (a murine chondrocytic cell line) encapsulated into the developed xanthan based 
microcapsules remained viable and were observed to proliferate for prolonged culture periods 
(up to 3 weeks) with enhanced metabolic activity. 
In summary, these studies suggested that xanthan polysaccharide can be an alternative to the 
current cell encapsulating materials but in vivo studies are necessary to validate this hypothesis. 
Additionally, the combination of self-assembly with micro-fabrication techniques demonstrated to 
be an innovative approach for the fabrication of microcapsules in cell-friendly conditions with 
controlled properties. 
In a distinct work, molecular self-assembly was combined with soft lithography to fabricate 
patterned self-supporting membranes in a single-step process (chapter VII). A positively charged 
multi-domain peptide (with or without the cell-adhesive sequence RGDS) was used to self-
assemble with the anionic ECM polymer hyaluronic acid. The assembling conditions were 
optimized to realize membranes with well-controlled properties, including membrane thickness, 
bioactive epitope availability, and topographical pattern morphology. The resulting self-
assembled membranes exhibited a hierarchical structure of nanofibers and surface 
microtopographies with various densities of RGDS. Rat bone marrow stem cells were shown to 
recognize the RGDS sequence and the topographical patterns, varying their morphology 
depending on the concentration of binding motif or specific physical features that were cultured 
on.  
The studies reported in this thesis proved that combining self-assembling materials with 
microfabrication technologies can be an effective approach to fabricate microcapsules and 
membranes with increased level of control over their structure, shape, bioactivity and overall 
performance. The versatility of the combined bottom-up and top-down fabrication processes 
described here may permit the development of novel hierarchical biomaterials with precise 
biomolecular and physical properties and the opportunity to better tune them with spatio-
temporal control. 
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AUTO-ORGANIZAÇÃO MOLECULAR E MICRO-FABRICAÇÃO DE ESTRUTURAS 
INOVADORAS PARA APLICAÇÕES BIOMÉDICAS DISTINTAS 
 
RESUMO 
Avanços em química supramolecular têm vindo a constituir novas oportunidades na formulação 
de novos biomateriais. A grande vantagem destes sistemas é a sua capacidade para gerar 
estruturas fibrilares semelhantes às existentes na matriz extra-celular dos tecidos e a 
possibilidade de integração na sua estrutura de grupos bioactivos para interacção celular. Por 
outro lado, a integração destes processos de auto-organização molecular nas micro-tecnologias 
existentes possibilita o fabrico de materais hierarquicamente organizados com elevados níveis 
de precisão e reprodutibilidade. Por consequinte, o trabalho apresentado nesta tese teve como 
objectivo principal desenvolver novos sistemas de biomateriais (microcápsulas e membranas) 
para encapsulamento e cultura de células através de técnicas de auto-organização molecular e 
micro-fabricação. Neste doutoramento investigou-se também a aplicação da goma xanthan, um 
polissacarídeo poli-aniónico produzido pela bacteria Xanthomonas campestris, como potencial 
matriz para encapsulamento de células. Numa primeira abordagem, o xanthan foi 
carboximetilado e as microcápsulas geradas por reticulação iónica deste composto. A geração 
de micro-cápsulas por auto-organização molecular foi conseguida pela síntese de derivados do 
xanthan pela conjugação de moléculas hidrofóbicas (palmitoil e fosfolípido) através da 
combinação do xanthan com péptidos com capacidade de auto-organização de carga oposta. 
Um outro objectivo deste trabalho, consistiu na produção de cápsulas à escala micrométrica 
com uma distribuição de tamanhos uniforme, favorável a transferências de massa e facilidade 
de injecção em terapias celulares. Para tal, foram desenvolvidos dispositivos para fabrico de 
microcápsulas (gerador de microcápsulas e micro-fluidicos) e métodos químicos (reticulação 
iónica e a auto-organização molecular) para produzir microcápsulas baseadas em xanthan. A 
micro-estrutura (morfologia, organização molecular) e propriedades (tamanho, espessura da 
membrana, permeabilidade, estabilidade) das microcápsulas desenvolvidas foram investigadas 
em detalhe. Microcápsulas feitas de xanthan carboxymetilado reticulado ionicamente (capítulo 
III) e por auto-organização molecular do palmitoyl xanthan (capítulo IV) foram produzidas 
através do gerador de micro-cápsulas com diametro cerca de 500 e 576 µm, respectivamente. 
A auto-organização molecular do fosfolípido-xanthan (capítulo V) e do xanthan nativo com 
péptidos de carga oposta (capítulo VI) foram conduzidas através de um dispositivo micro-
fluidico para obter estruturas capsulares estáveis com forma esférica regular e tamanho 
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controlado na escala micrométrica. Os resultados destes estudos mostraram que as 
propriedades das microcápsulas desenvolvidas podem ser facilmente controladas através da 
manipulação da concentração dos materiais e condições de organização. Além disso, os 
dispositivos utilizados foram bem sucedidos para guiar a formação de estruturas capsulares. 
Experiências de encapsulamento de células foram também realizadas para corroborar a 
hipótese inicial. Células da linha celular ATDC5 foram encapsuladas nas cápsulas de xanthan 
tendo permanecido viáveis. Adicionalmente, foram observadas a proliferar para longos períodos 
de cultura (até três semanas) com aumento da actividade metabólica. 
Em suma, estes estudos sugerem que o polissacárido xanthan pode constituir uma alternativa 
aos materiais convencionais utilizados em encapsulamento de células. Contudo estudos in vivo 
serão necessários para validar esta hipótese. 
A combinação de processos de auto-organização molecular com técnicas de micro-fabricação 
demonstrou ser um método inovador para a fabricação de microcápsulas em condições 
celulares favoráveis e com propriedades controladas. 
Por último, auto-organização molecular foi combinada com processos de fotolitografia para 
fabricar membranas com padrões topográficos (capítulo VII). Foi utilizado um péptido carregado 
positivamente (com e sem a sequência peptídica de adesão celular RGDS) para interagir com o 
polímero aniónico ácido hialurónico. As condições de organização molecular foram optimizadas 
para fabricar membranas com propriedades controladas tais como espessura da membrana, 
concentração de sequência bioactiva e morfologia do padrão topográfico. As membranas 
obtidas apresentaram uma estrutura altamente organizada constituida por nano-fibras contendo 
micro-topografias na superfíce com diferentes densidades de RGDS. Células estaminais da 
medula óssea de rato reconheceram a sequência RGDS e os padrões topográficas, variando a 
sua morfologia consoante a concentração de RGDS e morfologia do padrão. 
Os estudos apresentados nesta tese demonstraram que a combinação de auto-organização 
molecular com tecnologias de microfabricação constitui uma estratégia eficaz para fabricar 
microcápsulas e membranas com maiores níveis de controlo sobre a sua estrutura, forma, 
bioatividade e desempenho. 
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Section 2 (Chapter II – Materials and Methods) describes the scientific objectives and 
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chemicals, materials, methods and techniques used in the experimental work. This section also 
serves as a complement to the information given in each of the following experimental chapters.  
Section 3 contains 5 chapters (chapters III-VII) that describe original research. In Chapter III, a 
chemical derivative of xanthan gum polysaccharide (carboxymethyl xanthan) was investigated 
as a new artificial matrix for the encapsulation of chondrocytic cells. A novel micro-droplet 
generator was developed to produce microcapsules. Xanthan was further modified to obtain an 
amphiphilic system by conjugation with hydrophobic palmitoyl groups (Chapter IV) and a 
phospholipid molecule (Chapter V). Chapter VI presents the fabrication of microcapsules by 
combining a positively charged self-assembling peptide with xanthan. 
Chapter VII reports on the fabrication of hierarchical and bioactive self-supporting membranes, 
integrating physical and biomolecular elements, in a single-step process, that combines 
molecular self-assembly with soft lithography. 
The final section (Section 4, Chapter VIII - Conclusions) summarizes the significant findings in 
the experiments presented in the previous section and describes how the conclusions address 
the initial hypotheses. 
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Chapter I*  
SELF-ASSEMBLY IN NATURE: USING THE PRINCIPLES OF NATURE TO CREATE 
HIERARCHICAL COMPLEX PEPTIDE STRUCTURES FOR BIOMEDICAL APPLICATIONS 
ABSTRACT 
Self-assembly is a ubiquitous process in biology where it plays numerous important roles. It 
underlies the formation of a wide variety of complex biological structures, like for example the 
organization of lipid bilayers in cell membranes which is essential for maintaining the integrity 
and function of cells. Over the past two decades, materials scientists have aspired to exploit 
nature’s assembly principles to create artificial materials, with hierarchical structures and tailored 
properties, for the fabrication of functional devices. Towards this goal, both biological and 
synthetic building blocks have been subject of extensive research in self-assembly. In fact, 
molecular self-assembly is becoming increasingly important for the fabrication of biomaterials 
because if offers a great platform for constructing materials with high level of precision and 
complexity, integrating order and dynamics to achieve functions such as stimuli-responsiveness 
(pH, ionic strength, temperature, light), environmental adaptation (space confinement) and 
bioactivity (cell receptor signaling to promote regenerative processes). The importance of 
peptide self-assembling building blocks has been recognized in the last years, as demonstrated 
by the literature available on the topic. The simple structure of peptides, as well as their facile 
synthesis, makes peptides an excellent family of structural units for the bottom-up fabrication of 
complex nanomaterials. Additionally, peptides offer a great diversity of chemical (specificity, 
intrinsic bioactivity, biodegradability) and physical properties (small size, conformation, stability) 
to form self-assembled structures with different molecular configurations. The motivation of this 
review is not only to provide an overview on the design principles for peptide self-assembly but 
also to demonstrate how these principles have been applied to manipulate their self-assembly 
across the scales with numerous illustrative examples about such an exciting research. 
Applications of self-assembling peptides as biomaterials, including carriers for drug delivery, 
hydrogels and 3D networks for cell culture and tissue engineering, are also described 
 
_________________________________________ 
*This chapter is based on the following publication: 
Ana C. Mendes, Erkan T. Baran, Rui L. Reis, Helena S. Azevedo, Self-assembly in nature: using the 
principles of nature to create hierarchical complex peptide structures for biomedical applications, 
submitted
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1. SELF-ASSEMBLY DEFINITION 
Molecular self-assembly, the spontaneous organization of molecules into ordered aggregates 
due to their mutual interactions (from the non-covalent type) without external control, is of central 
importance to life (e.g., protein folding, pairing of nucleotides in DNA, formation of lipid bilayers - 
Figure I.1.). It generates much of the functionality of the living cell and provides the basis of 
supramolecular chemistry where the instructions of how to assemble larger entities are coded in 
the structural motifs of individual molecules1. 
The definition of molecular self-assembly still remains ambiguous, being used many times 
improperly. For instance, self-assembly and self-organization are two concepts that are often 
confused or even misunderstood. Halley and Winkler2 distinguish self-organization from self-
assembly based on thermodynamic principles, where self-organization implies a non-equilibrium 
process and self-assembly is reserved for spontaneous processes tending toward equilibrium. 
Two main classes of self-assembly have been considered: static and dynamic. Static self-
assembly is related with the local or global equilibrium of the systems without dissipation of 
energy3-5. In dynamic self-assembly, the formation of structures through supramolecular 
interactions only take place if the system is dissipating energy 3-5. 
2. BIOLOGICAL SELF-ASSEMBLIES 
Biology is replete with examples of highly functional complex nanoscale structures formed by 
self-assembly6. The importance of self-assembling in biological and biochemical activities can be 
easily understood considering the low consumption of energy required in the non-covalent 
interactions. It is a process that operates in the thermodynamic minimum. 
Figure I.1.A exemplifies one of the most powerful characteristics of biological systems: their 
ability to assemble individual molecules into large, complex, functional structures. A variety of 
biological structures, ranging from proteins and nucleic acids to viruses and cell membranes, 
possess a highly precise organization on the nanometer scale which derives from specific 
interactions at molecular level being this organization critical for their function. Biological self-
assembly uses biomolecular building blocks of precisely defined shape, size, hydrophobicity and 
spatial distribution. 
Protein folding (Figure I.1.A) clearly illustrates the non-covalent interactions involved in the self-
assembly in aqueous solution. The peptide sequence (primary structure) is synthesized from the 
20 amino acids by translation of a sequence present in a messenger ribonucleic acid (mRNA).. 
Chapter I. Self-assembly in nature: using the principles of nature to create hierarchical complex structures 
7 
When viewed in a simplistic perspective, proteins appear to be an assembly of linear covalent 
strands. Precise folded proteins involve, however, the assembly of prefolded intermediates 
before yielding perfectly functioning proteins. The secondary structure of proteins may be 
constituted by α-helices and β-sheets in their backbone. α-Helices occur when peptide bonds 
are connected by hydrogen bonds and can be visualized when protein chains exhibit a helix 
motif. The β-sheet tends to form when a protein folds back and forth upon itself. 
The formation of protein tertiary structure is mediated by how α-helices and β-sheets bend and 
pack into each other originating a protein subunit. The conformation of the tertiary structure is 
provided by the number and type of interactions (e.g. hydrogen bonds, hydrophobic and ionic 
interactions) and it is at this stage of protein folding that the functional regions of the protein (e.g. 
catalytic and binding points) become assembled. Lastly, the quaternary structure of proteins is 
formed when the subunits previously formed are interacting together. Nevertheless, it is the 
primary structure containing the specific order of amino acids that will dictate exactly how the 
folding will occur and consequently the same sequence will give every time the same structure, 
except when disturbance is introduced in the system4. These biomolecules play an important 
role in numerous vital functions in living systems. Besides their structural function, they are also 
transporting agents, scaffolds of biological catalysis (enzymes), protection agents and hormone 
receptors4,7. 
A particularly important example of self-assembly is provided by the double-stranded (ds) 
deoxyribonucleic acid (DNA) molecule. Two complementary chains of linear DNA strands, 
composed of millions of nucleotides, constituted of polyphosphate/sugar backbones attached to 
nucleobase residues (adenine (A), cytosine (C), guanine (G) and thymine (T)) wrap around one 
another in the familiar double helix (Figure I.1.B). DNA helix has a diameter of approximately 2 
nm, a helical repeat of 3.4 nm (10.5 base pairs) and persistent length of about 50 nm8. 
Complementary pairs of nucleobases (A-T and C-G) form strong hydrogen bonds that strongly 
sustain the strands together, supported by π-π stacking interactions. The stability resulted from 
the combination between these two pairs of nucleobases is unique and responsible for the 
effectiveness of DNA replication. 
Viruses are protein-based supramolecules, with different shapes and variety of sizes, that 
manifest their functionality through self-assembly. A typical virus possesses a protein outer shell 
(capsid) composed of multiple copies of coat proteins arranged in a symmetrical fashion, and 
housed within the viral genome, which contains all the essential genes to replicate within the 
host. In general, viruses adopt an icosahedral or helical structure, giving a sphere- rod-shape 
particle. Many viruses, such as herpes, polio, the human immunodeficiency virus (HIV) adopt the 
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icosahedral conformation that are confined into a lipidic bilayer designed as envelop. To 
assemble into an icosahedral geometry, its capsomers, the structural units of this kind of viruses, 
are distributed symmetrically despite their self-assembly from assymetrical components. For 
example, the tobacco mosaic virus (TMV), which self-assembles into rod like structures3-4, 
represents an excellent example of effective control over size of self-assembled structures. First, 
the TMV protein forms a two-layer disk, with 17 proteins in each ring. A special initiation 
sequence in the RNA then binds in the hole at the center. This cause the disk to dislocate, 
forming a lockwasher shaped ring with 16 1/3 subunits pert turn. The remaining subunits then 
stack in this structure elongating until the RNA is covered. Thousands of coat proteins (2130 
identical protein units each with 158 amino acid residues) self-assemble into 300 nm long 
cylinder (protein shell - capsid) around a single RNA molecule (that comprises 6400 
nucleotides) which acts as a template (Figure I.1.C). The length of the assembly is determined 
by the length of the enclosed RNA template. In the absence of the RNA template, the TMV coat 
proteins assemble into cylinders with the same diameter (18 nm) as the untemplated capsids but 
with variable length. The RNA template limits the self-assembly of the capsid proteins through 
specific molecular interactions. The head-to tail assembly of TMV represents a superb example 
of a biological system that takes advantage of the natural assembly pathway. One of the 
interesting features of the TMV is that if the virus is broken into its sub-unities, when re-mixed in 
physiological conditions, the virus has the ability to self-assemble exactly into the previous 
structure constituting a full replica. 
The cytoplasmic membrane (Figure I.1.D) is a phospholipid bilayer which serves to separate 
the inside environment of the cell from the outside. The phospholipid bilayer is arranged so that 
the polar ends of the molecules (the phosphate and glycerol portion of the phospholipid that is 
soluble in water) form the outermost and innermost surface of the membrane while the non-polar 
ends (the fatty acid portions of the phospholipids that are insoluble in water) form the center of 
the membrane This membrane is stable enough to serve as a barrier to the transport of water 
soluble ions (Na+, K+, Ca2+) and molecules and has the fluidity to allow the entrance of particles 
inside the cell by endocytosis (the process by which cells take in solutes or particles by 
enclosing them in vesicles or vacuoles pinched off from the cytoplasmic membrane). 
The previously described examples clearly show how sophisticated self-assembly can be and 
how nature’s assembly principles can be used to create supramolecular materials.  
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Figure I.1. Examples of biological self-assembled structures showing the building blocks and the relevant interactions 
involved in the self-assembly process. (A) Protein folding; (B) ds-DNA; (C) Tobacco mosaic virus (TMV); (D) Cell 
membrane. 
3. DESIGN OF SUPRAMOLECULAR MATERIALS 
From a materials science point of view, self-assembly is a simple and low cost bottom-up 
process to fabricate functional supramolecular materials from pre-existing components (building 
blocks) involving a reduced number of steps. Different building blocks (biological and synthetic, 
Table I.1.) have been extensively studied for this purpose. These building blocks can be atoms, 
molecules or macromolecules, and be designed (chemical nature of the blocks, composition, 
length, molecular architecture) to contain all the necessary information to direct their self-
assembly into complex materials for specific applications. In most cases, their self-assembly is 
reversible and allows the combination of different building blocks. While the instructions for 
assembly lie in the molecular structures (recognition, chirality) of the building components and 
on the precise positioning of functional groups that provide the intra- and intermolecular 
interactions, the nanostructures that emerge through self-assembly are controlled by the 
environment and the driving force. Each of these characteristics of the self-assembling system 
is described in detail in the following sections. 
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3.1. Self-assembling building blocks 
According with Whitesides9, the components of a self-assembling system consists of a group of 
molecules or segments of a macromolecule that interact with one another. These molecules or 
molecular segments may be the same or different. Their interaction leads from some less 
ordered state (a solution, disordered aggregate or random coil) to a final state (a crystal or 
folded macromolecule) that is more ordered.  
Proteins and DNA are not only examples of self-assembled biological structures, but these 
macromolecules have been used as building blocks for fabricating complex assemblies (Table 
I.1.). A wide range of different molecules can be used to form supramolecular nanostructures in 
a variety of different assembling conditions. The molecules must have the potential to form 
multiple non-covalent interactions with itself in a given solvent. In addition, certain structural 
features (e.g. helicity) and their persistence length are also key parameters.  
Amino acids are naturally occurring molecules being the molecular constituents of peptides and 
proteins. Peptides are versatile assembly components owed their intrinsic functional diversity, 
being chemically more diverse than DNA, and have been widely exploited as self-assembling 
building blocks. Their self-assembly has been studied in detail and will be the focus of this 
review. 
Lipids are the most important building blocks of cell membranes. Generally, they are composed 
of a hydrophilic head group and a hydrophobic tail region3,10. Due to the large variability in the 
head group and tail chemistries, lipids are often categorized into polar and non-polar. The 
hydrophobic nature and rigid structure of lipids creates a tendency of these molecules to 
aggregate into larger structures in which the position and orientation of the molecules is 
organized. In addition, the structural diversity of lipids (fatty acids, triglycerides, phospholipids, 
cholesterol) with different polarities, charged groups and lengths allows the formation of dynamic 
(e.g. monolayers, bilayers) and compartmentalized (e.g. micelles, vesicles) structures in water, 
acting as barriers, within isolated processes can occur. 
High molecular weight saccharides (polysaccharides) are produced annually by a broad variety 
of plants and microorganisms with remarkable chemical (neutral, charged, linkage type) and 
structural diversity (linear or branched, random coil or helical conformation). Polysaccharides 
contain multiple OH groups capable of hydrogen bonding. In addition, with their single molecular 
recognition functionality, polysaccharides are highly adaptable and can introduce densely-
charged templates into nanostructured assemblies11. 
In biology, nucleic acids (DNA and RNA) are fundamental molecules of life as carriers of 
molecular information. They play essential roles in gene heredity, regulation and expression. 
DNA’s base sequence stores and imparts instructions, while RNA’s sequence plays the role of a 
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messenger and a regulator of gene expression. As biological polymers, nucleic acids possess 
recognition capabilities and interesting chemical properties which depend on their base 
sequence. Nucleic acids can be synthesized with a nearly infinite number of sequences8. The 
nucleobases present in DNA and RNA molecules can form hydrogen bonds and - stacking 
interactions and these interactions can be engineered for the bottom-up fabrication of a variety 
of nanostructures. DNA double helix is inherently a nano-scale object. Although being more 
chemically labile, RNA molecules have structural components that are very similar to DNA. In 
addition, most RNAs are single-stranded molecules with nanoscale motifs that mediate precise 
intra- and inter-molecular interactions. Two strands of DNA or RNA with completely 
complementary sequences can bind to each other and form a fully bases-paired duplex 
structure. 
 
Table I.1. Biological and synthetic building blocks used for the supramolecular self-assembly into complex structures 
and their potential biomedical applications
6,12-16
. 
 
CPMV-cowpea mosaic virus;  phage-lambda bacteriophage; hHPBV- human hepatitis B virus 
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Viruses have been used as robust building blocks in nanosciences due to their canonical shape 
(rod or sphere) and size uniformity. The surface properties of viruses can be manipulated 
genetically or chemically without disrupting their integrity and morphology. They have been 
employed to generate long-range ordered assemblies for biomaterials development. 
Synthetic block copolymers, with their easily controllable properties (molecular dimension, 
composition, solubility, stability, stimulus responsive behavior) have been widely used for 
fabricating a variety of organized assemblies with distinct morphologies (micelles, vesicles, 
tubes) depending on the relative volume fractions of the blocks. Dendritic molecules (e.g. 
dendrons) are synthetic molecules which have a well defined (monodisperse) 3D branched 
architecture. Dentritic building blocks can assemble into more complex nanoscale assemblies 
(nanoparticles, nanofibers) by non-covalent interactions17. 
Surfactants are compounds that consist of a hydrophobic (usually a long hydrocarbon chain) 
and a hydrophilic (ionic or polar group)18. Examples of surfactants are the well-known sodium 
dodecylsulfate (SDS) and sodium oleate. Numerous studies have demonstrated that surfactants 
self-assemble in aqueous solution into micellar, vesicle and multilayer structures. 
3.2. Supramolecular interactions  
The interactions relevant in molecular self-assembly are non-covalent forces (electrostatic, 
hydrophobic, hydrogen bonding, van der Waals, aromatic stacking, metal coordination) that are 
individually weak (2-250 kJmol-1) when compared with to covalent bonds (100-400 kJmol-1) but 
collectively, if in sufficient number, they can generate highly stable assemblies and their subtle 
balance govern the shape and function of the final assembly (Figure I.2.). 
Electrostatic interactions 
Coulombic interactions are long range non-selective interactions that can result in attractive or 
repulsive effects. Ionic self-assembly has been employed as straightforward and reliable method 
for the organization of different building blocks (polyelectrolytes, charged surfactants, peptides 
and lipids, DNA). Charged groups, including phosphate of nucleic acids or carboxylates and 
amino groups on protein side chains, can interact with counterions and combined to form new 
materials. Binding of charged surfactants with oppositely charged polyelectrolytes is a typical 
example of ionic self-assembly19.  
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Hydrophobic effects 
The hydrophobic effect is a unique organizing force, based on repulsion of solute by the solvent 
instead of attractive forces at the site of organization. Non-polar molecules tend to avoid a non 
aqueous surrounding. Hydrophobic effects are responsible for the folding of proteins and the 
aggregation of amphiphiles into micelles and vesicles. 
Stacking effects (- stacking) 
In chemistry, pi stacking (also called π-π stacking) refers to attractive, noncovalent interactions 
between aromatic rings. - stacking is a popular chemistry concept describing how aromatic 
molecules are stabilized when oriented face-to-face as in a stack of coins. It explains how 
certain supramolecular structures are formed and especially in biology it explains the finer points 
of base pairing in DNA. - stacking between aromatic units, for example between aromatic side 
chain of certain aminoacids (e.g. tyrosine-tyrosine, tryptophan-phenylalanine interactions) 
mediate protein folding and are responsible for intermolecular stability.  
Hydrogen bonding 
Hydrogen bonds are formed between atoms such as oxygen or nitrogen that have 
electronegativity larger than hydrogen. The atom to which the hydrogen is connected is referred 
as hydrogen-bond donor and the other atom is called hydrogen-bond acceptor (Figure I.2.). 
Hydrogen bonding (H-bonding) interactions are highly directional and can be of either short- or 
long-range nature, leading to secondary structures such as α-helices and β-sheets in proteins. 
The strength of single hydrogen bonds depends mainly on the nature of donor or acceptor, 
although it is influenced by a larger extent by the solvent. Combining several hydrogen bonds in 
a functional assembly strengths the interaction and their spatial arrangement enhances its 
specificity. In DNA, H-bonding is responsible for highly specific molecular recognition. 
Tuning the strength and directionality of interactions among building blocks is the key feature 
that defines the field of supramolecular materials20. The interactions that provide high degree of 
directionality to the assembly process of the different building blocks are favorite elements in the 
design. By controlling the multiple interactions during assembly will lead to a wide range of 
ordered structures (ribbons, tapes, tubes, helices). For example, repulsive forces, due to ionic 
interactions, can be neutralized due to changes in pH, or addition of multivalent ions or charged 
polymers.  
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Figure I.2. An illustration showing the non covalent interactions involved in supramolecular chemistry and their 
strength
21
 
 
3.3. Molecular recognition 
The way in which one molecule recognizes and binds to another is a fundamental process that 
is important in many biochemical pathways (e.g. selective substrate recognition by specific 
enzymes) and also in analytical chemistry (e.g. receptor binding to particular analytes). 
Molecular recognition, the specific noncovalent association of one molecule with another, 
underlies the entire field of self-assembly and the chemical recognition information that is 
programmed into each molecule offers the potential for constructing supramolecular 
architectures. 
3.4. Chirality 
Chirality is a geometric property of a molecule (or spatial arrangement of atoms) of being non-
superposable on its mirror image; it is an important property in many biomacromolecules which 
results from the inherent chirality of the molecular building blocks (e.g. amino acids, 
nucleotides). Peptides are chiral, which can lead to the generation of materials of a particular 
handedness which in turn can add another level of recognition22. It has been predicted that the 
formation of lipid tubules is driven by the chirality of the bilayer, and the tubule diameter depends 
on magnitude of the chirality, i.e., the magnitude of the favored twist in the molecular packing15. 
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3.5. Environment and the driving force  
The self-assembly needs an environment in which it will occur and it is often related with a 
driving force. The driving force causes the movement of the system through the different 
possible configurations of the system on its way to the ordered final state. 
The self-assembly of molecules is normally carried out in solution or at an interface to allow the 
required motion of the components. The interaction of the components with their environment 
can strongly influence the course of the process. For self-assembly to occur, molecules must be 
mobile. In solution, thermal motion provides the major part of the motion required to bring the 
molecules into contact. Therefore one of the challenges consists on assuring the mobility of the 
components; as they become larger than molecules, Brownian motion rapidly becomes 
irrelevant, and gravity and friction become important. The concentration of self-assembling units 
is expected to influence the diffusion and the mobility of the components. Increasing the 
concentration will drive assembly of larger structures. 
For self-assembly to generate ordered structures, the association either must be reversible or 
must allow the components to adjust their positions within an aggregate once it has formed. The 
strength of the bonds between the components, therefore, must be comparable to the forces 
tending to disrupt them. For molecules, the forces are generated by thermal motion.  
3.6. Controlled self-assembly  
There are many pathways to trigger and/or drive the self-assembly by changing gradually the 
environmental conditions (e.g. building block concentration, pH, temperature, ionic strength, 
solvent), or by an external input (e.g. light, enzyme activity, magnetic or electric field). The 
presence of ions in solution, as well the pH and solvent polarity, are significant factors that affect 
the non covalent interactions and hence the assembly routes. The pH environment can 
modulate the degree of protonation/deprotonation of amino acids with ionizable groups (carboxyl 
and amino side chains, Table I.2.) in peptides and proteins and thus control their electrostatic 
interactions (attraction/repulsion). Similarly, ionic strength also affects the charge state of 
molecules. Charge screening effects by counterions have been widely used to drive the 
formation of peptide assemblies. In addition to their role as solution entities, ions are also 
important components in many self-assembly processes. Bulk self-assembly of small molecules 
frequently yields structures that exhibit a high degree of order on the nanometer scale, whereas 
at the micrometer scale they exhibit more disordered morphologies. A method to dynamically 
control the self-assembly process consist on designing self-assembling molecules that are 
sensitive to external stimulus, such as light or catalytic activities. This external stimulus can 
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convert a non-assembling precursor into self-assembling element which is produced locally. A 
major challenge in self-assembling is to control the kinetics of the process (nucleation and 
growth) and avoid defects in the formed assemblies. There is, therefore, a need to design self-
assembling systems (building blocks and assembling pathways) that allow the spatio-temporal 
control of the process.  
Temperature is also known to play a role on the kinetics of self-assembly by regulating the 
formation and size of ordered aggregates23. An interesting study reporting the use of 
temperature control on peptide amphiphile assembly at the micro and macroscale has been 
demonstrated by Stupp and co-workers by the formation macroscopic bundles of aligned 
nanofibers24. Light-triggered self-assembly was also demonstrated by the Stupp group by 
conjugation of a 2-nitrobenzyl group with the amide nitrogen of the amino acid closest to the 
hydrophobic segment (alkyl tail) of peptide amphiphile (PA)25. This chemical configuration 
protects the amide nitrogen from hydrogen bonding. The 2-nitrobenzyl group can be cleaved 
photochemically (upon light irradiation at 350 nm) restoring a standard PA. 
The highly- to non-specific activities of enzymes have been also explored in the context of 
dynamic self-assembly by designing self-assembling building blocks that are sensitive to 
enzymatic activities under controlled conditions of pH, temperature and ionic strength. Enzyme-
directed self-assembly can be achieved either by catalyzing the synthesis of a self-assembly 
molecules, or by removing a blocking from the molecules13. For that, several enzymes have 
been used, including proteases, phosphatases and esteresases, which catalyze hydrolysis 
reactions (formation of supramolecular assembly via bond cleavage) or by transferase enzymes 
(kinases) which might generate supramolecular assemblies via bond formation. A peptide 
amphiphile (PA) was designed containing a sequence which is a substrate of a protein kinase A 
(PKA)26. Upon treatment with PKA, the PA molecules became phosphorylated causing the 
disassembly of the cylindrical structures. Subsequent treatment with alkaline phosphatase 
enzyme, which cleaves the phosphate groups, resulted in PA reassembly. Another example of 
enzyme mediated self-assembly27 employs the natural enzyme alkaline phosphatase (ALP) and 
a phosphorylated, anionic nanofiber gel matrix to template, in 3D, hydroxyapatite nanocrystals. 
ALP liberates phosphates necessary for hydroxyapatite mineralization from organic phosphates. 
The gradual nature of this enzymatic process provides critical regulation of free phosphate 
concentration, preventing rapid, uncontrolled nonspecific mineralization in the incubating 
medium. 
The laboratory of Ulijn has provided very interesting examples on enzymatically controlled self-
assembly28-31. They have used a protease enzyme (subtilisin) to produce building blocks in a 
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reversible and spatially confined manners using aromatic peptide amphiphile (Fmoc-dipeptide 
methyl esters) as self-assembling precursors. Subtilisin catalyses the hydrolysis of these esters 
to yield a Fmoc-peptide that self-assembles into hollow nanotubular structures28. Because the 
rate of formation of the self-assembling building blocks is determined by the kinetics of the 
enzymatic reaction, different folded structures may be formed offering additionally the possibility 
of controlling the mechanical properties. 
These parameters play a key role in the thermodynamics and kinetic of the self-assembly 
process, thus acting on the morphology of the resulting assemblies. 
Templated self-assembly 
In templated self-assembly, a prefabricated template (2D substrate chemically or mechanically 
patterned) orients and directs the assembling components to (i) create structures with better 
long-range order than their non-templated counterparts, (ii) control the morphology of the 
resulting assemblies, and/or (iii) form novel structures/phases that would not favorable in the 
absence of the template32. The patterned substrate interacts selectively with the assembling 
components and their organization near the substrate is governed largely by the patterns on the 
template and this organization is propagated into the bulk of the assembling structure via the 
interaction between the components. Another approach towards templated self-assembly is the 
use of geometric confinement to orient bulk structures or to induce the formation of novel 
morphologies not found in bulk systems. Templated self-assembly can be used to hierarchically 
organize self-assembled structures for higher order assemblies. 
In the template self-assembly approach, specific physical and chemical interactions of the 
molecules and components with the surfaces are the driving forces for the formation of stable 
organized films at solid substrates. Vertical and horizontal segregation of components, their 
chemical binding and anchoring density determine supramolecular organization in a self-
assembled film. 
Guided self-assembly 
Another method to introduce hierarchical organization in supramolecular materials consists on 
using external forces, such as mechanical33, magnetic34 and electric forces for orientation. Like 
physical templates, externally applied fields can also be used to direct the self-assembly 
process. Field-directed self-assembly has the added advantage that fields can be switched 
on/off and tuned dynamically. Therefore, these external forces can be used to template 
assemblies with improved long-range order and controlled orientation. Time varying fields can 
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be used to agitate an equilibrium structure in order to allow energetically unfavorable defects to 
be removed from the system or to establish and sustain a dynamically self-assembled system. 
For example, the van Hest group has shown the alignment of diacetylene-containing PA 
nanofibers in presence of a strong magnetic field (20 T)34. A highly aligned morphology was 
observed where the fibers were oriented parallel to the applied magnetic field. Furthermore, the 
alignment on a molecular level was passed on to the high-molecular-weight chains that formed 
upon light-induced polymerization of the diacetylene groups and was reflected in optical 
properties of the material. This study shows that through a convenient hierarchical build up of 
self-assembling materials, structural information on a molecular scale is transferred to 
macroscopic properties, allowing the development of new materials that are well defined on all 
dimension scales. Later, the same group reported the patterning of a solid ﬁlm using polarization 
holography (variation of the light polarization direction) and diacetylene-containing PA ﬁbers 
aligned in a strong magnetic ﬁeld, with no template, mask, or mechanical contact with the ﬁlm35. 
Using polarized light, spatially conﬁned polymerization was achieved because polymerization 
only took place at positions where the polarization of the incident light was parallel to the ﬁber 
orientation, yielding a polymer pattern. 
X-ray irradiation was also shown to induce the crystallization of like-charge supramolecular 
peptide filaments by repulsive forces, but this phenomenon only occurred at low peptide 
concentrations ( 1 wt%; beyond this concentration the crystallization is spontaneous)36. The x-
ray triggered organization of peptide filaments from a disordered state to a hexagonally ordered 
state was attributed to an increase in charge density caused by x-ray irradiation leading to 
enhanced electrostatic repulsions among filaments. Addition of ions that screened the charges 
on the filaments suppressed the formation of crystalline structures. More recently, Stupp and co-
workers reported the effect of an electrical field during the dynamic self-assembly of a negatively 
charged polyelectrolyte and a positively charged peptide amphiphile in water leading to the 
formation of an ordered membrane37. The superposition of an external electric field during 
molecular co-assembly and diffusion of the charged species allowed controlling both growth rate 
and directionality of the fibrils that made up the membrane. Depending on the strength and 
orientation of the field, they observed a significant increase or decrease of up to nearly 100% in 
membrane thickness, or the controlled rotation of nanofiber growth direction by 90 degrees, 
which led to a significant increase in mechanical stiffness. These results suggest the possibility 
of using electric fields to control structure in self-assembly processes that involve the diffusion of 
oppositely charged molecules. 
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4. PEPTIDES AS SELF-ASSEMBLING BUILDING BLOCKS 
The unique self-assembling properties of peptides and their ability to form emergent structures 
are increasing being exploited for the development of new bioactive biomaterials. The 
successful synthesis of self-assembling peptides with different molecular designs and the 
pathways used to drive their supramolecular assembly are discussed in the following sections. A 
number of very important physiological and biochemical functions of life are influenced by 
peptides. For example, peptides are involved in receptor-mediated signal transduction, 
influencing cell-cell communication upon interaction with receptors. Another important feature of 
peptides is related with their aggregation state and its implications in human diseases. Long, 
unfolded polypeptides have an innate tendency to form aggregates, such as amyloid fibrils 
which are known to be involved in Alzheimer´s disease. The self-assembly process involved in 
collagen fibrillogenesis is also determinant for proper animal development and may be 
associated with certain pathological situations. The isolation of peptides from natural sources is 
often problematic and the demand of synthetic peptides in biological applications is steadily 
increasing. Peptides can be obtained through chemical synthesis or genetic engineering.  
Synthetic routes include conventional synthesis in solution or solid phase chemistry which allows 
for the synthesis of short peptides (2-30 amino acids). Several reviews covering solid-phase 
peptide synthesis have been published38-40. The easy preparation of short peptides by solid 
phase has provided ample opportunities for peptide design and to study the effect of molecular 
design on their properties. 
There are 20 natural (L-form) amino acids that are used by cells to synthesize peptides and 
proteins. The names, three-letter and one-letter codes, and structures of the 20 α-amino acids 
are given in Table I.2. With the exception of glycine (G), all amino acids are chiral and have the 
same basic structure, a central alpha carbon atom to which a hydrogen atom, an amino group, a 
carboxyl group and side chain R group are attached. The nature of their side chain (charged, 
polar, non-polar, aliphatic, aromatic, Table I.2.) contributes to their biochemical mode of action 
and dictates the conformation assumed by peptides and proteins. The aliphatic residues (A, I, L, 
M, V) provide a hydrophobic environment while amino acids with aromatic (F, W, Y) side chains 
can be engaged in - stacking. Neutral polar residues (N, Q, S, T) can be involved in the 
formation of hydrogen bonding through OH (S, T) or CONH (N, Q) groups. Basic (H, K, R) 
residues can be positively charged and acidic amino acids (D, E) can carry a negative charge. 
The presence of charged groups in these residues can be used to create electrostatic 
interactions that are important to drive (attractive forces) or to prevent (repulsive forces) the self-
assembly process. 
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Table I.2. The twenty gene-coding/natural L amino acids: structure and properties (nature and pKa values for the 
ionizable side chains and their tendency for α-helix-promoting/breaking and β-structure promoting/breaking. Neutral: 
0.8-1.00, no tendency either way)
13
.  
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Table I.2. (cont.) 
 
 
There are other amino acids that contain functional groups with the ability to bind other 
compounds. For example, cysteine (C) can bind to gold surfaces and histidine (H) has high 
affinity for binding Ni2+ ions. Additionally, Cys contains thiol groups (SH) available for the 
formation of intra and inter-molecular disulfide bonds (crosslinking) upon oxidation, while serine 
(S), threonine (T) and tryrosine (Y) provide chemical groups for chemical or enzymatic 
modification (e.g. OH groups in serine can be phosphorylated to yield phosphoserine). The 
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absence of a side chain in glycine (G) allows a higher degree of flexibility compared with other 
residues. On the contrary, proline (P) having its side chain attached to the amino terminus, can 
add structural rigidity due to its locked conformation13.  
Amino acids are therefore simple building blocks that provide relevant non-covalent interactions 
to build complex supramolecular assemblies. Peptides are formed by linking a series of amino 
acids by peptide (amide) bonds. Just using natural amino acids, the number of possible 
combinations that can be obtained for a single peptide or protein is extremely large (20n, where 
n is the number of amino acids in the sequence).  
As self-assembling building blocks, peptides are readily accessible through chemical synthesis; 
the information required for their self-assembly is encoded within their sequence; their self-
assembly is usually spontaneous (simple method to develop nanostructured materials), 
instantaneous (milliseconds) and reproducible (defined stable structures). Furthermore, by 
varying systematically the chemical structure (e.g. sequence size and nature of the amino acid 
side groups) during synthesis it is possible to adjust the self-assembling properties of the 
building blocks as well as to produce a variety of diverse nanostructures (e.g. micelles, fibers, 
vesicles)41. 
4.1. Classes of self-assembling peptides 
α-helix forming peptides  
α-helical coiled coil motifs are highly diverse, in terms of structure and function, and are 
therefore excellent starting units to form fibrous structures42. Most coiled coils are based on 
heptad sequence repeat (abcdefg). The first and fourth positions (a and d) are usually 
hydrophobic residues and the remaining sites largely polar. This configuration results in a rope-
like assembly that measures  1nm per heptad. Replicating the helical structure of collagen is 
very appealing. For example, Chaikof43 and Hartgerink44 have developed a strategy that 
employs electrostatic interaction to guide the self-assembly of hetetrimeric triple helices using 
aminoacid triplets (Pro-Arg-Gly)n, (Glu-Hyp-Gly)n, (Pro-Hyp-Gly)n on their peptide chain design. In 
a recent paper, Hartgerink45 described the synthesis of collagen mimetic peptides (Pro-Lys-
Gly)4(Pro-Hyp-Gly)4(Asp-Hyp-Gly)4 that was shown to replicate the self-assembly of collagen 
(from peptide chain to triple helix formation to nanofiber and finally to a hydrogel). This finding 
demonstrates the utility of electrostatic interactions for stabilizing triple helices.  
 
 
  
24 
β-sheet fibrillizing peptides  
A wide range of natural proteins possess intrinsic propensity to self-assemble into fibrillar 
nanostructures that are rich in β-sheet secondary structure46. The β-strands in the nanofibrils are 
organized perpendicularly to the fibril axis and connected through a dense hydrogen-bonding 
network between amides and carbonyls in the protein backbone47. Most β-sheet forming 
peptides share a common motif of alternating hydrophobic and hydrophilic residues. Another 
example of β-sheet fibrillizing peptide consist of a 11-residues sequence rich in glutamine, 
containing arginine and glutamic acid at positions 3 and 9 (AcQ2RQ5EQ2-CONH2). This peptide 
system is known to form anti-parallel β-sheets that at higher concentrations (0.01 mM) form 
semi-flexible tapes48. 
Knowles et al.49 demonstrated a scalable self-assembly approach for fabricating free-standing 
nanostructured films using from amyloidogenic proteins (polypeptides molecules capable of self-
assembly into β-sheet rich linear aggregates). 
Amphiphilic peptides 
Amphiphilic peptides are beginning to attract great interest in bionanotechnology due their 
versatility and potential to form bioactive nanostructures by self-assembly. Their self-assembly 
properties have been investigated and exploited by several groups and a recent review on the 
topic scrutinized the existence of  100 to 200 papers by May 201150. The laboratory of Stupp 
has given important contributions in understanding the self-assembly of peptide amphiphiles and 
the state-of-the art on self-assembling peptides described here is focused on the molecular 
design of Stupp’s PAs. The first element of design relies on its amphiphilic nature51. The peptide 
segment is covalently bond to a very hydrophobic segment, which can be a simple alkyl tail 
found in ordinary lipid molecules, or more complex aromatic-aliphatic segments, or even a 
steroid structure such as cholesterol. Their surfactant nature orients the more hydrophilic peptide 
segment into the water interface, and the hydrophobic segment to the interior of the 
supramolecular assembly. The peptide sequence can be further subdivided into three regions52. 
The peptide region close to the hydrophobic segment drives β-sheet formation (second element 
of design). There is strong theoretical evidence that β sheet formation between PAs is the 
driving force imposing a cylindrical geometry. This evidence is greatly supported by 
spectroscopic studies, which revealed a β-sheet secondary structure in which hydrogen bonding 
tends to be aligned along the long axis of fibers (with some degree of twisting or disruptions)53. 
The third element of design in PAs is the presence of net charge in the peptide sequence. The 
introduction of charged segments into the self-assembling peptide block not only enhances their 
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solubility in aqueous solutions but also suppress their self-assembly as a result of coulombic 
repulsion. The net charge also endows the PA responsive to pH variations and electrolyte 
addition and drives their self-assembly into cylindrical nanofibers upon neutralization or charge 
screening. As self-assembly proceeds, a network of bundled fibers is formed and gives origin to 
a self-supporting gel matrix. The fourth element of design is the epitope, a bioactive peptide 
sequence that bears a biological signal. This region of the peptide sequence is placed on the 
other extreme of the PA molecule, so it will be facing the water environment upon self-assembly, 
being accessible to be recognized by or to recognize other biomolecules. The nature of the 
cylindrical assembly of the PA system allows the presentation of high density of biological 
signals perpendicular to the long axis of the nanofiber, an external presentation that is favorable 
for cell signaling54. The Stupp lab has designed a variety of PA molecules with high control over 
their supramolecular shape and functionality. The amino acids in the peptide segment and the 
monomers in the alkyl tail can be varied to change the pathway of self-assembly and the 
physical features of the final self-assembled structure. β-sheet forming segment determines the 
geometrical features of PA assemblies, as well as the nanofibres internal order and cohesion. 
Self-complementary peptides 
The group of Zhang at MIT has developed a class of self-assembling peptides termed as self-
complementary ionic peptides inspired by the segment (RERERKRK)2 found in the Z-DNA 
binding protein zuotin55. The 16 amino-acid peptides, termed as RAD16-I (RADA)4), KLD-12 
((LKLD)3), EAK16-II ((AE)2(AK)2(AE)2(AK)2) are composed of alternating hydrophilic and 
hydrophobic amino acids residues, present β-sheet configuration and ability to form hydrogels 
through changes in ionic strength or pH (addition of salts or buffers56). These self-assembling 
peptide hydrogels have been shown to be effective in bone and optical nerve repair, drug 
delivery and as mediators to improve cardiac therapies56. Moreover, they have the ability to be 
functionalized to create cell-instructive scaffolds57. 
β-hairpin peptides 
β-hairpin peptide sequences have been explored58-59 by Schneider and Pochan, due to their 
ability to self-assemble into gels by its intramolecular folding propensity. The design of β-hairpin 
peptides comprises a tetra-peptide turn sequence (-VDPPT-) and two neighboring β strands of 
alternating hydrophobic valine (V) residues and hydrophilic lysine (K) residues (VK)4V
DPPT-
(KV)4-NH2)
59-60. This initial peptide sequence has been referred as MAX1. At acidic pH, the 
lysines are protonated preventing peptide self-assembly. Neutralizing the charge, by addition of 
counterions or increase of pH, results in the formation of self-supporting rigid hydrogels by self-
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assembly. Replacing the lysine residue at position 15 with a negatively charged glutamic acid 
(E) residue (VK)4V
DPPT-K(VE)(VK)2V-NH2), the gelation kinetic of the resultant peptide (MAX8) 
increased significantly in response to identical cell culture conditions61. It has been demonstrated 
that the gel properties (e.g., gelation kinetics, stiffness, network mesh size) of the β-hairpin 
peptides have the ability to be modulated for cell encapsulation61 or controlled release62 
purposes by changing the peptide sequence, concentration, ionic strength and/or temperature63. 
Multidomain peptides 
Hartgerink’s group has proposed a distinct design of peptides termed as multi-domain peptides 
(MDP). The MDP consists of an ABA block motif64-66 in which the B block is composed of 
alternating hydrophilic and hydrophobic amino acids (glutamine or serine and leucine, 
respectively) surrounded by the charged flanking A blocks (e.g. glutamate or lysine). K2(QL)6K2, 
K2(SL)6K2, E(QL)6E, E(SL)6E are examples of MDPs investigated by the Hartgerink group. The A 
block provide water solubility and counteract fiber assembly via electrostatic repulsion. This 
design allows all glutamine or serine side chains to lie on one face of the peptide and leucine 
side chains on the other. In aqueous environment there will be a significant driving force for two 
of these hydrophobic faces to pack against one another forming a hydrophobic sandwich which 
consequently stabilizes the fully extended conformation. An intermolecular β-sheet hydrogen-
bonding network can then be created between two or more pairs of these sandwiches. Different 
variations of these multidomain peptides66-68 have been previously synthesized and 
demonstrated to self-assemble into well-defined nanofibers64 with various bioactive 
epitopes67,69(Table I.3.) and form self-supporting gels when the charge is screened (e.g. in 
presence of multivalent anions such as phosphate)65. 
4.2. Methods and techniques for the characterization of self-assembling peptides 
There are a number of techniques that have been used to characterize the structural properties 
of self-assembling peptides and the formation of supramolecular assemblies. CD, NMR 
spectroscopies can provide information about the self-assembly behavior (folding) of peptides in 
solution while AFM and TEM have been used to provide high-resolution information on the size 
and nanoscale morphology of the nanostructures (Figure I.3.). 
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Figure I.3. Length scales of the forces involved in self-assembly
70
 (first panel) and the hierarchical complex structures 
generated by peptide self-assembly (second panel) Spectroscopy and microscopy techniques used for structural 
characterization of peptide molecules and assemblies from the nanometer to centimeter length scales (third panel). 
NMR: Nuclear magnetic resonance; X‑ray: X‑ray diffraction; CD: Circular dichroism; AFM: Atomic force microscopy; 
TEM: Transmission-electron microscopy; SEM: Scanning-electron microscopy. 
 
Summarizing, the network of nanofibers formed by peptide self-assembly are remarkably 
reminiscent of the filamentous structures found in the extracellular matrix (ECM). Cell-adhesion 
or macromolecular-binding sequences can be incorporated into the peptide structures and are 
natural choices to recreate bioactive artificial ECMs. Peptide nanofibers can display high epitope 
densities that facilitate receptor clustering for signaling and simultaneously maximize successful 
binding. Peptide self-assembly technology can further provide additional routes for the spatial 
and temporal program of selective binding of relevant biological molecules to nanofiber 
networks. For effective display of these signals on the nanoscale it is also necessary a careful 
synthetic design for presenting the peptide signals in a proper supramolecular setting that allows 
better interaction with target cell receptors. 
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5. APPLICATIONS OF SELF-ASSEMBLING PEPTIDE BIOMATERIALS IN 
REGENERATIVE MEDICINE 
The extracellular matrix (ECM) of tissues is a dynamic and hierarchically organized 
nanocomposite that regulates essential cell functions such as adhesion, migration, proliferation 
and differentiation. Engineering complex tissues requires biomaterial scaffolds that recapitulate 
the structure and composition of ECM to provide cells with physical and biochemical signals that 
are important for tissue development and organization (functional tissue). 3D scaffolds, in which 
cells are randomly distributed, offer limited control over spatial cell organization and tissue 
architecture. Microscale control over cell position and ECM composition may enable improved 
regulation of biochemical signaling, interactions between cells and ECM and cell-cell contacts.  
To recreate the structure and function of natural ECMs, and to promote cell-matrix interactions at 
the molecular level, self-assembly allows to create scaffolds based on a network of interwoven 
nanofibers. The nanofibers can have diameters as small as 10 nm (significantly smaller that 
those obtained by electrospinning, a top-down fabrication technique) and be designed with 
bioactivity to provide cells with instructive cues towards tissue formation.  
Materials that provide temporary function, while stimulating and guiding tissue regeneration, 
would be useful throughout medicine. At sufficiently high concentration, the fibrillization of 
peptides is accompanied by gelation. Nanofibers obtained by self-assembly can become 
entangled to form network hydrogels that have a variety of applications including artificial 
matrices for cell culture, controlled drug delivery and tissue engineering. This part of the review 
will focus on the application of self-assembling peptides as biomaterials and highlights the most 
relevant works that the authors considered of particular interest and significance in the field. 
Several excellent reviews are cited that are sources of more detailed descriptions and 
discussions. 
5.1. Peptide hydrogels for 3D cell culture 
Traditional cell culture is performed on 2D plastic surfaces which are far from the complex 3D 
environment where cells naturally reside. 3D environments provide another dimension for 
external mechanical and chemical inputs, which dramatically affects integrin ligation, cell 
contraction and associated intracellular signaling. Furthermore, 3D models might help to isolate 
and investigate specific cell-cell and cell-ECM interactions. Well-defined synthetic 3D systems 
require control not only of cell adhesion sites and matrix viscoelasticity, but of nano and 
microporosity (which regulates cell motility and the transport of soluble molecules), growth-factor 
binding and matrix degradation. Peptide hydrogels offer significant potential to recreate 3D cell 
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culture biomimetic environments because the formation of these self-assembled matrices occurs 
under physiological and cytocompatible conditions enabling the direct encapsulation of cells in a 
3D environment. Zhou and co-workers, developed a peptide-based bioactive hydrogel as 3D 
scaffolds for anchorage-dependent cells71. This hydrogel is formed through self-assembling of 
two aromatic short peptide derivatives: Fmoc-FF (Fluorenylmethoxycarbonyl-diphenylalanine) 
and Fmoc-RGD (arginine-glycine-aspartate) and exhibited a highly hydrated, stiff and 
nanofibrous network comprising bioactive ligands at the fiber surface, mimicking some features 
of the extracellular matrix. Encapsulated dermal fibroblasts were observed to adhere, spread 
and proliferate within this hydrogel, suggesting the use of these self-assembled matrices as 
suitable model scaffolds for 3D cell culture. 
Several works describing the use of self-assembled peptide hydrogels for cell encapsulation and 
3D cell culture (Table I.3.) have been reported in the literature13,72. Some examples will be also 
described in the topic peptide hydrogels as scaffold for tissue engineering. 
5.2. Peptide hydrogels for delivery of bioactive factors 
Peptide-based matrices have also been used for the delivery of therapeutic agents such as 
proteins and small molecules (e.g. drugs). Physical encapsulation/entrapment of proteins (e.g. 
lysozyme, trypsin inhibitor, bovine serum albumin (BSA), and Immunoglobulin (IgG) was 
reported by Koutsopoulos using self-complementary ionic peptide gels (Table I.3.)73. It was 
demonstrated that the protein release through the peptide hydrogels was dependent on the 
protein size and the density of the peptide nanofibers. Similar strategy was applied by Branco 
and co-workers74 for entraping proteins, BSA, IgG, lysozyme, α-lactalbumin, myoglobin and 
lactoferrin within β-hairpin gels. The release rate of the protein was shown to be dependent on 
the charge density of the protein. 
These systems have also been used for the controlled release of small drugs. Herein, the drug is 
encapsulated by physical entrapment within the gel, as reported by Altunbas et al62 in the 
encapsulation of the hydrophobic polyphenol curcumin within β-hairpin gel. The release rate was 
modulated as function of peptide concentration. Webber26 also demonstrated the ability to 
encapsulate chemotherapeutics, such as doxorubicin (cancer drug) in the core of peptide 
amphiphiles nanofibers. The drug was released through the disassembly of peptide nanofibers 
triggered by enzymatic phosphorylation of a serine residue. 
Self-assembling peptides have also been designed to act as reservoir for the local and temporal 
release of growth factors (GFs) through the incorporation of GF binding sequences. Stupp and 
co-workers found peptide sequences by phage display with binding affinity for BMP-2 (e.g. 
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YPVHPST75 and TGF-β1 (e.g. LPLGNSH)76 growth factors with potential use in bone and 
cartilage regeneration, respectively. The use of heparin binding peptide sequences has been 
also applied for the controlled release of angiogenic growth factors for therapeutic applications in 
islet transplantation and cardiovascular disease77. 
5.3. Peptide hydrogels as scaffolds for tissue repair 
Bone 
Despite four decades of research on bone regeneration therapies, the gold standard in bone 
replacement therapy is still the use of autografts (patient’s own bone) or allografts (donor bone). 
However, both approaches present drawbacks such as morbidity and severe pain complications 
at the donor-site of harvesting, risk of septic complications, viral transmission or disease transfer 
and limited bone volume at donor site78. In that respect, there is an enormous need for synthetic 
replacements for bone repair and regeneration. The use of self-assembling peptides for bone 
repair applications has been reviewed56,79. Several studies demonstrated the potential of these 
materials for bone regeneration. For example, 3D self-assembled peptide nanofibers were 
shown to enhance significantly the in vitro proliferation and osteogenic differentiation of 
mesenchymal stem cells when compared with conventional cell culture plate80. Moreover, it was 
found that self-assembling peptide sequences containing the phosphoserine (S(P)) residue and 
the RGD cell adhesion sequence (C16O-C4G3S(P)RGD) have the ability to induce hydroxyapatite 
mineralization in 2D81. Later, this combination of signaling epitopes (5% RGDS and S(P) 95%) 
simultaneously with pre-osteoblastic cells were loaded as a gel into a porous titanium foam in 
order to increase biocompatibility of typical metallic implants82-83. The ability of these amphiphilic 
self-assembled matrices (GS(P)E2L3A3-OC16 and SDGRK2L3A3-OC16) to induce faster bone 
regeneration at tissue interfaces was demonstrated. The same nanofiber matrix was tested in a 
rat femoral critical size defect  and showed significant bone formation84. In another study, 
peptide functionalized with RGDS (CH3(CH2)14CONH–GTAGLIGQ–RGDS) and DGEA 
(CH3(CH2)14CONH–GTAGLIGQ–DGEA) sequences were investigated as an ECM-mimicking 
biomaterial to provide an instructive microenvironment for osteogenic differentiation of human 
mesenchymal stem cells85, showing osteogenic differentiation with and without the addition of 
osteogenic media. Additionally, self-assembled nanostructures consisting of BMP receptor-
binding peptides86-87, as mentioned previously, have been explored due to its osteoinductive 
potential to be applied in bone repair therapies. RAD16 peptide based gels have also been 
demonstrated to be valuable in enhancing of bone regeneration56,88-89. 
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Cartilage 
Cartilage is an avascular tissue with low capacity of self-repair mainly due to the reduced 
availability of chondrocytes and absence of progenitor cells in cartilage tissue, and restricted 
mobility of chondrocytes in the dense ECM. Cartilage lesions, caused by trauma or disease, 
results in the loss of partial or complete tissue functionality. Thus, one of the approaches in 
regenerative medicine for repairing cartilage defects consist on the use of an injectable system 
capable of gelling in situ, to deliver autologous chondrocytes and stimulating cells to produce 
cartilage. Significant advances have been made in developing self-assembling gels for creating 
well-controlled 3D environments for encapsulating chondrocytes to foster the formation of 
cartilage. For instance, a self-assembling KLD-12 peptide hydrogel was used as a 3D scaffold 
for encapsulation of chondrocytes90. This self-assembling matrix was found to support cell 
survival and to retain the chondrocytic phenotype with increased production of 
glycosaminoglycans and type II collagen (components of cartilage ECM). Moreover an increase 
in dynamic stiffness of the matrix material during the culture period was observed. In another 
study, bone marrow stromal cells were encapsulated within a self-assembling peptide hydrogel 
containing two peptide sequences (KLD-12 and RADA16-I) known to enhance chondrogenic 
differentiation 91. Chondrogenesis in these self-assembling peptide matrices was shown to be 
superior when compared with agarose hydrogels, as shown by extracellular matrix production, 
DNA content, and aggrecan molecular structure.  
Also in the context of cartilage repair using self-assembling peptide hydrogels, a peptide 
amphiphile (Table I.3.) was designed to form nanofibers for cartilage regeneration and 
displaying a high density of TGFβ-1 binding sequence. These materials were shown to support 
the survival and promote the chondrogenic differentiation of MSCs76. Moreover, regeneration of 
articular cartilage in a full thickness chondral defect treated with microfracture in a rabbit model, 
with or even without the addition of exogenous growth factor, was also observed.  
Central nervous system 
The central nervous system (CNS) is a dynamic organ which is prone to injury and 
degeneration. Stimulation of the central nervous system to regenerate after trauma (e.g. after 
spinal cord injury, SCI) both structurally and functionally, still remains a significant challenge due 
to the inherent complexity of the adult CNS, as well as the inability of the central neurons to 
regenerate correct axonal and dendritic connections. Strategies for regenerating the adult CNS 
include cellular replacement, neurotrophic factor delivery, axon guidance and removal of growth 
inhibition, manipulation of intracellular signaling, cellular bridging and artificial substrates, and 
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modulation of the immune response92. Artificial substrates may be useful for repair of lesions 
where cellular bridging is necessary. The ideal artificial substrate will have a molecular 
composition that is easily manipulated and immune tolerant, and will contain a porous structure 
for nerve regeneration and cell repopulation that will be easily absorbed by the CNS. Different 
types of self-assembled peptide hydrogels have been investigated for CNS repair. A peptide 
amphiphile containing the IKVAV epitope (Table I.3.) and able to form three-dimensional 
networks of nanofibers by self-assembly, was used to encapsulate neural progenitor cells. The 
IKVAV sequence is derived from the protein laminin responsible for neurite growth54. This 
artificial nanofiber scaffold was shown to induce very rapid differentiation of cells into neurons, 
while discouraging the development of astrocytes comparatively to laminin. These findings had 
led the same authors to use a similar PA molecule containing the IKVAV epitope (C16O-
(SL)2A3EIKVAV) in vivo using a mouse model of SCI
93. The peptide solution was injected at the 
site of injury where gelation took place. It was found that treatment with the PA reduced 
astrogliosis, reduced cell death and increased number of oligodendroglia at the injury site. In 
addition, the IKVAV based peptide gel promoted the regeneration of injured motor and sensory 
axons, while in injured spinal cords treated with peptide gel (without IKVAV sequence) axons 
were unable to traverse the lesion. Later, using two SCI models (compression and contusion) 
and two different species (mice and rats), the injection of IKVAV PA on the animal functional 
recovery was investigated94. This study confirmed the regeneration potential of the IKVAV PA in 
improving behavioral outcome by stimulating axon regeneration through the lesion.  
Peptide hydrogels, formed by self-assembly of ionic self-complementary peptides ((RADA)4 and 
(RARADADA)2) at physiological conditions, were also shown to perform successfully in 
neurorepair strategies95. It was demonstrated the ability of these gels to support neuronal cell 
attachment, differentiation and extensive neurite outgrowth, being permissive substrates for 
functional synapse formation between the attached neurons. The authors postulated that the 
bioactivity of these peptides is due to the similarity of the tripeptide arginine-alanine-aspartate 
(RAD) sequence in the peptide with the RGD motif which is known as a binding site for some 
cell integrins. The ability of these peptide hydrogels for brain repair was also demonstrated using 
a severed optic tract in a hamster model. Injection of peptide solution at the lesion site created a 
permissive environment for regenerated axons to reconnect to target tissues with sufficient 
density to promote functional recovery, as demonstrated by a return of lost vision96. In another 
study, (RADA)4 peptide was used as a scaffold for transplantation of neural progenitor cells and 
Schwann cells into the transected dorsal column of spinal cord of rats to evaluate its potential for 
spinal cord injury repair97. The self-assembled matrix was shown to promote survival, migration 
and differentiation of both cells. In addition, migration of host cells, growth of blood vessels and 
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axons into the scaffolds was also observed. The same hydrogels were also investigated on the 
reconstruction of acutely injured brain. Increased brain tissue restoration was observed in 
groups treated with this hydrogel98.  
Revascularization therapies 
Angiogenesis, the process of new blood vessels formation, assumes great relevance in wound 
healing. Heparin based molecules have shown to play an important role in angiogenesis due to 
their ability to bind, stabilize, and protect proangiogenic proteins such as vascular endothelial 
growth factor (VEGF) and basic fibroblast growth factor (FGF-2). Based on this knowledge, 
heparin was used to trigger the self-assembly of peptide amphiphile molecules99-100 containing 
heparin binding sequences (C16O-A4G3-LRKKLGKA) demonstrating the ability of these systems 
to stimulate new blood vessel formation in vivo. In diabetes type I, loss of vascular networks 
during islet isolation from donor tissue is common. However, implanting heparin-containing 
peptide gels delivering VEGF, FGF-2 in diabetic mouse significantly increased vascular density 
in the transplant site and improved islet engraftment, as evidenced through the higher cure 
percentages and shorter times to achieve normoglycemia101. These heparin binding peptide 
nanofibers with heparin displayed on their surfaces has shown to increase islet survival and 
insulin secretion and if combined with angiogenic growth factors lead to enhanced levels of islet 
endothelial cells sprouting102 that may be valuable in islet transplantation to treat diabetes type I. 
There is a need of cell-based therapies for ischemic tissue repair in cardiovascular diseases, as 
result of limited regeneration of cardiomyocytes103. To overcome this limitation, a biocompatible 
matrix is normally required to support cell functions during the transplantation, once the direct 
cell transplantation (embryonic stem or endothelial progenitor cells) results in low cellular viability 
and minimal retention104. A scaffold constituted of self-assembled peptide nanofibers containing 
fibronectin-derived RGDS cell adhesion epitope was used to encapsulate bone marrow-derived 
stem and progenitor cells in vivo104. Enhanced viability, proliferation and adhesion of 
encapsulated cells suggested the potential of these materials to be applied in cell therapies for 
ischemic diseases. Self-assembled RAD16 based gels have also shown to support the survival 
of encapsulated endothelial and myocardial cells105 and the potential to create a 3D micro-
environment when injected in myocardium by recruiting both endogenous endothelial and 
smooth muscle cells with stimulation of vascularization103.  
Heparin binding peptide nanofiber gels were observed to have binding ability for paracrine 
factors from hypoxic conditioned stem cell media106. When injected in coronary artery ligation, 
the preservation of hemodynamic function in a mouse ischemia (reperfusion model of acute 
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myocardial infarction) was observed and revascularization in chronic rat ischemic hind limb 
models was stimulated. 
Peptide nanostructures containing bioactive signals offer exciting novel therapies with potential 
impact in regenerative medicine. Table I.3. display some examples of self-assembling peptide 
structures containing different biological epitopes for specific applications. 
 
Table I.3. Self-assembling peptide biomaterials presenting different epitopes for a variety of regenerative applications. 
Peptide sequence/design 
Self-assembling block + 
epitope 
Supramolecu
lar material 
Self-
assembling 
mode 
Application Reference 
C16O-A4G3EIKVAV 
Negative PA + Laminin-derived 
cell adhesion sequence 
Gel formed by 
addition of 
culture 
medium 
Selective 
differentiation of 
neural progenitor 
cells. 
54 
C16O-V3A3E3RGDS 
Negative PA + Fibronectin-
derived cell adhesion sequence 
Gel formed by 
the addition of 
Ca2+ ions. 
Cell delivery in cell-
based therapies. 
104 
HSNGLPLGGGSEEEAAAVVV(
K)-CO(CH2)10CH3 
TGFβ1 binding sequence + 
Reverse negative PA  
Gel formed by 
the addition of 
Ca2+ ions. 
Cartilage 
regeneration 
76 
C16O-
V2A2K3GKLTWQELYQLKYKGI
-NH2 
Positive PA + VEGF-mimetic 
peptide 
Non-
assembled 
material  
Ischemic tissue 
repair 
107 
RGDSKKLLA(K)-(COC8H16)-
diacetylene-(C2H25) 
Fibronectin-derived cell 
adhesion sequence + Positive 
diacetylene PA  
Patterned gel 
formed by 
diffusion of 
NH4OH vapor 
and further 
polymerized 
by UV 
radiation. 
Substrate to study 
behavior of human 
mesenchymal stem 
cells 
108 
C16O-GTAGLIGQERGDS 
Negative PA + Enzymatic 
(MMP-2) cleavage sequence+ 
Fibronectin-derived cell 
adhesion sequence 
Gel formed by 
the addition of 
Ca2+ ions. 
Dental tissue 
regeneration 
109 
Ac-K(SL)3SLRG(SL)3KRGDS-
CONH2 
Positive MDP + Enzymatic 
cleavage sequence (MMP-2) + 
Fibronectin-derived cell 
adhesion sequence 
Gel formed by 
the addition of 
phosphate or 
heparin 
Dental pulp tissue 
engineering 
110 
Ac-
GGRDSGGGQQKFQFQFEQQ-
Microgel formed by 
the addition of 
Cell 
encapsulation. 
111 
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CONH2 
Fibronectin-derived cell 
adhesion sequence + β-sheet 
fibrillizing peptide 
Ac-GGIKVAVGGG-(Q11)-
CONH2 
Laminin-derived cell adhesion 
sequence + β-sheet fibrillizing 
peptide 
PBS in a water-in-
oil emulsion. 
Hydrogel formed 
by the addition of 
PBS. 
 
 
Defined 
matrices for 
endothelial 
cells growth. 
Ac-GRGDSPG-G(RADA)4-
CONH2 
Fibronectin-derived cell 
adhesion sequence + Self-
complementary peptide 
Ac-YIGSRGG(RADA)4-
CONH2 
Laminin-derived cell 
adhesion sequence + Self-
complementary peptide 
Gel formed by 
addition of 
hepatocyte 
culture medium.  
Gel formed by 
addition of PBS.  
Peptide 
immobilized on 
syntethic 
membranes for 
hepatocyte 
culture.  
Substrate for 
endothelial cell 
culture 
57,56,112 
 
Fmoc-FF, Fmoc-RGD 
Fmoc-protected dipeptide + 
Fibronectin-derived cell 
adhesion sequence 
Gel formed by pH 
and temperature 
changes 
Cell 
encapsulation/
3D culture  
71 
 
TGFβ1- Transforming growth factor beta 1 (chondrogenesis promoter protein); VEGF- Vascular endothelial growth 
factor (angiogenic signaling protein). 
6. SUMMARY AND OUTLOOK 
The exciting findings on peptide self-assembly suggest that this bottom-up technology can offer 
tools to the three-dimensional assembly of supramolecular objects at scales and with 
geometrical complexity and regularity not accessible to top-down technologies. Despite the level 
of precision, there has been difficult to construct these self-assembling systems across length 
scales. Hierarchical structures are of great advantage for tissue engineering applications as they 
provide a more natural environment for cells to grow and develop into tissues. In addition, the 
mechanical properties of materials intimately reflect the nature of the intermolecular interactions 
that held together their building units into large-scale hierarchical systems. Understanding how 
to control the fabrication and organization of matter across multiple length scales is of growing 
interest to construct complex materials with practical utility namely as complex biomaterials for 
applications in tissue regeneration, drug delivery and cell culture. 
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Chapter II  
MATERIAL AND METHODS  
 
Scientific objectives and experimental approach  
The general aim of the PhD work presented in this dissertation was to investigate alternative 
self-assembled and microfabricated matrices (microcapsules and membranes) to encapsulate 
cells and serve as scaffolds for cell culture intended for applications in the biomedical field. The 
specific aims of this work were: 
(i) develop and characterize materials based on xanthan polysaccharide that can undergo 
gelation (by ionic crosslinking or self- assembly) and evaluate their potential as cell 
encapsulation matrices; 
(ii) develop methods for producing microcapsules based on xanthan derivatives with controlled 
size and shape; 
(iii) demonstrate the ability of xanthan-based microcapsules to support and sustain cell viability 
and function; 
(iv) fabricate self-assembling patterned membranes with characteristics resembling the native 
ECM; 
(v) investigate how microscale features and biochemical signals on self-assembled membranes 
affect the adhesion and morphology of bone marrow stem cells.  
The above mentioned objectives were established based on the following hypotheses: 
(i) Xanthan gum could offer very interesting rheological and functional properties for developing 
encapsulating matrices; this polysaccharide remains largely unexplored as a potential 
biomaterial; 
(ii) Self-assembly can be an advantageous alternative to the conventional crosslinking methods 
used to fabricate capsular structures for cell encapsulation in mild conditions; 
(iii) Biopolymers (xanthan gum and hyaluronan polysaccharides) combined with synthetic self-
assembling peptides can lead to innovative biomaterial systems and provide new applications in 
biomedicine; 
(iv) Self-assembly nanofabrication and its integration into existing microtechnologies can offer 
new possibilities to fabricate highly structured biomaterials with increased level of bioactivity for 
cell culture and growth in biomimetic environments. 
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This chapter aims to provide detailed information concerning the used materials, reagents and 
technologies applied for processing the materials, characterization techniques and the biological 
assays used in this PhD work. Furthermore, it serves as a complement to the information given 
in each of the following experimental chapters. The organization of this chapter can be easily 
understood in Figure II.1.. 
 
 
Figure II.1. Schematic overview showing the materials and integration of technologies to fabricate microcapsules and 
patterned membranes developed in this PhD work. 
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1. MATERIALS 
1.1. General chemicals 
The majority of the chemical reagents, unless otherwise noted, was purchased from Sigma-
Aldrich (USA) and used as provided. Fmoc-protected amino acids and (2’,4’-dimethoxyphenyl-
fmoc-aminomethyl)-phenoxyacetamidonorleucyl-4-methylbenzhydrylamine (MBHA-rink amide) 
resin were purchased from Novabiochem (USA) and O-(benzotriazol-1-yl)-N,N,N’,N’-
tetramethyluronium (HBTU) from Carbosynth (UK). Reagents and solvents for high-performance 
liquid chromatography (HPLC) were of HPLC grade and obtained from Fluka (Steinhein, 
Germany). Similarly, reagents for spectroscopic analysis (e.g. potassium bromide (KBr) for FTIR 
and deuterated solvents for 1H-NMR) were obtained with the adequate requirements for each 
technique. Details are presented for each chemical when used for the first time in this chapter. 
 
1.2. Xanthan gum 
Xanthan gum is an extracellular polysaccharide produced by the bacterium Xanthomonas 
campestris 1-4. The primary structure of xanthan consists of (1→4)-linked glucose units, similar 
to the structure of cellulose backbone, substituted at O-3 of alternate glucose residues, with a 
trisaccharide (Figure II.2.). The trisaccharide consists of one glucuronic acid unit between two 
mannose units. The terminal mannose moiety may carry pyruvate residues linked to the 
positions 4 and 6 with an unknown distribution. D-Mannose unit linked to the main chain 
contains an acetyl group at position O-6 1-5.  
 
Figure II.2. Chemical structure of xanthan gum repeating unit. 
The pyruvic acid content of xanthan can vary substantially depending on the strain of X. 
campestris, resulting in different viscosities of xanthan solutions. Molecular modelling studies 
 52 
suggest that xanthan gum can assume a helical structure, with the side branches positioned 
almost parallel to the helix axis and stabilizing the structure 1-3,5. The presence of acetic and 
pyruvic acids is the mainly responsible for the polyanionic character of this polysaccharide. 
Xanthan forms very viscous solutions, and, at sufficiently high polymer concentration, it exhibits 
weak gel-like properties 1,6. Furthermore, it was shown to be biocompatible 4, biodegradable 
being widely used in food, cosmetics and pharmaceuticals because of its encouraging reports 
on safety 1. The use of xanthan gum as matrix for the encapsulation of mammalian cells has not 
been reported in the literature. Based on its intrinsic properties, simultaneously with the 
opportunity to explore the potential of this biopolymer as cell encapsulation matrix, xanthan gum 
was selected as starting material in this PhD work.  
1.2.1. Characterization of native xanthan (starting material)  
The xanthan gum from Xanthomonas campestris used in this PhD work was obtained from 
Sigma/Aldrich (USA) without chemical characterization concerning its molecular weight, 
monosaccharide, pyruvate and acetate content. Therefore, a significant effort was devoted to 
characterize the starting material before its chemical modification. 
1.2.1.1. Elemental analysis 
The carbon, hydrogen, and nitrogen contents of xanthan were determined by elemental analysis 
using a LECO CHNS-932 (USA) elemental analyser and following the manufacturer’s standard 
procedures. 
 
Table II.1 Elemental composition of native xanthan gum (starting material). The values represent the mean of two 
replicates with standard deviation. 
Sample 
%C %H %N %O
a
 
Native xanthan 35.660 ± 0.099 5.710 ± 0.098 0.560 ± 0.003 58.070 ± 0.194 
a 
by difference 
Oxygen was calculated by difference and cafein (C= 49.48%, H=5.19% N=28.85%) was used as 
standard material. The results are presented on Table II.1. 
1.2.1.2. Determination of sugar composition (monosaccharide content) 
. The monosaccharide content of xanthan can be appreciated in Table II.2. 
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Table II.2 Sugar composition of native xanthan gum (starting material). The values represent the mean of three 
replicates with standard deviation. 
Sample 
Man 
(mol%) 
Glc 
(mol%) 
GlcA 
(mol%) 
Total sugars 
(mg/g) 
 
Native xanthan gum 29.1 ± 0.5 56.7 ± 0.8 14.2 ± 0.8 851.3 ± 15.8 
Neutral sugars were determined as alditol acetates as described by Coimbra et al.7. A pre-
hydrolysis with 72% H2SO4 for 3 h at room temperature was performed in order to solubilise the 
material. Afterwards, the polysaccharide was submitted to a hydrolysis with H2SO4 2 M at 120 ºC 
during 1 h. 2-Deoxyglucose was used as internal standard. Monosaccharides were reduced with 
sodium borohydride and acetylated by acetic anhydride using methylimidazole as catalyst. The 
alditol acetate derivatives formed were analyzed by gas chromatography (GC) equipped with a 
30 m column DB-225 (J&W Scientific, Folsom, CA, USA) with i.d. and film thickness of 0.25 mm 
and 0.15 m, respectively and using a flame ionisation detector. The oven temperature program 
used was: initial temperature 200 ºC, a rise in temperature at a rate of 40 ºC/min until 220 ºC, 
standing for 7 min, followed by a rate of 20 ºC/min until 230 ºC and maintain this temperature 1 
min. The injector and detector temperatures were, respectively, 220 and 230 ºC. The flow rate of 
the carrier gas (H2) was set at 1.7 mL/min. 
Uronic acids were quantified by a modification 7 of the 3-phenylphenol colorimetric method 8. 
Samples were prepared by hydrolysis with 72% H2SO4 for 3 h at room temperature followed by 1 
h in 1 M H2SO4 at 100 ºC. A calibration curve was made with D-galacturonic acid. The hydrolysis 
and analysis of the samples was done in triplicate. 
Methylation analysis. Linkage analysis was carried out by methylation as described by Ciucanu 
and Kerek 9. Xanthan samples (1-2 mg) were dissolved in 1 mL of anhydrous dimethylsulfoxide 
(DMSO), then powdered NaOH (40 mg) was added and allowed to react during 30 min, followed 
by addition of CH3I (80 µL) that was allowed to react during 20 min. The methylated 
polysaccharides were hydrolyzed with 2 M TFA at 121 ºC for 1 h, and then reduced and 
acetylated as previously described for neutral sugar analysis. The partially methylated alditol 
acetates (PMAA) were separated and analyzed by gas chromatography-mass spectrometry 
(GC-MS) on an Agilent Technologies 6890N Network (USA). The GC was equipped with a DB-1 
(J&W Scientific, Folsom, CA, USA) capillary column (30 m length, 0.25 mm of internal diameter 
and 0.15 µm of film thickness). The samples were injected in splitless mode (time of splitless 5 
min), with the injector operating at 220 ºC, and using the following temperature program: 45 ºC 
for 5 min with a linear increase of 10 ºC/min up 140 ºC, and standing for 5 min at this 
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temperature, followed by linear increase of 0.5 ºC/min up to 170 ºC, and standing for 1 min at 
this temperature, followed by linear increase of 15 ºC/min up to 280 ºC, with further 5 min at 280 
ºC. The helium carrier gas had a flow rate of 1.7 mL/min and a column head pressure of 2.8 psi. 
The GC was connected to an Agilent 5973 mass quadrupole selective detector operating with an 
electron impact mode at 70 eV and scanning the range m/z 40–500 in a 1 s cycle in a full scan 
mode acquisition. 
1.2.1.3. Determination of acetate and pyruvate degree of substitution of native xanthan  
The acetate and pyruvate content (Table II.3) was determined by 1H NMR spectroscopy in a 
Varian Unity Plus 300 MHz spectrometer (USA) by reference to an external standard (sodium 
acetate) as described by Hamcerencu 4. Xanthan was dissolved in D2O (3 g/L) in presence of Na 
acetate (3x10-3 M). 1H NMR spectra were recorded at 75 °C. Three peaks were considered: two 
peaks at  = 1.47 and  = 2.16 ppm attributed to pyruvate and acetate groups bound to the 
xanthan and one at  = 1.90 ppm.  
 
Figure II.3. Integrals of 
1
H signals of acetate and pyruvate groups of xanthan (3 g/L) and of external standard (sodium 
acetate) for calculation of acetate and pyruvate degree of substitution. 
From the integrals of 1H signals corresponding to both substituents by reference to external 
standard protons one can calculate the number of the substituents (NA, NP)/gram of 
polysaccharide and, finally the number of acetate and pyruvate groups (nA, nP)/side chain of 
xanthan: 
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             APAA NNNn 42921829          APPP NNNn 42921829           (II.2) 
hA, hP, hE - integrals of 
1H signals corresponding to acetate (hA) and pyruvate (hP) group, and to 
external reference (hE), respectively; cE, cP - concentration of Na acetate (cE, mole/L) and 
polysaccharide (cP, g/L); 829 - molar weight of repeating unit of xanthan without acetate or 
pyruvate; 42 - molar weight of acetate group; 92 - molar weight of pyruvate group. 
 
Table II.3. Acetate and pyruvate degree of native xanthan gum (starting material) per side chain. The values 
represent the mean of three replicates with standard deviation. 
Sample 
Acetate Degree (%) Pyruvate Degree (%) 
Native xanthan 44.4 ± 5.1 35.2 ± 2.6 
 
1.2.1.4. Determination of molecular weight of native xanthan 
The molecular weight (Mw) of xanthan gum used in this work was determined by size-exclusion 
chromatography (SEC). The samples were dissolved in an aqueous 0.1 M NaNO3 solution 
(0.4% w/v). A PL-GPC 110 chromatograph was equipped with a pre-column PLaquagel-OH 15 
μm and two SEC columns in series (PLaquagel-OH40 15 μm, 300 × 7.0 mm and PLaquagel-
OH60 15 μm, 300 × 7.0 mm). The pre-column, the SEC columns, the injection system, and the 
refractive index detector were maintained at 36 ºC. The eluent (aqueous 0.1 M NaNO3 solution) 
was pumped at a flow rate of 0.9 mL min-1. The analytical columns were calibrated with pullulan 
standards (Polymer Laboratories, UK) in the range of 5.8-1600 kDa. The average molecular 
weight of xanthan gum was estimated as 152 kDa (Table II.4). 
 
Table II.4. Molecular weight of native xanthan gum (starting material). 
Sample Mw (KDa) Mn (KDa) Mw/Mn 
Native xanthan gum 152 174 0.87 
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1.2.2. Chemical modifications of xanthan gum 
Xanthan is able to form self-supporting gels in the presence of ions, although they are not stable 
in the long term when placed in aqueous solutions. Within the scope of this PhD work, we have 
performed chemical modifications of xanthan to evaluate its potential to be used as cell 
encapsulation matrix. 
1.2.2.1. Carboxymethylation 
The first attempt to enhance the stability of xanthan hydrogels was to perform the 
carboxymethylation of xanthan to increase the amount of carboxylic groups (chapter III). 
Carboxymethyl xanthan (CMX) was prepared by adapting the carboxmethylation procedure used 
for chitosan described by Chen and Park 10. 10 g of xanthan from Xanthomonas campestris and 
13.5 g sodium hydroxide (Panreac, Spain) were mixed in 100 mL of solvent mixture of 
water/isopropanol (Fluka, Germany) using a top stirrer. The mixture was allowed to react at 50 
ºC in a water bath (Thermostat IKA, Germany) for 1 h. Two solvent mixtures were used (1/1 and 
1/4, v/v) to yield xanthan with different degrees of carboxymethylation designated by CMX1 and 
CMX2 respectively. Then, 15 g monochloroacetic acid, dissolved in 20 mL of isopropanol, were 
added dropwise to the reaction mixture for 30 min. The reaction was carried out for 4 h at the 
same temperature and stopped by adding 200 ml of ethanol 70% (Panreac, Spain). At the end, 
the obtained solid precipitate was filtered and rinsed with 70–90% of ethanol to desalt and 
dewater and further vacuum dried at room temperature. 
1.2.2.2. Palmitoylation 
Hydrophobized polysaccharides have been extensively studied in biomedical field due to their 
capability to spontaneously self-assemble in water into stable and functional structures. The 
possibility to generate and use this type of structures in cell friendly conditions, avoiding the use 
of potential harmful crosslinkers, together with the potential of xanthan to be used as cell 
encapsulating matrix, has motivated its hydrophobization with aliphatic palmitoyl on chapter IV. 
Xanthan was dissolved in distilled water (1 wt%) at room temperature in a round-bottom glass 
flask. The polymer solution was placed in an ice-water bath and vigorously stirred using a 
mechanical stirrer (IKA, Germany). Palmitoyl chloride was then added dropwise at different 
ratios, as shown in Table II.5. The reaction mixture was allowed to stand at room temperature 
under continuous stirring for 23 h. The reaction was stopped by the addition of excess of cold 
ethanol and filtered. The final product was dried at room temperature until constant mass. 
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Table II.5. Sample designation for each palmitoyl xanthan (PX) conjugate. 
Sample designation Xanthan (mmol) 
Palmitoyl chloride 
(mmol) 
Xanthan/Palmitoyl 
chloride ratio (w/w) 
PX(X=0.50P) 0.58 1.18 0.50 
PX(X=0.75P) 0.58 0.78 0.75 
PX(X=1.40P) 0.58 0.42 1.40 
PX(X=1.70P) 0.58 0.35 1.70 
1.2.2.3. Phospholipid conjugation 
Previously, the conjugation of simple hydrophobic alkyl chains to xanthan demonstrated to be 
quite effective on its amphiphilic self-assembly process and cell encapsulation. Based on these 
findings and following a more biomimetic approach, xanthan was conjugated/hydrophobized with 
a phospholipid (2-sn-glycero-phosphoetilamine, DOPE) by standard bioconjugation reaction with 
carbodiimides (chapter V). 
Xanthan, with an average molecular weight of 152 kDa11, was dissolved in 2-(N-
morpholino)ethanesulfonic acid buffer solution (MES, Sigma), at 55 mM at room temperature. 
The xanthan solution was placed in an ice water bath, under inert atmosphere, and the pH was 
adjusted to 5.5. The N-hydroxysuccinimide (NHS) (with the same molarity of xanthan) was 
added under stirring, previously the addition of ethyl(dimethylaminopropyl)carbodiimide (EDC) at 
molar concentration of [NHS]/0.6. The pH was maintained at 5.5 and later DOPE was added at 
the same molarity of xanthan12. The reaction took place overnight (15 h) and was stopped by the 
addition of excess of cold ethanol. The precipitate was filtered and dried at room temperature 
until constant mass. 
1.3. Alginate 
Alginate, also known as alginic acid (if uronic acid groups are in –COOH) is an anionic 
polysaccharide that constitutes the cell wall of brown seaweeds. Alginates are linear unbranched 
copolymers containing β (14) linked ᴅ-mannuronic acid (M) and α (14) linked L-guluronic 
acid (G) residues 13. These monomers are arranged in alginate molecules in regions made up 
exclusively of one unit or the other, or as regions in which monomers alternate in sequence. 
Alginate is well known for its ability to form stable gels with divalent cations such as Ca2+. 
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Moreover, it has been widely studied for cell encapsulation purposes 14-15 and for this reason 
was selected for comparison purposes (control material) in chapter III. 
The alginic acid used in the referred chapter is a sodium salt from brown algae and obtained 
from Fluka (Norway) with average Mw 100 kDa. 
1.4. Poly-L-Lysine (PLL) 
PLL is a polypeptide constituted of 25-30 L-lysine residues. Due to its polycationic character it 
has been widely used in cell microencapsulation to increase the strength of microcapsules and 
to control the membrane molecular weight cut-off16.  
In the present work, poly-L-lysine hydrobromide obtained from Sigma/Aldrich (USA) with Mw of 
30-70 kDa was used to increase the strength of CMX, PX and xanthan-DOPE microcapsules 
(chapters III, IV and V). 
1.5. Hyaluronan (HA) 
Hyaluronan, also known as hyaluronic acid or hyaluronate, is one of a group of polysaccharides 
typically found in the connective tissues of vertebrates, known as glycosaminoglycans. It is an 
extremely large polymer made up of disaccharide repeating unit of N-acetylglucosamine and 
glucuronic acid linked together via alternating β-1,4 and β-1,3 glycosidic bonds (Figure II.5). 
 
Figure II.5. Chemical structure of hyaluronan repeating unit. 
HA exhibits a remarkable combination of properties, like polyanionic character, linear 
unbranched random-coil structure and large size, making HA solutions extremely elastoviscous. 
Moreover, the HA repeating unit disaccharide is identical in all species and all tissues and is 
therefore never itself recognized as immunologically foreign. Another important factor underlying 
the medical utility of HA derives from the magnitude and pathways available for systemic HA 
metabolism. In the normal body, the disposal of HA is almost entirely effected by the complete 
catabolism rather than excretion. HA is present in the extracellular matrix, on the cell surface, 
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and inside the cell and is therefore associated with numerous cellular processes such as 
signaling (cell adhesion and migration), inflammation and wound healing 17.  
Based on the described characteristics and demonstrated biological properties of HA, this 
biopolymer (with an average molar mass of 2.0 MDa, Lifecore Biomedical, Inc, USA) was 
selected to fabricate bioactive self-assembled membranes (chapter VII). 
1.5.1. HA fluorescent labelling 
HA was labeled with 5-(Aminoacetamido) Fluorescein (Invitrogen, USA) using EDC chemistry as 
described elsewhere 18. HA (50 mg) was dissolved in 20 mL of water to give 0.25% (w/v) 
solution. Then, a solution of 5 mg of dye in 20 mL of DMF was added. Next, 100 mg of NHS was 
added, and the solution pH was adjusted to 4.75 by adding 0.01 M HCl. Finally, 50 mg of EDC 
was added, and the solution pH was maintained at 4.75 by adding 0.01 M HCl. After 14 h, the 
solution was transferred to dialysis tubing and dialyzed exhaustively against 100 mM NaCl, 
followed by dialysis against distilled water. The solution was then lyophilized to give the 
fluorescent HA-dye. 
1.6. Multidomain peptides 
The multidomain K2(QL)6K2 peptide (Figure II.6.A) consists of an ABA block motif 
19 comprising a 
central block of glutamine-leucine (QL) repeats and two flanking positively charged lysines (K). 
 
Figure II.6. Chemical structure of the self-assembling peptides used in this PhD work: K2(QL)6K2 multidomain peptide 
without (A) and containing the cell adhesive RGDS sequence (B). 
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Different variations of these multidomain peptides 20-21 have been previously synthesized and 
demonstrated to self-assemble into well-defined nanofibers 19 with various bioactive epitopes 21-
22. 
1.6.1. Peptide synthesis 
Peptides can be synthesized by conventional synthesis in solution or by solid phase (SP) 
chemistry 23. This later method is based on the attachment of N-α-protected amino acid to an 
insoluble support (usually a resin). Subsequently, the N-α-blocking group is removed 
(deprotected) and the next amino acid coupled through a peptide bond. The 
deprotection/coupling cycle is repeated until the desired sequence of amino acids is generated.  
 
Figure II.7. Diagram of solid-phase synthesis of peptide molecules. 
At the end, the peptide is cleaved from the resin to obtain the peptide as a free acid or amide, 
depending on the chemical nature of the resin (Figure II.7.). Solid phase peptide synthesis is 
advantageous comparatively to solution-phase methods, once it allows an easier separation of 
intermediates, reagents and by-products, being therefore less laborious. 
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Solid phase peptide synthesis was used to synthesize the following peptides: K2(QL)6K2 (Figure 
II.6.A) and K2(QL)6K2RGDS (Figure II.6.B) described on chapters VI (for microcapsule formation 
with xanthan) and VII (for membrane fabrication with hyaluronic acid). The peptides were 
synthesized using standard 9-fluorenylmethoxycarbonyl (Fmoc) chemistry on an automated 
peptide synthesizer (CS Bio, USA) at 1 mmol scale on a 4-methylbenzhydrylamine (MBHA) rink 
amide resin. Once synthesized, cleavage of the peptide from the resin and deprotection of the 
protecting groups was carried out with a mixture of trifluoroacetic acid (TFA)/ triisopropylsilane 
(TIS)/ water (95/2.5/2.5) for 3 h at room temperature. After filtration of the cleavage mixture, 
excess TFA was removed by rotary evaporation. The resulting viscous peptide solution was 
triturated with cold diethylether. The white precipitate was collected by filtration, washed with 
cold ether, and allowed to dry under vacuum overnight. The solid powder was stored at -20 ºC 
for further characterization and purification. 
1.6.2. Peptide characterization 
1.6.2.1. Electron-spray ionization mass spectrometry (ESI-MS) 
Mass spectrometry is an analytical technique that measures the mass/charge ratio (m/z) of ions 
and has been used to determine the exact mass of molecules and to study their structure24. It 
has been widely used in the characterization of peptides and proteins because of its accuracy 
and the relatively small amount of material required (fmols). The ESI-MS principle consists of 
ionizing chemical compounds to generate charged molecules or molecule fragments and 
measuring their mass/charge ratios. The mass of the synthesized peptides described on 
chapters VI and VII was determined by ESI-MS to verify their identity. Samples were dissolved in 
water/acetonitrile (0.1% TFA) and analyzed in HPLC-MS (Finnigan LXQ, USA). 
1.6.2.2. High-pressure liquid chromatography (HPLC). 
HPLC is a chromatographic technique with abiity to identify, quantify and purify the individual 
compounds of a mixture. The sample, which may have affinity for the liquid mobile phase or to 
the solid stationary phase, is injected and pumped to flow through a chromatographic column 
(that contains the stationary phase) under a high pressure, where the separation of the mixture 
compounds take place. Further, the separated analyte passes through an appropriate detector 
sensitive to the desired compound that provides a chromatogram where the characteristic 
retention time and the amount of the analyte can be appreciated. This technique is being widely 
used in the characterization of peptides and proteins due to excellent resolution for a wide range 
of chromatographic conditions for very closely related molecules as well as structurally quite 
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distinct molecules; facility to manipulate chromatographic selectivity through changes in mobile 
phase characteristics and the excellent reproducibility of repetitive separations 25. 
Reverse phase (RP) HPLC was used in this PhD work to analyze the purity of the synthesized 
peptide molecules. HPLC was performed in a Smart Line analytical system from Knauer 
(Germany) using a water/acetonitrile gradient with 0.1% TFA (added to the mobile phase to 
improve solubility and peak resolution) at 1 mL/min. The peptides were run on a difunctionally 
bonded silica-based C18 column (Atlantis® T3, 4.6 x 150 mm, 5 μm, Waters, USA) and their 
detection made in an UV detector (Knauer, Germany) by absorbance at 220 nm. 
Figure II.8. displays the MS spectra and HPLC traces of the synthesized peptides (crude 
samples). MS analysis confirmed their successful synthesis and the HPLC showed a main peak, 
corresponding to the peptide, as well as other minor peaks related with impurities present in the 
crude sample, indicating the need of further purification by HPLC methods. 
1.6.3. Peptide purification 
The peptides were then purified on a 2545 Binary Gradient (Waters, USA) HPLC system using a 
preparative reverse-phase C18 column (Atlantis Prep OBD T3 Column, 30 x 150 mm, 5 µm, 
Waters, USA) and a water/acetonitrile (containing 0.1% TFA) gradient at flow rate of 20 mL/min. 
The UV absorption was monitored at 220 nm in a Waters 2489 UV/visible detector. 
 
 
 
 
 
 
 
 
FigureII.8. MS (A, B) and HPLC (C and D) characterization of  K2(QL)6K2 and K2(QL)6K2RGDS peptides after 
purification. K2(QL)6K2 expected mass: 1977.44; [M+2H]
2+
: calculated 989.72, observed 990; [M+3H]
3+
: calculated 
660.15, observed 660.3. K2(QL)6K2RGDS expected mass: 2392,43; [M+2H]
2+
: calculated 1197.22, observed 1197.45; 
[M+3H]
3+
: calculated 798.48, observed 798.60. 
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The purified fraction(s) were verified using mass spectrometry and concentrated via rotary 
evaporation to remove the acetonitrile and lyophilized. TFA counter-ions were exchanged by 
sublimation from hydrochloric acid (0.1 M). Finally, the peptides were dialyzed against deionized 
water using dialysis tubing (500 MWCO, Spectrum Europe B.V., The Netherlands) to remove 
salts, lyophilized, to obtain a fluffy powder, and stored in closed containers at -20 ºC until use. 
The purity and accurate mass of each peptide were verified using liquid chromatography/MS 
and the chromatogram and mass spectra are given in Figure II.8. 
 
2. DEVELOPMENT AND APPLICATION OF MICROFABRICATION TECNHIQUES 
Microfabrication techniques have been used to produce devices with dimensions in the 
micrometer to millimeter range. Key advantages of these techniques include small device size 
and sampling volume, and reproducibility. Therefore, one of the goals of this PhD research, was 
to use microtechnologies to guide the self-assembly across the scales to control the shape and 
structure of the final assemblies. Three distinct microfabrication techniques were developed and 
applied. A microdroplet generator and a microfluidic device were developed for cell 
encapsulation. The fabrication of micropatterned membranes was achieved through soft 
lithography processes. 
2.1. Microdroplet generator 
 
Figure II.9. Schematic representation of the microdroplet generator. 
 64 
 
The microdroplet generator (Figure II.9.) is a simple device that was developed to generate 
spherical capsules at micrometer scale for cell encapsulation purposes26. This device was 
applied to fabricate microcapsules and encapsulate cells within carboxymethylated and palmitoyl 
xanthan, as described in chapters III and IV, respectively. 
2.1.1. Microdroplet generator fabrication 
This cell encapsulation device is based on micro-droplet generation inside of an autoclavable 
silicone tubing (Novosil, Fisher Scientific, USA) with 1 mm internal diameter, which is punctured 
with a blunt-ended syringe needle vertically and sealed with a silicone glue (Figure II.9). The 
injection of polymer solution is made through a syringe pump (Alladdin WPI, England) into a 
stream of mineral oil and results in the formation of a water-in-oil emulsion, because of 
immiscibility of two phases, and the generation of spherical droplets. The tubing system is also 
connected with a peristaltic pump (Ismatec, Switzerland) that pumps the mineral oil (Aldrich, 
Germany) from an oil reservoir to the other end of the tubing: a glass collector where the 
polymer droplets are cured in a gel inducer. A magnetic top stirring apparatus, made up of 
Teflon® with a magnet, was placed on the top of collector in order to stir solution without 
introducing a mechanical stress on the formed microcapsules. Providing a steady injection and 
flow rate of polymer solution and oil, respectively, the micro-droplets are produced in a narrow 
size distribution. The whole system is autoclavable and can be used many times after proper 
cleaning of setup 26. 
2.1.2. Microcapsule preparation 
Xanthan derivatives were first dissolved in the proper buffer solution at concentrations previously 
optimized (CMX powder was dissolved in DMEM at 5 wt% concentration and palmitoyl xanthan 
was dissolved in HEPES buffer solution (55 mM, pH 7.4, Sigma) supplemented with 0.1 M CaCl2 
at concentration of 1 wt %). Both solutions (CMX and PX) were injected in the microdroplet 
generator. The applied operation rate of peristaltic and syringe pumps were set at 0.35 
mL/minute and 20 µL/min, respectively. 
The CMX micro beads generated were collected into a solution containing 1.5% CaCl2 (Merck 
Chemical Co., Germany) and 0.9% NaCl (Carlo Erba, Italy), while PX microbeads were collected 
in PBS (Sigma, USA), where the self-assembly into hollow micro-capsules took place. In both 
situations, 10 µL of Tween 80 was added to the collection solution as emulsifying agent. The 
CMX and PX capsules were gently stirred for 15 min and then washed with PBS in order to 
remove traces of mineral oil. Afterwards, the collected microcapsules were transferred into a 
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poly-L-lysine solution (0.1 wt%) for 10 min in order to strengthen the outer surface of the 
microcapsules  
Similarly, alginate was used to produce microcapsules to serve as controls (chapter III). The 
alginate microcapsules were successively coated with the poly-L-lysine (0.05 wt%) for 5 min.  
2.2. Microfluidics technology 
Microfluidic devices have been recognized as a potential tool for the fabrication of micro-
engineered hydrogels 27-28. This fabrication process allows the generation of hydrogels with 
controlled size and shape by changing viscosity of polymer solution, flow rate and dimensions of 
micro channels. Small amounts of fluids can be manipulated using channels with dimensions of 
tens to hundred of micrometers. Moreover, it allows the manipulation of multiphase flows 
operating under laminar flow (without turbulence) enabling the generation of homogeneous 
structures using self-assembling materials for encapsulation of delicate biological agents and 
cells 27-29. Moreover, it can provide a miniature and sterile platform without the need of a clean 
room making this fabrication process suited for cell encapsulation. Aiming to obtain 
microcapsules with lower size than those previously fabricated and considering the advantages 
versus suitability of microfluidics to be used with self-assembling materials30-31, this technology 
was applied to fabricate microcapsules and encapsulate cells with xanthan-DOPE (chapter V) 
and xanthan-peptide (chapter VI).  
2.2.1. Microfluidics device fabrication 
The device design was made by CAD software and printed onto a transparency sheet by using a 
desk top laser printer. This pattern subsequently served as a mask for copper etching. The laser 
toner has been successfully exploited previously for applications as an etch mask for metal 
plates intended for microfluidics application 32. A copper plate (1.5x1.5 cm, 0.675 mm thick, 
0.99% annealed, Alfa Aesar, USA) was used as a substrate for developing microfluidic 
channels. The melted toner adheres to the copper and is insoluble in ferric chloride solution, 
allowing it to serve as an etch mask for microchannel fabrication. Initially, the copper plate 
surface was cleaned by rubbing thoroughly with a fine steel wool. The plate was then sonicated 
5 min in a solution of acetone-water (50%). The cleaned plate was transferred onto a hot plate at 
200 oC and incubated for 2 min. The heated plate was then transferred immediately to printed-
face of transparency and a metal block weighing approximately 10 kg was placed onto copper 
plate to facilitate toner transfer. After 2 min, the copper plate and transparency was placed to a 
freezer (-20 oC) and incubated for 5 min. After cooling, the transparency was carefully peeled off 
from copper plate. The back and front surface of plate, where there is no toner, was covered 
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with plastic duct tape to protect unmasked region from etching process. The plate was etched in 
FeCl3 solution (35%, 50 mL) in a glass beaker for 30 min at room temperature by manual 
shaking of the solution. The etching was stopped by removing the plate and washing it under 
running water. After removing duct tapes from the etched plate, the plate was placed into 
acetone-water solution (50%) and sonicated for 10 min to remove toner from the surface. 
Beside, a poly(dimethyl siloxane) (PDMS) seal was prepared at 1/10 crosslinker/monomer ratio 
(w/w) (SYLGARD® 184 silicone elastomer kit, Dow Corning, USA) and curing the mixture for 2 
days at 37 oC in a rectangular mould. The seal was perforated at inlets and outlets of vertical 
and horizontal channels reserved for polymer-cell and oil flow, respectively (Figure II.11.A). A 
piece of poly(tetrafluoro ethylene) (TEFLON) block was also machined for securing and precise 
positioning of the perforated silicone seal and allowing the transfer of fluids by providing 4 
adapters at the backside for connecting silicone tubing from peristaltic and syringe pump (Figure 
II.10.). 
 
Figure II.10. Schematic representation of the microfluidics set-up for cell encapsulation (A) showing details of the 
microfluidics apparatus. View of dissembled microfluidics device which consists of a metal chip, silicone seal and 
TEFLON case (B). 
2.2.2. Microcapsule preparation 
The production of the xanthan-phospholipid (chapter V) and xanthan-peptide (chapter VI) 
microcapsules was done in the developed microfluidics.  
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Xanthan-DOPE (phospholipid) was dissolved in HEPES buffer solution (55 mM, pH 7.4) 
supplemented with 0. 1 M CaCl2 at concentration of 1 wt% and native xanthan (1 wt%) was 
dissolved in PBS. The xanthan solutions were injected into the microfluidics device using a 
syringe pump. The polymer microdroplets were generated inside the microfluidics device by 
shear stress when entered into a stream of mineral oil. The formed homogenous microdroplets 
were collected in a collector vessel containing PBS (for xanthan-phospholipid microcapsules) 
and K2(QL)6K2 solution (for xanthan-peptide microcapsules) at different concentration (0.1, 0.25 
and 0.5 wt%). About 10 µL of Tween 80 was added as emulsifying agent. The self-assembly of 
xanthan-DOPE and xanthan-peptide into microcapsules took place in the collector vessel by 
gently stirring the polymer droplets for 15 minutes on a magnetic stirrer. To investigate the 
stability of the xanthan-DOPE microcapsules, they were also coated with poly-L-lysine solution 
(0.1 wt%) for 10 minutes for comparison purposes. 
2.3. Soft photolitography 
Despite the broad range of strategies to pattern polymers, photolithography has been the most 
widely used. It is a cost-effective high-throughput technique that is suitable for large-area 
surface patterning with good alignment, allowing high-resolution patterning, controlled 
topography with broad range of features 33-34. At biological level, photolithographically generated 
polymer patterns have been demonstrated the ability to manipulate and control the localization 
of cells and the interactions of cell–cell and cell–substrate 33,35-38. 
The integration of soft litograhy (top-down) with self-assembly (bottom-up) can offer new 
possibilities to fabricate miniaturized biomaterials, with high levels of precision and 
reproducibility, exhibiting increased bioactivity and hierarchical structure across the scales. 
Soft photolithography was applied to create micropatterns on self-assembling membranes 
(chapter VII). 
2.3.1. Fabrication of topographic PDMS molds  
Molds comprising several microtopographical patterns were fabricated using a soft lithography 
process. The patterns were generated in SU8-10 photoresist (Microchem Corporation, USA) 
using conventional contact mode UV photolithography (Mask Aligner MJB4, SUSS Microtec, 
Germany) with a rigid chrome mask as follows. SU8-10 photoresist was spin coated onto a 
(111)-oriented silicon wafer (Siltronix) at 500 rpm for 5 s followed by 4000 rpm for 30 s, 
achieving a layer approximately 8 µm thick. The sample was baked at 65 ºC for 2 min and 95 ºC 
for 5 min prior to UV exposure (3.3 s at 30 mW.cm-2 ) and baked post-exposure at 65 ºC for 1 
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min followed by 95 ºC for 5 min. The topographical patterns were then developed with SU8 
developer (Microchem, USA). The resulting samples were silanized with trichloro(1H,1H,2H,2H-
perfluorooctyl)silane (Sigma-Aldrich, USA) before being used as molds for the production of 
patterned PDMS substrates (Figure II.11.). The patterns were comprised of different geometries, 
channels (10 µm wide, 10 µm in separation, and 8 µm in height), posts (10 µm wide, 10 µm in 
separation, and 8 µm in height), and holes (10 µm wide, 10 µm in separation, and 8 µm deep), 
and posts and holes (20 µm wide, 20 µm in separation, and 8 µm in height). 
2.3.2. Membrane fabrication 
2.3.2.1. Smooth membranes 
Smooth membranes were fabricated by casting hyaluronic acid solution (2 MDa, 1 wt% in water) 
on a polydimethylsiloxane (PDMS, Sylgard 184, Dow Corning, USA) substrate. The PDMS 
substrate was prepared by mixing the prepolymer and crosslinker at a 10:1 ratio, degassing for 
10 min under vacuum and curing for 2 h at 65 ºC. The PDMS was oxygen plasma treated in a 
plasma cleaner (PDC-002, Harrick Cientific Corporation, USA), in order to increase the 
wettability of the surface. The K2(QL)6K2 peptide (1 wt% in water) was next added on top of the 
HA, generating a membrane upon contact between the solutions. The membrane was allowed to 
age for either 4 or 24 h at 4, 21 and 50 ºC. The membranes were also prepared inverting the 
positions of the HA and peptide: peptide solution was cast onto the PDMS substrate with the HA 
added on top. The effects of time and temperature on the membranes were also analyzed. 
Membranes containing different amounts of the RGDS motif were prepared by mixing the 
K2(QL)6K2 and K2(QL)6K2RGDS peptides in different ratios (1:10 and 3:10) prior to the co-
assembly with HA. 
To get better insight into the self-assembly process, namely on the mixture of the components 
during membrane formation, fluorescently labeled HA (prepared as described in 1.5.1.) was 
used to prepare the self-assembled membranes. The membranes were prepared as described 
before, with variations in time, temperature and positioning of peptide and fluorescent HA. 
2.3.2.2. Topographically patterned membranes 
Topographically patterned membranes were fabricated by casting the peptide solution onto the 
hydrophilic PDMS molds followed by the addition of the HA on the top of peptide solution (Figure 
II.11.). The membranes were aged for 24 h at room temperature. The self-assembled 
membranes were removed from the patterned PDMS molds by immersion in ethanol (70%) and 
then characterized.  
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Figure II.11. Schematic representation of overall process to fabricate patterned membranes by soft photolithography. 
 
3. METHODS AND TECHNIQUES FOR CHARACTERIZATION OF DEVELOPED MATERIALS 
AND MATRICES 
3.1. Physico-chemical characterization of developed materials 
3.1.1. Solubility analysis 
Solubility is related with ability of a substance to dissolve and depends on the solvent as well as 
on the temperature and pressure. The solubility of each palmitoyl xanthan conjugate described 
on chapter IV was tested in water, ethanol, dimethyl sulfoxide, acetone, dichloromethane, 
tetrahydrofuran, by placing 10 mg of palmitoyl xanthan in 4 mL of each solvent. The suspension 
solution was mixed by vortex and placed in a water bath at 37 ºC overnight. Solubility was 
examined visually for any undissolved solute particles 39.  
3.1.2. Determination of the degree of substitution (DS) 
The DS for xanthan derivatives can be defined as moles of substituent introduced per structural 
unit of the xanthan polymer being relevant on the chemical characterization of the 
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synthesized/modified xanthan based polymers. We have used two methods to determine the DS 
of xanthan derivatives. 
3.1.2.1. Acid-base titration 
The degree of substitution of CMX and xanthan-DOPE (Chapter III and V, respectively) was 
determined by acid-base titration. The polymers were dissolved in distilled water and the pH of 
the solutions adjusted to 2 with hydrochloric acid 0.2 M. The solutions of xanthan derivatives 
were titrated with NaOH and the volume of NaOH, as well as the pH values, were recorded. 
Three replicates were performed for each sample and DS was calculated following the 
procedure adapted from 40 as follows: 
)(
)(
epms
epXru
nMm
nM
DS


       (II.3.) 
MXru is the molecular weight of xanthan repeating unity (851); nep is the number of moles of 
substituent introduced in the native structure of xanthan at the ending point of the titration; Mms is 
the molecular weight of substituent inserted in the native structure of xanthan gum. 
3.1.2.2. Elemental analysis.  
The DS (fraction of hydroxyl groups modified per average of repeating unit of palmitoyl xanthan 
(X=1.7P) (chapter IV) was calculated on basis of %C from elemental analysis results. The 
elemental composition of palmitoyl xanthan was determined as described on 1.2.1. of this 
chapter for native xanthan. The results of elemental analysis are presented on Table II.6. 
 
Table II.6 Elemental composition of palmitoyl xanthan (PX(X=1.7P)). The values represent the mean of two replicates 
with standard deviation. 
Sample %C %H %N %O
a
 
Palmitoyl xanthan 37.935 ± 0.148 5.895 ± 0.134 0.554 ± 0.019 55.617 ± 0.04 
a 
by difference 
Considering that each repeating unit of xanthan has 11 hydroxyl groups (Figure II.2), the 
maximum possible DS value would be 11 (100%). The DS values for palmitoyl xanthan were 
determined as shown in Table II.7. 
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Table II.7. Determination of palmitoyl xanthan DS.  
Sample Average Carbon/% Mol number DS 
Xanthan 
(35 Carbon/molecule) 
35.66
 a
 
(35.66/(35x12)= 
0.0849 (0.0118)/0.0849)x100 
= 13.9 % 
(per repeating subunit) 
Palmitoyl xanthan 37.93
 a
 - 
Palmitoyl Chloride 
(16 Carbon/molecule) 
2.275
 b
 
(2.275/(16x12)= 
0.0118 
a 
From elemental analysis (Tables II.1. and II.6.)
 
b 
Difference between palmitoyl xanthan and xanthan  
 
3.1.3. Fourier transform infrared (FTIR) spectroscopy 
FTIR is a spectroscopic technique that can provide information about the chemical structure of 
materials. It is based on the absorption of the infrared light by the material that may result in 
distinct molecular excitation/vibration. Once the energies provided by the molecular excitations 
are related with specific vibrational states of atomic and molecular units, they can be converted 
into a FTIR spectrum and the presence of the chemical groups can be identified.  
FTIR was applied to characterize the xanthan derivatives (carboxymethylated xanthan, chapter 
III; palmitoyl xanthan, chapter IV; xanthan-DOPE, chapter V). Prior to analysis, potassium 
bromide (KBr, PIKE Techonologies, USA) pellets were prepared by mixing the xanthan 
derivative powder with KBr (Xanthan derivative/KBr, 1/10, wt/wt). The spectrum was taken with 
the average of 32 scans and a resolution of 4 cm-1 in an IR Prestige-21 (SHIMADZU, Japan) 
spectrophotometer. 
3.1.4. Proton nuclear magnetic resonance (1H NMR) spectroscopy  
NMR is based on the fact that the nuclei have spin which is electrically charged. When a 
magnetic field is applied there is an energetic transition associated to a precise resonant 
frequency. The signal that matches this transfer is measured and converted into a NMR 
spectrum. Thus, for proton NMR (1H NMR) spectroscopy, the information is provided concerning 
the hydrogen’s atom environment in the molecule. Since protons from the solvent should not 
interfere in the analysis, deuterated solvents are usually preferred. This spectroscopic technique 
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was used in chapters IV and V to characterize the palmitoyl xanthan and xanthan-DOPE, 
respectively. 
Samples containing different ratios of xanthan/palmitoyl chloride were dissolved at a 
concentration of 1 wt% in deuterated dimethylsulfoxide. Xanthan-DOPE was dissolved in 
deuterated water at the same concentration. Fully relaxed 1H NMR spectra were acquired in a 
Varian Unity Plus 300 MHz spectrometer (USA). 
3.1.5. Wide angle x-ray scattering (WAXS) 
WAXS is an X-ray diffraction technique which can provide information about the macromolecular 
structure of the materials and thin films. This is based on the analysis of peaks provided by the 
Bragg´s law scattered to wide angles.  
Palmitoyl xanthan (chapter IV) conjugates and xantha-DOPE (chapter V) were characterized by 
WAXS technique to verify any molecular organization after the introduction of hydrophobic 
molecules in the native xanthan structure. WAXS measurements were performed using a Bruker 
AXS NanoStar (USA) with a HiStar 2D detector with scattering angles from 5 to 60 º.  
3.1.6. Differential scanning calorimetry (DSC) 
DSC is a thermoanalytical technique that measures the temperatures and heat flows associated 
with transitions in materials as a function of time and temperature in a controlled atmosphere. 
These measurements provide quantitative and qualitative information about physical and 
chemical changes that involve endothermic or exothermic processes, or changes in heat 
capacity. 
DSC analysis is described in chapter IV to investigate eventual transitions in palmitoyl xanthan 
conjugate and was performed in a calorimeter (TA instruments, USA) with a heating program of 
10 ºC min-1 from 10 to 200 ºC under nitrogen at flow of 20 cm3.min−1. 
3.1.7. Circular dichroism (CD)  
CD spectroscopy is a form of light absorption spectroscopy that measures the difference in 
absorbance of right- and left-circularly polarized light in molecules 24. It has been shown that CD 
spectra between 260 and 180 nm can be used to analyze the secondary structure of peptides 
and proteins (e.g. alpha helix, parallel and antiparallel beta sheet). 
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CD was used to study the effects of palmitoylation and the conjugation with DOPE on the 
secondary structure of native xanthan. Palmitoyl xanthan and xanthan-DOPE were dissolved in 
ultrapure water overnight at concentration of 0.1 wt%. The measurements were performed in a 
Stopped-flow circular dichroism spectropolarimeter (PiStar-180, Applied Photophysics, UK) at 25 
ºC using Quartz cells with a 0.1 cm path length. The spectra were recorded from 300 to 180 nm 
with a scan rate of 100 nm/min and are an average of five accumulations. 
3.1.8. Zeta potential measurements 
Zeta potential is widely used for the quantification of the electrical charge of particles, polymers 
or proteins. Although the electrical charge is not measured directly, it can be calculated using 
established theoretical models. 
Zeta potential measurements of xanthan, hyaluronan and peptide solutions (chapters IV, VI and 
VII) were performed at different pHs and temperatures using a Zetasizer NanoZS Instrument 
(ZEN 3600, Malvern Instruments, UK). Prior to the measurements, samples were dissolved at 
concentration of 0.1 wt% and their pH adjusted using 0.1 M HCl and 0.1 M NH3OH. The 
solutions were filtered using a pyrogen free 0.45 μm disposable membrane filter (Schleicher and 
Schuell Bioscience, Germany). 
3.1.9. Quartz crystal microbalance with dissipation (QCM-D) monitoring 
The QCM instrument operates with a quartz disc in contact with two electrodes. Since the quartz 
is a piezoelectric material, its excitation by an electric field produces an acoustic wave that 
propagates and makes the crystal oscillate. The resonance frequency is dependent on the total 
oscillating mass. The detection principle is based on the resonance frequency shifts due to 
addition or removal of mass on the crystal surface. Mass adsorption increases the frequency 
while mass losses induce decrease of frequency. The mass can be calculated by the Sauerbrey 
equation that correlates proportionally the frequency change with the mass adsorbs. 
In order to study the interactions between xanthan and K2(QL)6K2 peptide, QCM analyses were 
performed on chapter VI. QCM measurements were performed with an instrument with 
dissipation monitoring (QCM-D) from Q-Sense (Göteborg, Sweden). The experiments were 
performed at 24 ºC with 50 L/min flow rate using gold coated crystals (model QSX301, Q-
Sense, Göteborg, Sweden) previously cleaned with H2O2(30%)/NH3(25%)/H2O (1:1:5) during 10 
minutes at 75 ºC. The system was initially equilibrated with phosphate buffered saline (PBS) 
solution (10 mM, pH7.4) to obtain a stable frequency and dissipation baseline signal. Once the 
signals were stable, the buffer was replaced by a solution of xanthan (0.25 wt% in PBS) during 
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25 minutes. Then, the buffer was again introduced to remove weakly bound material. This step 
was followed by the introduction of the peptide solution (0.0025; 0.0625 or 0.125 wt% in H2O) or 
BSA solution (0.5 mg/mL in PBS). Finally the system was rinsed with PBS solution. 
Thickness was calculated by the Voigt model 41 incorporated in Q-Sense software using different 
overtones (7th; 9th, 11th,13th). The layer viscosity values used in the model were between 0.001 
and 0.01 kg.ms-1,, the layer shear modulus between 10 and 105 Pa, and layer thickness values 
were between 10-10 a 10-6 m. For xanthan, a fluid density of 1000 kg.m-3, fluid viscosity of 0.001 
kg.ms-1 and layer density of 850 kg.m-3 were used. For the peptide modeling, a fluid density of 
1300 kg.m-3, fluid viscosity of 0.003 kg.ms-1 and layer density of 1600 kg.m-3 were used. For 
BSA modeling, a fluid density of 1000 kg.m-3, fluid viscosity of 0.001 kg.ms-1 and layer density of 
1500 kg.m-3 were used. 
3.1.10. Scanning transmission electron microscopy (STEM) 
Transmission electron microscopy (TEM) is a microscopy technique based on the interaction of 
a beam of electrons that are transmitted through a thin sample which enables high resolution at 
the nanoscale. 
Samples of xanthan (control) and water-soluble PX conjugate (Chapter IV) for STEM 
observations were prepared by placing one drop of the polymer solution and (0.1 wt%) onto a 
300-mesh copper grid coated with carbon film, followed by 1% (w/v) of uranyl acetate (Electron 
Microscopy Sciences) staining for 3 minutes. The samples were analyzed and photographed 
using a Hitachi Su electron microscope in S-TEM mode. 
3.1.11. Polarized light microscopy 
This is a simple technique that includes illumination of the sample with polarized light. This 
technique is commonly used with birrefringent samples where the polarized light interacts 
strongly with the sample and generates contrast with the background.  
The morphology of xanthan-DOPE assemblies in aqueous conditions was also directly 
examined by polarized light microscopy. Native xanthan and xanthan-DOPE were dissolved in 
distilled water and the solution dropped onto a glass slide The samples were observed in a 
polarized light optical microscope (Olympus type BH-2) and recorded with a Olympus digital 
camera type DFC280. 
3.2. Characterization of developed self-assembled matrices (microcapsules and 
membranes) 
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3.2.1. Microcapsules  
3.2.1.1. Morphology 
Bright field microscopy  
In bright field microscopy, the sample is illuminated and some of the transmitted light is 
absorbed on its dense areas causing white light and contrast. A bright field microscopy image is 
a dark sample on a bright background.  
Optical microscopy was used to assess the size, shape and morphology of the microcapsules on 
chapters III-VI in a bright field light microscope (AXIOVERT 40 CFL, Zeiss, Germany) equipped 
with a digital camera (Canon Power shot G8, Japan).  
Scanning Electron Microscopy (SEM)  
SEM is a microscopic technique that images a sample by scanning through a high energetic 
beam of electrons. Those electrons may interact with sample surface resulting in the emission of 
secondary electrons that is further converted in the micrographs 42. Non-conductive samples are 
usually coated with a thin conductive metal layer in order to minimize charge accumulation.  
SEM was used to evaluate the morphological details (at nano and microscale) of the developed 
microcapsules. Prior to the SEM observations, the microcapsules were fixed with glutaraldehyde 
(Electron Microscopy Sciences, USA) solution (3% v/v in PBS) at 4 ºC for 1 h. The samples 
were further dehydrated in a graded ethanol series followed by immersion in 100% 
hexamethyldisilazane (HMDS, Electron Microscopy Sciences, USA). Microcapsules were cut in 
half to expose the membrane cross-section and the internal surface of microcapsules. The 
microcapsules were mounted on aluminum stubs and sputter coated with Pt/Pd target (80/20) 
generating a thin film with 6 nm of thickness (208 HR High Resolution Sputter Coater, 
Cressington). The microcapsules were imaged on an ultra-high resolution field emission gun 
scanning electron microscope (FEG/SEM, FEI Nova 200 NanoSEM). 
3.2.1.2. Permeability 
The mass transport properties through an encapsulation membrane are crucial for the success 
of the encapsulating matrix. The influx of essential molecules, such as oxygen and nutrients and 
the efflux rate of therapeutic products and wastes are critical for cell survival. Additionally, the 
encapsulation membrane may avoid the influx of immune cells and antibodies, which might 
destroy the enclosed cells 14,43. 
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To assess the permeability of xanthan-DOPE and xanthan-peptide microcapsules, described on 
chapters V and VI respectively, to antibody molecules, the Immunoglobulin G (IgG, Mw = 146-
155 KDa, Abcam, UK) was used. Prior use, IgG was labeled with fluorescein isothiocyanide 
(FITC) in order to determine the diffusion of the protein into microcapsules by fluorescence 
spectroscopy. The IgG was dissolved in sodium carbonate buffer (0.1 M, pH 9) at 2 mg/mL 
concentration. The fluorescein dye, dissolved in DMSO (1 mg/mL) was added per mL of protein 
solution and gentle mixed for 8 hour at 4 oC in the dark. Afterwards, the reaction was quenched 
by adding ammonium chloride to a final concentration of 50 mM. The solution was placed into 
dialysis tubing and dialysed against distilled water in the dark to remove unconjugated FITC. 
Finally, the dialyzed solution was freeze-dried in a light protected vessel. For permeability 
studies, equal volumes of microcapsules and IgG-FITC (15 mg/mL solution in NaCl 0.9%) were 
shaken in a water-shaker bath at 37 ºC and aliquots of 5 µL were collected from 0 to 3 h. 
Concentrations of IgG-FITC were measured by fluorescence (485/528 nm) on a microplate 
reader (BIO-TEK, SYNERGIE HT, USA). 
3.2.1.3. Mechanical stability  
Microcapsule resistance to mechanical stress is another important criterion for the success of 
cell microencapsulation 14-15,44. A microcapsule should be resistant enough to be durable during 
its production, handling and to resist to the mechanical stress without the loss of its membrane 
integrity 45. Xanthan-DOPE and xantham-DOPE/PLL were subjected to agitation in saline 
solution (chapter V). For xanthan-peptide microcapsules (chapter VI) they were immersed in a 
hypotonic environment and later the microcapsules were exposed to PBS solution and agitated 
with glass microbeads to evaluate its mechanical strength in conditions resembling in vivo shear 
stress.  
Induction of mechanical stress using agitation  
The mechanical strength of xanthan-DOPE microcapsules was evaluated by agitating the 
microcapsules (uncoated and coated with PLL) in a flat rotator at maximum rate (about 240 rpm, 
DSR-2800V, Digisystem Laboratory Instruments Inc, Taiwan). The microcapsules were put in 24 
well plates (10 per well) with 1 mL of PBS. At various time intervals (1, 2, 3, 6, and 24 h) the 
number of damaged capsules was counted by direct observation on light microscope and the 
percentage of ruptured capsules in function of time was determined. 
Induction of mechanical stress using osmotic pressure 
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Aliquots of xanthan-peptide microcapsules were placed in 10 mL of water and incubated for 24 h 
at 37 ºC in a water shaker bath (procedure adapted from 44). At various time intervals, the 
capsules were collected and observed in a bright field light microscope (AXIOVERT 40 CFL, 
Germany) equipped with a digital camera (Canon Power shot G8, Japan) and the number of 
ruptured capsules counted. 
Induction of mechanical stress using bead agitation 
Xanthan-peptide microcapsules were placed in flasks containing 20 glass beads (3 mm 
diameter, VWR Scientfic Products Corporation) and 30 mL of PBS solution in a flat rotator 
shaking at maximum rate (about 300 rpm) (DSR-2800V, Digisystem lab.instruments.inc). At 
various time intervals (2, 5, 7, 24 h) the number of ruptured capsules was counted by 
observation in a bright field light microscope (AXIOVERT 40 CFL, Germany) equipped with a 
digital camera (Canon Power shot G8, Japan). The percentage of ruptured capsules in function 
of time was determined (procedure adapted from 44). 
3.2.2. Membranes  
3.2.2.1. Morphology 
SEM  
The morphology and uniformity of membrane surface and cross-section were investigated by 
SEM. The membranes for SEM analysis were prepared according with the procedure described 
in section 3.2.1.1. Then, they were mounted in a silicon wafer further sputtered coated with 20 
nm of gold. The membranes were imaged on Nova NanoSEM microscope (FEI, Netherlands). 
Confocal microscopy 
In fluorescence microscopy, morphological details can be observed by the analysis of 
fluorescent samples through fluorescent light instead or additionally to reflection and absorption 
provided by the simple optical microscope.  
The membranes prepared with fluorescein-HA were imaged using an SP2 confocal microscope 
(Leica Microsystems, Germany). 
3.2.3. Biological assessment 
3.2.3.1. Cell sources 
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Cell lines 
Cell lines are immortalized cultures of cells genetically modified with ability to be subcultivated 
more than 70 times after the primary isolation without restriction 46. In this PhD work, ATDC5 cell 
line was used in the encapsulation studies described in chapters III to VI. ATDC5 cells are a 
murine chondrocytic cell line that has been widely used as a monolayer culture system to study 
chondrogenic differentiation 47. 
Primary cells 
Primary cels are usually obtained directly from the parent tissue and have the same karyotype 
and chromosome number as those in the original tissue and subsequently are not immortalized. 
Mesenchymal stem cells have been shown the capability of self-renewal and differentiation into 
various connective tissue lineages 48. Rat mesenchymal stem cells (rMSC) were used on the 
biological assessment of the membranes described in chapter VII to evaluate the effect of the 
developed bioactive patterned membranes on cell adhesion and morphology. 
3.2.3.2. Culture and encapsulation ATDC5 cells on xanthan-based microcapsules 
The murine ATDC5 chondrocyte cells were cultured in basic medium, consisted of Dulbecoo’s 
Modified Eagle’s Medium (DMEM, Sigma-Aldrich, USA) with phenol red, supplemented with 
10% fetal calf serum (FCS, Biochrom AG, Germany), 5 mM L-Glutamine (Sigma, USA) and 1% 
of antibiotic-antimycotic mixture (Sigma, USA) and maintained at 37 °C in a humidified 
atmosphere of 5% CO2. The medium was replaced every two days. At passage 7, cells were 
detached with trypsin/EDTA and counted in a hemacytometer for encapsulation. 
The effect of xanthan based microcapsules on cellular metabolic activity was assessed by 
encapsulating ATDC5 cells using the microdroplet generator (chapters III and IV) and the 
microfluidics device (chapters V and VI). The cells were suspended in the mentioned polymers 
and microcapsules containing cells were produced according with the procedure described on 
the section 2.1.2. and 2.2.2. of this chapter for microcapsule preparation.  
3.2.3.3. Seeding and culture of rat mesenchymal stem cells on fabricated membranes 
Rat mesenchymal stem cells (rMSCs) isolated from bone marrow of rat tibia and femur, were 
provided by the Animal Research Center (SEA) of the Parc Científic Barcelona. Cells were 
expanded in Dulbecco’s modified Eagle’s medium (DMEM; Life Technologies, Spain) 
supplemented with fetal bovine serum (10%, FBS; Attendbio Research, Spain), L-glutamine (0.2 
mM), penicillin (100 units ml-1) and streptomycin (0.1 mg ml-1) (Sigma-Aldrich, Spain). 
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rMSCs of passage 3–6 were suspended in serum-free DMEM and seeded at 12 500 cells cm-2 
onto smooth and patterned membranes with and without the RGDS sequence (chapter VII). 
After 4 h of culture, all medium was replaced with DMEM containing 10% FBS to allow cell 
proliferation. 
3.2.3.4. Cell viability and proliferation 
To investigate the ability of xanthan based microcapsules (chapter III-IV) to support cell viability, 
encapsulated cells were examined using several biochemical analyses. Viability of cells was 
assessed by fluorescence microscopy using a live/dead assay and the metabolic activity of the 
encapsulated cells was analyzed by the AlamarBlue® assay. 
Cell viability - Live/dead assay 
The live/dead assay was used to evaluate the viability of the encapsulated cells. This is a two-
color fluorescence assay that allows direct determination of live and dead cells by fluorescence. 
Live cells can be visualized through the conversion of the permeable non-fluorescent calcein 
acetomethyl (Calcein-AM) to the intensly fluorescent green calcein (excitation~495 
nm/emission~515 nm). Dead cells have damaged membrane and consequently the propidium 
iodine (PI) enters in the damaged cells and becomes fluorescent when bound to nucleic acids. 
PI produces a bright red fluorescent in damaged or dead cells (excitation 488 nm/ emission 617 
nm).  
Calcein AM (Sigma, USA) solution (2/1000, v/v) was prepared in DMEM medium without FCS 
and phenol red. Propidium iodide (PI, Molecular Probes, Invitrogen, USA) solution was prepared 
by mixing 2 µL PI (1 mg/mL) with 20 µL (1 mg/mL) RNAse A (USB corporation, USA) and 2 mL 
PBS. The microcapsules with encapsulated cells and controls were collected from the culturing 
plates and incubated with calcein-AM and propidium iodide solutions at 37 ºC for 10 min 
protected from light. Samples were then observed under fluorescent microscopy using an 
Axioplan Imager Z1m microscope (Zeiss, Germany). 
Metabolic activity - AlamarBlue® assay 
This assay uses an oxidation-reduction indicator that both fluoresces and changes color in 
response to chemical reduction of growth medium resulting from metabolic activity. The cellular 
viability can be assessed by several methods based on the reduction of tetrazolium compounds 
such as Thiazolyl Blue Tetrazolium Bromide (MTT) or (MTS) 15. Nevertheless, AlamarBlue® 
provides several advantages over the other methods: the proliferation and viability can be 
assessed, furthermore it is easy to implement and it is not toxic, which allow the concomitant 
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evaluation of the same culture at several time points, and by consequence their usage for 
additional assays.   
The metabolic activity of encapsulated cells over time was assessed using the AlamarBlue® 
assay (AbD Serotec,UK). AlamarBlue® was added (10% of the volume of the well) to each well 
containing the encapsulated cells and the plate was incubated at 37 ºC for 20 hours protected 
from light. After incubation, 100 µL of solution was taken from each well and placed in a 96 well 
plate. The absorbance was read at 570 and 600 nm on a microplate reader (BIO-TEK, SYNERGIE 
HT, USA). The percentage of reduced AlamarBlue® was calculated according the manufacturer 
instructions. 
Cell proliferation – DNA quantification assay 
Cell proliferation was evaluated by quantifying the DNA content of the encapsulated ATDC5 
cells over time. A fluorimetric dsDNA quantification kit (PicoGreen, Molecular Probes, Invitrogen, 
USA) was used that contains an ultra sensitive fluorescent nucleic acid stain for quantifying 
double-stranded DNA (dsDNA) in solution. For this purpose, the samples collected at days 1, 7, 
14 and 21 were washed twice with sterile PBS (Sigma, USA) solution and transferred into 1.5 
mL microtubes containing 1 mL of ultra-pure water. Capsules with and without cells were stored 
at -80 ºC until further analysis. Prior to DNA quantification, samples were thawed and broken by 
pipetting up and down using a syringe with a needle to cause material disruption and facilitate 
DNA extraction. 28.7 µL of each sample and standards (0-2 mg/mL) were transferred to an 
opaque 96 well plate. Then 71.3 µL of PicoGreen solution and 100 µL of Tris-EDTA buffer were 
added. Standards and samples were prepared in triplicate. The plate was incubated for 10 
minutes in the dark and the fluorescence was measured using an excitation wavelength of 485 
nm and emission of 528 nm. DNA amounts were calculated from the calibration curve.  
3.2.3.5. Cell morphology 
Bright field microscopy 
Microscopy observations of the encapsulated cells were carried out over the course of the in 
vitro culture on chapters III-VI. A bright field light microscope (AXIOVERT 40 CFL, Zeiss, 
Germany) equipped with a digital camera (Canon Power shot G8, Japan) was used and images 
were acquired at 10x magnification.  
Histology 
Hematoxylin is a widely used nuclear stain, while eosin is used solely to enhance the contrast of 
the stain. H&E staining is based on a color change on the nucleus of cells in the tissue sections 
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from red to blue when there is a pH change (pH  3).  H&E staining was used on chapter III to 
examine the morphology of cells encapsulated within the microcapsules. Cell cultured 
microcapsules for histology were rinsed three times in PBS and then fixed in 3.7% formalin in 
PBS for 1 hour at room temperature. After fixation, samples were dehydrated in a graded 
ethanol series (70, 90, 95 and 100%) followed by immersion in xylene. Specimens were 
embedded in paraffin and cut in 4 µm-thick sections (MICROM HM355S Microtome, INOPAT, 
USA). Sections were then dewaxed and stained with Harris Hematoxylin (Sigma, USA) and 
eosin (H&E staining). 
Immunostaining 
In order to investigate the effect of the physical (topographies) and biochemical (RGDS) signals 
present in the developed self-assembling membranes (chapter VII) on cell adhesion and 
morphology, immunostaining was performed. After 18 h, the culture medium was removed and 
the samples were washed twice with PBS to remove any non-adherent cells. Cells were fixed 
with 4% (w/v) formalin (Sigma- Aldrich, Spain) in PBS for 30 min. To visualize the actin 
cytoskeleton, cells were stained with phalloidin-fluorescein isothiocyanate (phalloidin–
FITC,Sigma-Aldrich, Spain) at a 1:500 dilution in PBS for 1h at room temperature. The remained 
phalloidin was removed and the nuclear fluorescent stain, 4’,6-diamidino-2-phenylindole 
dihydrochloride (DAPI; Invitrogen, Spain), was added. Finally, the samples were placed in a 
glass slide with a droplet of Fluoro-Gel mountant (Aname, Spain). The cells were visualized 
using an SPE confocal microscope (Leica Microsystems, Germany). 
SEM 
Cells encapsulated within microcapsules and cultured on the membranes were examined under 
SEM to analyse cell morphology and its interactions with the matrices. Samples were prepared 
as described in section 3.2.2.1. of this chapter. 
4. STATISTICAL ANALYSIS 
A Student's t-test was used throughout this thesis to assess the statistical difference between 
two sample means. Results of DNA quantification and cell viability, zeta potential and membrane 
thickness were expressed as a mean ± standard deviation with n=3 for each group on chapters 
III to VII. Statistical significance of differences was determined using unpaired student’s t-test 
multiple comparison procedure at a confidence level of 95% (p<0.05).  
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Chapter III*  
ENCAPSULATION AND SURVIVAL OF A CHONDROCYTIC CELL LINE WITHIN XANTHAN 
DERIVATIVE 
ABSTRACT 
There is a renewed interest in using polymers of natural origin to obtain hydrogels for cell 
encapsulation, as they usually undergo gelation under mild conditions. The aim of this work was 
to investigate the potential of xanthan, a bacterial extracellular polysaccharide, as a new artificial 
matrix for the encapsulation of a chondrocytic cell line (ATDC5 cells) and to compare it with 
alginate, the most widely used material for encapsulation of living cells. Towards this goal, we 
have developed a novel micro-droplet generator to produce microcapsules. The system is based 
on a sterilizable silicone tubing which can be applied conveniently to almost every biology 
laboratory without using sophisticated microfabrication techniques of microfluidics. The prepared 
microcapsules were characterized according with their size, shape, surface morphology and 
stability. Microcapsules with an average diameter of 500 m and homogenous size distribution 
were obtained. The morphology revealed by scanning electron microscopy showed 
microcapsules with a quite smooth surface and a capsule membrane of 5 m with two distinct 
layers. ATDC5 cells encapsulated in carboxymethyl xanthan (CMX) microcapsules remained 
viable and were observed to proliferate for prolonged culture periods. When compared with 
alginate microcapsules, cells in CMX showed enhanced metabolic activity and proliferating 
rates. Furthermore, the cells exhibited a round morphology typical of chondrocytes, indicating 
that CMX promoted the retention of the chondrogenic phenotype and suggesting the potential of 
this matrix to be applied in cell-based therapies for cartilage tissue engineering approaches. 
 
 
 
 
 
_________________________________________ 
*This chapter is based on the following publication:  
Ana C. Mendes, Erkan T. Baran, Rui C. Pereira, Helena S. Azevedo, Rui L. Reis, Encapsulation and 
Survival of a Chondrocyte Cell Line within Xanthan Gum Derivative, Macromolecular Biosciense, 12 (3): 
350-359, 2011. 
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1.INTRODUCTION 
Cell microencapsulation is a technology with enormous clinical potential for the treatment of a 
wide range of human diseases such as diabetes1-3, hemophilia, anemia, hypoparathyroidism, 
renal failure 1,4-7, osteoarthritis 8-14 and also for constructing artificial organs 1. In cell 
encapsulation, cells are protected from immune rejection by an artificial, semipermeable 
membrane, potentially allowing transplantation (allo- or xenotransplantation) without the need for 
immunosuppression 1,4-7,15-18. For the clinical success of cell encapsulation, it is crucial to have a 
source of cells, a biocompatible, as well as mechanically and chemically stable membrane of 
suitable permeability, which is able to provide immune protection to the implant 1,4-6,15-16. 
Although efforts have been made in order to accomplish these goals, the available systems still 
present limitations regarding their reproducibility during microcapsule preparation and long term 
viability of encapsulated cells. During the past decade, several polyelectrolytes, such as 
polysaccharides and polypeptides, have been widely used for the fabrication of capsules, due 
their ability to form gels through complexation with oppositely charged polymers (e.g. 
alginate/poly-L-lysine 3,17) or by ionic crosslinking of the polyanionic biopolymer in the presence 
of a counterion (e.g. Ca2+, Ba2+). In these cases, the gelation processes is cell-compatible, since 
they do not require harsher chemicals, and the gels provide a highly hydrated three-dimensional 
network. Furthermore, these materials can be injected into the body, hence enabling the 
clinician to transplant the cell-polymer combination in a minimally invasive way 19. 
Cell based therapies have demonstrated an enormous potential for the long term repair of 
cartilage defects 8-14 and the alginate-based hydrogels have been widely used as a convenient 
three-dimensional (3D) cell culture model system 9-11,13,20-21. This system has demonstrated the 
ability to prevent chondrocytes from undergoing de-differentiation as well as restore cartilaginous 
phenotype to de-differentiated chondrocytes 22. In addition, alginate systems have shown to 
promote the synthesis of cartilage matrix components, such as proteoglycans and collagen type 
II 21,23. Although alginate/poly-L-lysine polyelectrolyte complexes have been widely investigated 
for cell encapsulation, they still present some drawbacks concerning their long-term mechanical 
performance and biocompability 7,24  
Xanthan gum is an extracellular polysaccharide produced by the bacterium Xanthomonas 
campestris 25-28. The primary structure of xanthan consists of (1→4)-linked glucose units, 
similar to the structure of cellulose backbone, substituted at O-3 of alternate glucose residues, 
with a trisaccharide. The trisaccharide consists of one glucuronic acid unit between two 
mannose units (Figure III.1.A). 
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The terminal mannose moiety may carry pyruvate residues linked to the positions 4 and 6 with 
an unknown distribution. D-Mannose unit linked to the main chain contains an acetyl group at 
position O-6 25-29. The pyruvic acid 
content of xanthan can vary 
substantially depending on the strain of 
X. campestris, resulting in different 
viscosities of xanthan solutions. 
Molecular modelling studies suggest 
that xanthan gum can assume a helical 
structure, with the side branches 
positioned almost parallel to the helix 
axis and stabilizing the structure 25-27,29. 
The presence of acetic and pyruvic 
acids is the main responsible for the 
polyanionic character of this 
polysaccharide. Xanthan forms very 
viscous solutions, and, at sufficiently 
high polymer concentration, it exhibits 
weak gel-like properties 25,30. 
Furthermore, it was shown to be 
biocompatible 28, biodegradable and it 
is widely used in food, cosmetics and 
pharmaceuticals because of its 
encouraging reports on safety 25.  
The application of other microbial polysaccharides with gelling properties, such as gellan gum, 
has been reported in the literature for the encapsulation of human chondrocytes for cartilage 
regeneration 31 but to the best of our knowledge, the use of xanthan gum as cell encapsulation 
matrix has only been described by our group 32. Therefore, the present work aims to investigate 
the potential of a xanthan derivative (carboxymethyl xanthan, CMX) as a new matrix for the 
encapsulation of ATDC5 cell line which has been widely used as a model to study chondrogenic 
differentiation in vitro 33-37. Furthermore, microcapsules made of alginate, a widely used material 
in cell encapsulation and in cartilage tissue engineering, were used for comparison purposes. To 
test our hypothesis, we have used a simple microdroplet generator, based on a tubing system, 
to produce microcapsules with homogenous size distribution and micrometer size favorable for 
Figure III.1. Chemical structure of xanthan repeating unit (A) 
and carboxymethyl xanthan (B). 
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mass transfer and easy injects for cell therapy. In vitro studies were performed to evaluate the 
ability of the CMX mirocapsules to support cell viability, proliferation and cell functions. 
2. MATERIALS AND METHODS 
Materials 
All chemicals, including xanthan gum from Xanthomonas campestris, monochloroacetic acid and 
poly-L-ysine (PLL), were obtained from Sigma/Aldrich unless otherwise indicated. The chemicals 
were used as received. 
Determination of molecular weight of native xanthan  
The average molecular weight (Mw) was determined by size-exclusion chromatography (SEC). 
The samples were dissolved in an aqueous 0.1 M NaNO3 solution (0.4% w/v). A PL-GPC 110 
chromatograph was equipped with a pre-column PLaquagel-OH 15 μm and two SEC columns in 
series (PLaquagel-OH40 15 μm, 300 × 7.0 mm and PLaquagel-OH60 15 μm, 300 × 7.0 mm). 
The pre-column, the SEC columns, the injection system, and the refractive index detector were 
maintained at 36 ºC. The eluent (aqueous 0.1 M NaNO3 solution) was pumped at a flow rate of 
0.9 mL min-1. The analytical columns were calibrated with pullulan standards (Polymer 
Laboratories, UK) in the range of 5.8-1600 kDa. The average molecular weight of xanthan gum 
was estimated as 152 kDa32. 
Carboxymethyl xanthan (CMX) synthesis 
Carboxymethyl xanthan was prepared by adapting the carboxmethylation procedure used for 
chitosan by Chen and Park 38. 10 g of xanthan from Xanthomonas campestris and 13.5 g 
sodium hydroxide (Panreac, Spain) were mixed in 100 mL of solvent mixture of 
water/isopropanol (Fluka, Germany) using a top stirrer. The mixture was allowed to react at 50 
ºC in a water bath (Thermostat IKA, Germany) for 1 h. Two solvent mixtures were used (1/1 and 
1/4, v/v) to yield xanthan with different degrees of carboxymethylation designated by CMX1 and 
CMX2 respectively. Then, 15 g monochloroacetic acid, dissolved in 20 mL of isopropanol, were 
added dropwise to the reaction mixture for 30 min. The reaction was carried out for 4 h at the 
same temperature and stopped by adding 200 ml of ethanol 70% (Panreac, Spain). At the end, 
the obtained solid precipitate was filtered and rinsed with 70–90% of ethanol to desalt and 
dewater and further vacuum dried at room temperature.  
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CMX Characterization 
Fourier Transform Infra Red spectroscopy (FTIR) 
The chemical modification of xanthan was analysed by infrared spectroscopy in an IR Prestige-
21(SHIMADZU, Japan) spectrophotometer. Prior to analysis, potassium bromide (KBr, PIKE 
Techonologies, USA) pellets were prepared by mixing the CMX powder with KBr (CMX/KBr, 
1/10, wt/wt). The spectrum was taken with the average of 32 scans and a resolution of 4 cm-1. 
Determination of the degree of substitution (DS) 
The degree of substitution of CMX was determined by acid-base titration. CMX (0.2 g) was 
dissolved in 40 mL of distilled water. The pH of the solution was adjusted to 2 with hydrochloric 
acid and then CMX was titrated with 0.1 N NaOH. The volume of added NaOH, as well as the 
pH values, were recorded. Three replicates were performed for each sample. DS was calculated 
following the calculation procedure used for carboxymethyl chitosan and described by Ge and 
co-authors39 as follows: 
)(2.0
)(
epCM
epXru
nM
nM
DS


       (III.1) 
MXru is the molecular weight of Xanthan repeating unity (851); nep is the number of mol of 
carboxymethyl groups at the ending point of the titration; MCM is the molecular weight of the 
carboxymethyl groups inserted in the native structure of Xanthan gum. 
Cell culture and encapsulation  
The murine ATDC5 chondrocyte cells were cultured in basic medium, consisted of Dulbecoo’s 
Modified Eagle’s Medium (DMEM, Sigma-Aldrich, USA) with phenol red, supplemented with 
10% fetal calf serum (FCS, Biochrom AG, Germany), 5 mM L-Glutamine (Sigma, USA) and 1% 
of antibiotic-antimycotic mixture (Sigma, USA) and maintained at 37 °C in a humidified 
atmosphere of 5% CO2. The medium was replaced every two days. At passage 7, cells were 
detached with trypsin/EDTA and counted in a hemacitometer for encapsulation. 
The cells were encapsulated into CMX microcapsules using a novel in house micro-droplet 
generator40 as illustrated in Figure III.2. A. In this system, an autoclavable tubing (Novosil, Fisher 
Scientific, USA) with 1 mm internal diameter was punctured with a blunt end needle in a vertical 
position and sealed with a silicone glue. This assembly can be autoclaved numerously and can 
be assembled with peristaltic pump (Ismatec, Switzerland) and syringe pump (Alladdin WPI, 
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England) as shown in Figure III.2.B. One end of the tubing was connected to an oil reservoir 
(Aldrich, Germany) and the other end to a glass collector where the droplets were cured in a 
crosslinker solution. A magnetic top stirring apparatus, made up of Teflon® with a magnet, was 
placed on the top of collector in order to stir solution without introducing a mechanical stress on 
the formed microcapsules. The operation rate of peristaltic and syringe pump was set at 0.35 
mL/minute and 20 µL/min, respectively.  
 
Figure III.2. (A) Schematic representation of the micro-droplet generator. (B) Photograph showing the apparatus used 
to produce the microcapsules 
 
Prior to encapsulation, CMX powder (sterilized by autoclaving for 10 min at 121 oC) was 
dissolved in DMEM (5 wt%) until obtaining a homogeneous solution. Subsequently, a cell 
suspension at cellular density of 10x106 cells/mL was mixed with aqueous CMX solution. The 
microdroplets generated by the device were fed into the crosslinker solution containing 1.5% 
CaCl2 (Merck Chemical Co., Germany) and 0.9% NaCl (Carlo Erba, Italy) as shown in Figure III. 
2.B. The CMX capsules were stirred gently for 15 min and then washed with PBS (Sigma, USA) 
in order to remove traces of mineral oil. Afterwards, the collected microcapsules were 
transferred into a poly-L-lysine solution (0.1 wt%, 30-70 kDa) for 10 min in order to strengthen 
the outer surface of the microcapsules. Finally, the coated microcapsules were transferred to 
DMEM culture medium and cultured in a 24-well polystyrene plate, previously coated with 
agarose (4 wt% in PBS) to avoid the adhesion of non-encapsulated cells.  
Alginate (alginic acid sodium salt from brown algae, average Mw 100 kDa, Fluka, Norway) was 
used to produce microcapsules to serve as controls. They were also produced following a 
procedure similar to the one described for CMX microcapsules. The alginate microcapsules 
Chapter III. Encapsulation and Survival of a Chondrocyte Cell Line within Xanthan Gum Derivative 
95 
were successively coated with the poly-L-lysine (0.05 wt%) for 5 min. The encapsulated cells 
(n=3) were maintained in vitro culture for a period of 3 weeks in DMEM with media exchange 
every 2 days. Empty microcapsules were also maintained throughout the culture period to serve 
as controls. 
Microcapsule Characterization 
Light microscopy analysis 
Microscopic observations of the encapsulated cells and controls were carried out over the 
course of the in vitro culture to examine the cell morphology and growth. A bright field light 
microscope (AXIOVERT 40 CFL, Zeiss, Germany) equipped with a digital camera (Canon Power 
shot G8, Japan) was used and images were acquired at 10x magnification.  
Scanning Electron Microscopy (SEM) analysis 
Prior to the SEM observations, the microcapsules were fixed with glutaraldehyde (Electron 
Microscopy Sciences, USA) solution (3% v/v in PBS) at 4 ºC for 1 h. The samples were further 
dehydrated in a graded ethanol series (20, 50, 60, 70, 80, 90 and 100%) followed by immersion 
in 100% hexamethyldisilazane (HMDS, Electron Microscopy Sciences, USA). Microcapsules 
were cut in half to expose the membrane cross-section and the internal surface of 
microcapsules. The specimens were mounted on aluminum stubs and sputter coated with Pt/Pd 
target (80/20) generating a thin film with 6 nm of thickness (208 HR High Resolution Sputter 
Coater, Cressington). The microcapsules were imaged on an ultra-high resolution field emission 
gun scanning electron microscope (FEG/SEM, FEI Nova 200 NanoSEM). 
Cell viability and proliferation post-encapsulation 
To investigate if the CMX microcapsules can support cell viability and proliferation, encapsulated 
cells were examined using several biochemical analyses. Viability of cells was assessed by 
fluorescence microscopy using a live/dead assay; the metabolic activity of the encapsulated 
cells was analyzed by the AlamarBlue® assay and cell proliferation evaluated by DNA 
quantification. 
Live/dead cell assay 
Calcein AM (Sigma, USA) solution (2/1000, v/v) was prepared in DMEM medium without FCS 
and phenol red. Propidium iodide (PI, Molecular Probes, Invitrogen, USA) solution was prepared 
by mixing 2 µL PI (1 mg/mL) with 20 µL (1 mg/mL) RNAse A (USB corporation, USA) and 2 mL 
PBS. The microcapsules with encapsulated cells and controls were collected from the culturing 
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plates and incubated with calcein-AM and propidium iodide solutions at 37 ºC for 10 min 
protected from light. Samples were then observed under fluorescent microscopy using an 
Axioplan Imager Z1m microscope (Zeiss, Germany). 
Metabolic activity of encapsulated cells - AlamarBlue® assay 
The metabolic activity of encapsulated cells over time was assessed using the AlamarBlue® 
assay (AbD Serotec,UK). AlamarBlue® was added (10% of the volume of the well) to each well 
containing the encapsulated cells and the plate was incubated at 37 ºC for 20 hours protected 
from light. After incubation, 100 µL of solution was taken from each well and placed in a 96 well 
plate. The absorbance was read at 570 and 600 nm on a microplate reader (BIO-TEK, SYNERGIE 
HT, USA). The percentage of reduced AlamarBlue® was calculated according the manufacturer 
instructions. 
Cellular proliferation assay 
ATDC5 proliferation within the capsules was determined using a fluorimetric dsDNA 
quantification kit (PicoGreen, Molecular Probes, Invitrogen, USA). For this purpose, the samples 
collected at days 1, 7, 14 and 21 were washed twice with sterile PBS (Sigma, USA) solution and 
transferred into 1.5 mL microtubes containing 1 mL of ultra-pure water. Capsules with and 
without cells were stored at -80 ºC until further analysis. Prior to DNA quantification, samples 
were thawed and broken by pipetting up and down using a syringe with a needle to cause 
material disruption and facilitate DNA extraction. 28.7 µL of each sample and standards (0-2 
mg/mL) were transferred to an opaque 96 well plate. Then 71.3 µL of PicoGreen solution and 
100 µL of Tris-EDTA buffer were added. Standards and samples were prepared in triplicate. The 
plate was incubated for 10 minutes in the dark and the fluorescence was measured using an 
excitation wavelength of 485 nm and emission of 528 nm. DNA amounts were calculated from 
the calibration curve.  
Histology 
Cell cultured microcapsules for histology were rinsed three times in PBS and then fixed in 3.7% 
formalin in PBS for 1 hour at room temperature. After fixation, samples were dehydrated in a 
graded ethanol series (70, 90, 95 and 100%) followed by immersion in xylene. Specimens were 
embedded in paraffin and cut in 4 µm-thick sections (MICROM HM355S Microtome, INOPAT USA). 
Sections were then dewaxed and stained with Harris Hematoxylin (Sigma, USA) and eosin (H&E 
staining). 
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Statistical analysis 
Results of DNA quantification and cell viability are expressed as a mean ± standard deviation 
with n=3 for each group. Statistical significance of differences was determined using unpaired 
student’s t-test multiple comparison procedure at a confidence level of 95 % (p<0.05). 
3. RESULTS AND DISCUSSION 
CMX Characterization 
When designing materials for cell encapsulation, several properties should be considered. For 
instance, the amount and the character of functional groups contained in monomer units will 
influence the intermolecular interactions and consequently complex formation. Complexation is 
enhanced by the charge density in the polyanion, which depends on the chemical structure, the 
pKa of the polyelectrolyte, as well the pH of the solution. Xanthan by itself is able to form self-
supporting gels in the presence of ions, although they are not stable in presence of aqueous 
solutions in the long term. For increasing gel stability, xanthan was carboxymethylated and its 
chemical composition was characterized in order to control capsule properties and performance 
in biological solutions. The chemical modification on xanthan was confirmed in FTIR spectra 
(Figure III.3.A) by the decrease of the C-O-H band intensity at 1425 cm-1 and O-H stretching at 
3400 cm-1. 
In addition, the absorption band at 1616 cm-1, attributed to C=O groups of pyruvate, was 
increased significantly after carboxymethylation, while the carbonyl peak, which is provided by 
the acetate at 1741 cm-1 in native xanthan, was not observed in CMX. This may indicate that the 
acetyl group was hydrolyzed by sodium hydroxide during carboxymethylation and consequently 
converted into carboxymethyl group. 
Comparing the spectra of modified xanthans, CMX2 presents more evident changes than CMX1 
when compared with native xanthan, indicating higher level of modification. To confirm this 
hypothesis, we determined the degree of substitution which was found to be higher for CMX2 
(4.38) than for CMX1 (0.35) (Figure III.3.B). Due to the higher degree of substitution of CMX2 
and its ability to form gels, we selected this carboxymethylated xanthan for subsequent 
encapsulation studies. 
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Figure III.3. (A) FTIR spectra of native xanthan and carboxymethylated xanthans with different degrees of 
modification (CMX1 and CMX2). (B) Degree of substitution obtained from acid-base titration. 
Microcapsule preparation and encapsulation of cells 
A simple microencapsulation process was developed by using a silicone tubing and blunt ended 
syringe needle which can be prepared in biology laboratories without need for advance 
techniques and skills which are required for preparation of microfluidic devices.  
The size of microcapsules can be adjusted by using tubing at desired internal diameter that are 
commercially available in wide size range. The device can be sterilized by autoclaving and 
connected to pumps easily on aseptic conditions. The first step of microcapsule formation is the 
extrusion of the polymer solution through the micro-droplet generator which enables a 
homogenous size distribution. The microcapsules were then formed by crosslinking of generated 
droplets in a crosslinking solution while preserving physiological conditions for cells. 
The morphology and microstructure of the microcapsules were analysed using scanning electron 
microscopy (Figure III.4). 
Capsules with spherical shape and a diameter of 500 µm were obtained. At higher 
magnifications (Figure III.4.B,. C) the microcapsule external surface appears to be quite smooth. 
Their relatively small and uniform size (high surface to volume ratio) has been considered 
advantageous under a mass transport and immunological response perspectives 4,15-16,41. At the 
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same time, capsules with rough surfaces should be avoided since they can elicit immunological 
reactions when implanted 15,41. 
 
Figure III.4. SEM images showing the overall structure of CMX microcapsules (A), the microstructure of the 
microcapsule external surface (B, D) and cross-section of microcapsule membrane (D). (E) Zoom-in of (D) showing 
the interface between CMX and poly(L-lysine) complex (F, G) Magnified images revealing morphological details of 
CMX and poly(L-lysine) layers respectively. 
SEM images of the microcapsule cross-sections (Figure III.4.D) reveal an amorphous membrane 
with thickness of about 5 µm and two layers with distinct morphologies. The magnified photos 
highlighted a fibrous structure which results in a porous matrix. The Image J software (NIH, 
USA) analysis showed that those structures have highly conserved dimension with the mean 
width of 35. 97 nm ± 6.3 (Figure III.4.C) and 29.89 ± 6.9 nm (Figure III.4.G) from capsule surface 
and cross sectioned area of microcapsule wall, respectively. This result may indicate that the 
complex formation between poly(L-lysine) and CMX might be affected by macromolecular 
tertiary structure of both biopolymers and as a result, reproducible tubular structures were 
formed. A successful capsule membrane for cell transplantation should allow rapid diffusion of 
nutrients, wastes, and important metabolic products. From those fibrous network structures it 
can be expected that the capsule wall can be quite permeable to nutrients and permit high 
viability conditions for encapsulated cells inside microcapsule. Moreover, it is expected that the 
permeability of the capsules can be controlled by changing the degree of modification of 
xanthan, the concentration and molecular weight of both polymers (xanthan and poly-L-lysine). 
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Cytotoxicity is an important criterion for any biomaterials used in tissue engineering. We 
analyzed the cytotoxicity of the CMX capsules over ATDC5 cells via MTS (3-(4,5-
dimethylthiazol-2-yl)-2-(4-sulfophenyl)-2H-tetrazolium salt) assay (data not shown). Cells were 
exposed to the extracts from CMX capsules in contact with culture medium for 24, 48 and 72 h. 
Latex rubber extract and fresh complete culture medium were used respectively as negative and 
positive controls. The results showed that the CMX capsules do not cause any deleterious 
change in the metabolic activity of ATDC5 cells and consequently CMX capsules can be 
considered safe for cell encapsulation. 
In vitro viability and proliferation of ATDC5 cells cultured within microcapsules  
In vitro studies are necessary to ensure that CMX microcapsules did not cause cell death or 
inhibit cell proliferation. The morphology and viability of encapsulated cells were investigated 
after several days in culture (Figures III 5.A, .6.A).  
 
Figure III.5. In vitro viability and proliferation of ATDC5 cells cultured in CMX and alginate microcapsules. (A) 
Fluorescence microscopy images displaying the live/dead assay of encapsulated cells (green cells are live, red cells 
are dead) showing that the cells remain viable in the microcapsules up to 21 days of culture. (B) Metabolic activity and 
(C) proliferation of encapsulated cells determined by AlamarBlue® assay and DNA quantification. Results are 
expressed as means ± standard deviation with n=3. *Indicates a significant difference (p< 0.05) between CMX and 
alginate microcapsules for different time points. ** indicates significant difference (p< 0.05) between different time 
points for CMX microcapsules. 
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Cells formed small aggregates with strong green fluorescence observed inside the capsule 
(Figures III.5.A), demonstrating high viability of ATDC5 cells post-encapsulation. Furthermore, 
an even cell distribution can be observed throughout the culturing time (Figures III.5.A, .6.A) in 
alginate and CMX microcapsules, but in the latest times (14 and 21 days), ATDC5 cells 
encapsulated in CMX showed their tendency to form cellular aggregates (Figures III.5.A) 
demonstrating a potential chondrogenic phenotypic behaviour. Scanning electron microscopy 
also revealed the formation of cell aggregation inside the capsules (Figure III.7.D-E).  
The metabolic activity of ATDC5 cells was investigated throughout the culturing period using 
AlamarBlue® assay (Figure III.5.B). The results showed that ATDC5 cells encapsulated in CMX 
matrix were able to reduce AlamarBlue® over the 21 days of in vitro culture (Figure III.5.B). 
Except for day 7, the cells encapsulated in the CMX microcapsules showed higher metabolic 
activity than the cells within alginate microcapsules. Although at the day 1 and 7 this difference 
was not significant (p>0.05), it was rather significant (p<0.05) for the latest time points (14 and 
21 days).  
To support the results provided from AlamarBlue® assay, cell proliferation was investigated by 
DNA quantification. DNA quantification (Figure III.5.C) revealed a steady and significant (p<0.05) 
increase in the DNA amounts with culturing time as a result of improved cellular proliferation in 
CMX microcapsules. When compared to the DNA values for cells encapsulated in alginate, 
significantly higher cellularity was observed (p<0.05) for CMX microcapsules in the latest days. It 
should be noted that at days 1 and 7, no statistical difference was observed between the 
cellularity level in both materials (p>0.05). A common limitation of polyelectrolyte complexes is 
lack of permeability to larger molecules, such as proteins, because these systems are normally 
characterized by a dense membrane structure 42. The ATDC5 cells remained viable within 
microcapsules for up to 3 weeks in culture. The CMX microcapsules could therefore provide 
sufficient nutrient diffusion necessary for cell survival and proliferation. 
ATDC5 is a very well established cell line known to be an excellent in vitro chondrogenic model 
for determining events during chondrogenesis 33-37. Cell-matrix interactions during 
chondrogenesis are promoted by the three-dimensional (3D) environment 34. In CMX 
microcapsules, ATDC5 cells retained their tendency to form cellular aggregates and they 
expressed higher metabolic activity than in alginate capsules used in our study. 
H&E staining of cells encapsulated in the CMX microcapsules (Figure III.6.B) revealed that 
ATDC5 cells retained their rounded morphology throughout the culture and tend to form 
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cartilage nodule-like aggregates after 21 days of culture in the CMX microcapsules. This fact 
denotes that CMX microcapsules promoted the retention of the chondrocytic phenotype.  
 
Figure III.6. Bright field light microscopy images of living cells encapsulated in CMX microcapsules (A) and 
microcapsule sections stained with H&E (B) after different culturing times. 
 
SEM analysis on cell cultured microcapsules revealed that the cells attached on the internal 
microcapsule surface, interact with the surrounding matrix by their extended filopodias (Figure 
III.7.B, E) and tend to form small aggregates over 21 days (Figure III.7.D-E). 
 
Figure III.7. SEM images showing the interior of the CMX microcapsules after 1 and 21 days of culture. (A, B) 
Morphological characteristics of the cells attached to the microcapsule inner surface. (D, E) Cell aggregates formed 
after 21 days of culture. (C, F) Microstructure of the microcapsule inner surface showing highly porous structure (F). 
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We speculate that the presence of ATDC5 cells and aggregates on the capsule wall may be a 
result of higher nutrient availability in these regions, since it is expected a better diffusion of 
nutrients near the capsule wall surface. At higher magnification, SEM image (Figure III.7.F) 
shows a fibrillar microstructure typical of natural ECM. Such fibrillar structure may offer 
additional advantages, when compared to the dense structure of other systems used for 
producing capsules, as it might allow a better control over capsule permeability. 
In the current work, we have used a standard cell line to evaluate the ability of CMX 
microcapsules to support cell viability and proliferation. Given these encouraging preliminary 
results, we are undertaking encapsulation experiments with human articular chondrocytes in 
carboxymethyl xanthan to be applied as cell-based therapies in cartilage tissue engineering 
approaches. 
 
4.CONCLUSIONS 
This study presents a novel process that utilizes a micro-droplet generator to prepare 
microcapsules using the xanthan gum polysaccharide. The optimized process conditions 
enabled generating microcapsules with long-term stability and the encapsulation of a 
chondrocytic cell line. Encapsulated cells showed high viability (the cells survive in culture for at 
least three weeks) and retained the property of forming cell aggregates. In conclusion, our 
studies suggest that carboxymethyl xanthan can be an alternative to the current cell 
encapsulating materials, but in vivo studies are necessary to confirm our hypothesis. 
Nonetheless, CMX microcapsules may offer significant potential for long term cell culture in 
bioreactors for applications in cell therapies. 
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Chapter IV* 
PALMITOYLATION OF XANTHAN POLYSSACCHARIDE FOR SELF-ASSEMBLY 
MICROCAPSULE FORMATION AND ENCAPSULATION OF CELLS IN PHYSIOLOGICAL 
CONDITIONS 
ABSTRACT 
Hydrophobized polysaccharides have emerged as a promising strategy in biomedical field due 
to the versatility to design functional structures through the spontaneous self-assembly in cell-
friendly conditions. Based on this concept, xanthan, a bacterial extracellular polysaccharide with 
potential as encapsulating matrix, was conjugated with hydrophobic palmitoyl groups to obtain 
an amphiphilic system able to form capsules by self-assembly processes. The conjugation of 
xanthan was performed at different xanthan/palmitoyl chloride ratios and Fourier transformed 
infra red, 1H nuclear magnetic resonance spectroscopies, as well as wide angle X-ray diffraction, 
differential scanning calorimetry were performed to characterize the obtained conjugates. The 
results showed that the increase of the hydrophobic reactant promoted higher hydrophobic 
interaction and consequently higher molecular organization. At certain palmitoyl concentrations 
and through a proper balance between charge repulsion and hydrophobic interaction, the 
amphiphilic molecules showed to self-assemble into stable capsular hollow structures in the 
presence of physiological ion concentration and pH. Poly-l-lysine coated microcapsules with an 
average diameter of 450 m and homogenous size distribution were obtained. The morphology 
revealed by scanning electron microscopy showed microcapsules with two distinct layers. The 
ability of Palmitoyl-Xanthan microcapsules to sustain viability and proliferation of encapsulated 
cells was confirmed by AlamarBlue and DNA assays. These findings suggest the application of 
Palmitoyl-Xanthan microcapsules as a potential material for cell encapsulation in cell-based 
therapies.  
 
 
 
 
_________________________________________ 
*This chapter is based on the following publication:  
Ana C. Mendes, Erkan T. Baran, Cláudia Nunes, Manuel A. Coimbra, Helena S. Azevedo, Rui L. Reis, 
Palmitoylation of xanthan polysaccharide for self-assembly microcapsule formation and encapsulation of 
cells in physiological conditions, Soft Matter,7: 9647-9658, 2011. 
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1. INTRODUCTION 
Supramolecular chemistry makes use of non-covalent interactions to achieve the controlled 
assembly of molecular segments, providing a versatile tool for the spontaneous organization of 
molecules into stable and functional structures 1-2. Self-assembly can occur through a change in 
temperature, pH or ion concentration or triggered by radiation 3. Self-assembled structures can 
mimic aspects of biological systems such as artificial cell membranes, enzymes, channels which 
makes this methodology suitable to be applied for bottom-up fabrication of new biomaterial 
systems that can be used as artificial matrices for cell culture. 
Hydrophobized polysaccharides have been extensively studied in biomedical field due to their 
capability to spontaneously self-assemble in water into functional nanostructures (bilayer 
membranes, micelles, tubes and vesicles) 4-8. In general, such hydrophobized polymers consist 
of a water-soluble main chain, the polysaccharide, carrying a small number of hydrophobic 
groups. The polysaccharide backbone, presents numerous favorable characteristics such as 
biodegradability, low toxicity and abundance of functional groups for further modification. The 
amphiphilic nature imparted after hydrophobic modification gives them the possibility to be used 
in a wide range of applications such as emulsion stabilizers, surface modifiers for liposomes and 
nanoparticles 9-10 and as drug delivery vehicles 11-12.  
Xanthan gum (Figure IV.1.A). is an anionic extracellular bacterial polysaccharide  with the ability 
to organize into liquid crystaline phases at specific conditions 13-17 providing an anysotropic 
nature as a result of the helical structure. This biopolymer was shown to be biocompatible 17, 
biodegradable and exhibits gel-like properties, being widely used in food, cosmetic and 
pharmaceutical industries because of the encouraging reports on safety 15. Recently, Mendes 
and co-workers 18 have reported the potential of this biopolymer as cell encapsulation matrix. 
They demonstrated that stable xanthan microcapsules were generated and encapsulated cells 
remained viable and were observed to proliferate for prolonged culture periods. 
Herein, we present the synthesis of an amphiphilic polysaccharide, in which palmitoyl groups are 
attached to an anionic polysaccharide chain (xanthan gum) and demonstrate that the 
amphiphilic polysaccharide (palmitoyl xanthan) is able to self-assemble into capsules in saline 
solutions. The properties and performance of palmitoyl xanthan microcapsules were studied by 
exploiting the balance between the hydrophobic and ionic interactions. A second aim of this 
study was to evaluate the ability of these self-assembled matrices to support the viability, 
function, and proliferation of encapsulated cells. 
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Figure IV.1. Chemical structure of xanthan repeating unit (A) and palmitoyl xanthan (B) 
 
2. MATERIALS AND METHODS 
Materials 
All chemicals, including xanthan gum from Xanthomonas campestris, palmitoyl chloride and 
poly-l-ysine (PLL), were obtained from Sigma/Aldrich unless otherwise indicated. The chemicals 
were used as received. Characterization of native xanthan (elemental composition, degree of 
acetylation, molecular weight and monosaccharide content) is reported on experimental section 
of this thesis. 
Preparation of palmitoyl xanthan (PX) 
Xanthan was dissolved in distilled water (1 wt%) at room temperature in a round-bottom glass 
flask. The polymer solution was placed in an ice-water bath and vigorously stirred using a 
mechanical stirrer (IKA, Germany). Palmitoyl chloride was then added dropwise at different 
ratios as shown in Table IV.I. The reaction mixture was allowed to stand at room temperature 
under continuous stirring for 23 h. The reaction was stopped by the addition of excess of cold 
ethanol and filtered. The final product was dried at room temperature until constant mass. 
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Table IV.1. Sample designation for each palmitoyl xanthan conjugate. 
Sample designation Xanthan (mmol) 
Palmitoyl chloride 
(mmol) 
Xanthan/Palmitoyl 
chloride ratio (w/w) 
PX(X=0.50P) 0.58 1.18 0.50 
PX(X=0.75P) 0.58 0.78 0.75 
PX(X=1.40P) 0.58 0.42 1.40 
PX(X=1.70P) 0.58 0.35 1.70 
 
Characterization of PX 
Solubility 
The solubility of each Palmitoyl-Xanthan conjugate was assessed in organic solvents by placing 
10 mg of PX in 4 mL of each solvent. The suspension solution was mixed by vortex and placed 
in a water bath at 37 ºC overnight. Solubility was examined visually for any undissolved solute 
particles 19. 
Fourier transform infrared (FTIR) spectroscopy. 
The chemical modification of xanthan with palmitoyl was analysed by infrared spectroscopy. 
Prior to analysis, potassium bromide pellets were prepared by mixing the native xanthan and 
PXs powder with potassium bromide (KBr, PIKE Techonologies, USA) at 1/10 (wt/wt) PX/KBr 
ratio. The spectra were acquired on an IR Prestige-21 (SHIMADZU, Japan) spectrophotometer 
with the average of 32 scans and a resolution of 4 cm-1. 
1H Nuclear magnetic resonance (NMR) spectroscopy 
Samples containing different ratios of xanthan/palmitoyl chloride were dissolved at a 
concentration of 1 wt% in deuterated dimethylsulfoxide (d-DMSO). Fully relaxed 1H NMR spectra 
were acquired in a Varian Unity Plus 300 MHz spectrometer. 
Wide angle x-ray scattering (WAXS) 
The PX conjugates were characterized by WAXS technique to verify any molecular orientation. 
WAXS measurements were performed using a Bruker AXS NanoStar with a HiStar 2D detector 
with scattering angles from 5 to 60 º. 
Differential scanning calorimetry (DSC) 
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DSC analysis of PX conjugates were performed in a calorimeter (TA instruments, USA) with a 
heating program of 10 ºC min-1 from 10 to 200 ºC under nitrogen at flow of 20 cm3.min−1. 
Circular dichroism (CD) 
CD was used to study the effects of palmitoylation on the secondary structure of native xanthan. 
PX(X=1.7P) and native xanthan were dissolved in ultrapure water overnight at concentration of 
0.1 wt%. The measurements were performed in a Stopped-flow circular dichroism 
spectropolarimeter (PiStar-180, Applied Photophysics, UK) at 25 ºC using Quartz cells with a 0.1 
cm path length. The spectra were recorded from 300 to 180 nm with a scan rate of 100 nm/min 
and are an average of five accumulations. 
Dynamic light scattering (DLS) and zeta potential measurements 
DLS and zeta potential measurements were performed using a Zetasizer NanoZS Instrument 
(ZEN 3600, Malvern Instruments, Worcestershire, UK). Prior the analyses, PX(X=1.7P) and 
xanthan solutions were prepared at concentration of 0.1 wt% and their pH was adjusted to 5, 6, 
7 and 8 using 0.1 M HCl, and 0.1 M NH3OH). The solutions were filtered using a pyrogen free 
0.45 μm disposable membrane filter (Schleicher and Schuell Bioscience, Germany). 
Scanning transmission electron microscopy (STEM) 
TEM samples of xanthan (control) and water-soluble PX conjugate were prepared by placing 
one drop of the polymer solution and (0.1 wt%) onto a 300-mesh copper grid coated with carbon 
film, followed by 1% (w/v) of uranyl acetate (Electron Microscopy Sciences) staining for 3 min. 
The samples were analyzed and photographed using a Hitachi Su electron microscope in S-
TEM mode. 
Microcapsule formation by self assembly and characterization 
To study the capability of the palmitoyl-xanthan conjugates to form suitable capsules for cell 
encapsulation, we have selected PX(X=1.7P) conjugate having into account its solubility in 
aqueous solutions. Various concentrations of PX(X=1.7P) solutions (1-3%) were tested for 
microcapsule preparation. 1% solution provided smooth and spherical microcapsules and this 
concentration was further used in the subsequent studies. PX(X=1.7P) was dissolved in HEPES 
buffer solution (55 mM, pH 7.4, Sigma) supplemented with 0.1 M CaCl2 at concentration of 1 
wt% and further sterilized by UV light for 20 min in a laminar flow cabinet. Capsules were formed 
by extrusion of the polymer solution from a disposable plastic syringe with a 2.5 G diameter 
needle into a flask containing PBS.  
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Microcapsule morphology: scanning electron microscopy (SEM) 
Previous to SEM observation, the capsules were fixed subsequently for 1 h with formaline 3.7% 
and 3% v/v of glutaraldehyde (Electron Microscopy Sciences) in PBS. The samples were further 
dehydrated in graded ethanol series (20, 50, 60, 70, 80, 90 and 100%) followed by immersion in 
100% hexamethyldisilazane (HMDS, Electron Microscopy Sciences). The specimens were 
transferred and mounted on aluminum stubs and allowed to dry at room temperature. 
Microcapsules were cut in half to expose the membrane cross-section and the internal surface of 
microcapsules. Prior to observation, they were sputter coated with Pt/Pd target (80/20) 
generating a thin film with 6 nm of thickness (208 HR High Resolution Sputter Coater, 
Cressington). The microcapsules were imaged on an ultra-high resolution field emission gun 
scanning electron microscope (FEG/SEM, FEI Nova 200 NanoSEM). 
Cell encapsulation and culture 
To validate the utility of PX as cell encapsulating matrix, we carried out cell culture studies within 
the PX microcapsules. The murine ATDC5 chondrocyte cells were cultured in basic medium, 
consisted of Dulbecoo’s Modified Eagle’s Medium (DMEM, Sigma-Aldrich) with phenol red, 
supplemented with 10% fetal calf serum (FCS, Biochrom AG), 5 mM L-Glutamine (Sigma) and 
1% of antibiotic-antimycotic mixture (Sigma) and maintained at 37 °C in a humidified 
atmosphere of 5% CO2. The medium was replaced every two days. At passage 9, cells were 
detached with trypsin/EDTA and counted in a hemacytometer for encapsulation. A cell 
suspension (5x106 cells/ml, 0,5 ml) was mixed with PX(X=1.7P) solution (1.5 ml, 1 wt% final 
concentration). The cells were encapsulated into the PX(X=1.7P) matrix using a novel micro-
droplet generator developed in our group as previously reported 18,20 (Figure IV.2.).  
Briefly, an autoclavable tubing (Novosil, Fisher Scientific) with 1 mm internal diameter was 
punctured with a blunt end needle (12 G) in a vertical position and sealed with a silicone glue. 
This assembly was then connected to a peristaltic pump (Ismatec, Switzerland) for perfusion of 
mineral oil and syringe pump (Alladdin WPI, England) for gel-cell injection in a sterile laminar 
flow cabinet. One end of tubing was connected to an oil reservoir and the other end to a glass 
collector, where the micro droplets of gels can be self assembled in a PBS solution. The 
operation rate of peristaltic and syringe pump was set at 0.35 ml/minute and 0.50µl/min, 
respectively. The microcapsules were stirred in collection vessel for 15 min and then transferred 
into 0.1 wt% poly-L-lysine solution and stirred for 10 min. The coated microcapsules were 
transferred into tissue culture wells with DMEM and cultured in standard conditions (37 ºC and 
5% CO2) for 1, 7, 14 and 21 days. The medium was exchanged every 2 days. 
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Figure IV.2. Schematic of the set-up for cell encapsulation showing details of the micro-droplet generator. A solution 
of palmitoyl xanthan, with or without cells, was injected into a stream of mineral oil resulting in the formation of 
spherical droplets and a water-in-oil emulsion due to the immiscibility of the two phases. The polymer microdroplets in 
oil were then carried into a gelling inducer solution (phosphate buffer solution, PBS). In PBS, the palmitoyl xanthan 
droplets self-assemble into capsular gel structure. The hollow capsules were then collected and treated with poly-L-
lysine to strengthen the outer surface of the microcapsules. 
 
Cell viability - live/dead cell assay 
Calcein AM (Sigma) solution (2/1000, v/v) was prepared in DMEM medium without FCS and 
phenol red. Propidium iodide (PI, Molecular Probes, Invitrogen) solution was prepared by mixing 
2 µL PI (1 mg/mL) with 20 µL (1 mg/mL) RNAse A (USB corporation) and 2 mL PBS. The 
microcapsules with encapsulated cells and controls (without cells) were collected from the 
culturing plates and incubated with calcein-AM and propidium iodide solutions at 37 ºC for 10 
min protected from light. Microcapsules were then observed under fluorescent microscopy using 
an Axio (Zeiss HAL 100/HBO 100; Axiocam MRc5 (Zeiss).  
Metabolic activity of encapsulated cells - AlamarBlue® assay 
The metabolic activity of encapsulated cells over time was assessed using the AlamarBlue® 
assay (AbD Serotec). AlamarBlue® was added (10% of the volume of the well) to each well 
containing the encapsulated cells and the plate was incubated at 37 ºC for 20 hours protected 
from light. After incubation, aliquots were taken and transferred to a 96-well plate and the 
absorbance was measured at 570 and 600 nm on a microplate reader (BIO-TEK, SYNERGIE HT, 
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USA). The percentage of reduced AlamarBlue® was calculated according the manufacturer 
instructions. 
Cellular proliferation assay – DNA quantification 
ATDC5 proliferation within the capsules was determined using a fluorimetric DNA quantification 
kit (PicoGreen, Molecular Probes, Invitrogen). For this purpose, the samples collected at days 1, 
7, 14 and 21 were washed twice with sterile PBS (Sigma, USA) solution and placed in 1 mL of 
ultra-pure water. Capsules with and without cells were stored at -80 ºC until further analysis. 
Prior to DNA quantification, samples were thawed and broken by pipetting up and down using a 
syringe with a needle to cause material disruption and facilitate DNA extraction. 28.7 µL aliquots 
and standards (0-2 mg/mL) were transferred to an opaque 96 well plate. Then 71.3 µL of 
PicoGreen solution and 100 µL of Tris-EDTA buffer were added. Standards and samples were 
prepared in triplicate. The plate was incubated for 10 minutes in the dark and the fluorescence 
was measured using an excitation wavelength of 485 nm and emission of 528 nm. DNA 
amounts were calculated from the calibration curve. 
Statistical analysis 
The results of DNA quantification and cell viability are expressed as a mean ± standard deviation 
with n=3 for each group. Statistical significance of differences was determined using unpaired 
student’s t-test multiple comparison procedure at a confidence level of 95 % (p<0.05). 
3. RESULTS AND DISCUSSION 
The synthesis of palmitoyl xanthan was accomplished in a single-step reaction (Figure IV.1.). 
Hydrohobically-modified xanthans were prepared with different hydrophobic modification ratio 
(Table IV.I.). 
Solubility analysis 
The solubility of the palmitoyl/xanthan conjugates was tested in polar protic and aprotic solvents 
(Table IV.II.). PX(X=1.7P) Palmitoyl xanthan is the only conjugate that showed solubility in water 
which is a basic requirement for cell encapsulation in aqueous physiological buffer solutions. As 
shown in Table IV.2., all the PXs conjugates are soluble in DMSO, but PX(X=1.4P) and 
PX(X=1.7P) are also soluble in THF and PX(X=0.75P) also dissolves in DCM.  
The conjugates soluble in organic solvents could be further used as biomaterials, in particular for 
the production of nano- and microparticles by using an emulsion and solvent 
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extraction/evaporation methods. In our study, however, the PX(X=1.7P) conjugate was selected 
as suitable conjugate for microencapsulation of mammalian cells as it provides an amphiphilic 
and self-assembly property in physiological pH and ionic strength. 
 
Table IV 2. Solubility of PX conjugates in various polar aprotic (THF, DCM, Acetone, DMSO) and protic (ethanol and 
water) solvents. 
Sample 
designation 
Tetrahydro
furane 
(THF) 
(DEC: 7.5) 
Dichloromethane 
(DCM) (DEC: 9.1) 
Acetone 
(DEC: 21) 
Dimethyl 
Sulfoxide 
(DMSO) 
(DEC: 
46.7) 
Ethanol 
(DEC: 
16.8) 
Water 
(DEC: 
80) 
PX(X=0.50P) Swelled Swelled - Dissolved - - 
PX(X=0.75P) Swelled Dissolved - Dissolved - - 
PX(X=1.40P) Dissolved Swelled - Dissolved Swelled - 
PX(X=1.70P) Dissolved Swelled - Dissolved Swelled 
Dissolv
ed 
- : not dissolved, nor swelled. DEC: Dielectric constant. 
FTIR spectroscopy 
FTIR spectrum (Figure III.3.A) of native xanthan shows carbonyl (C=O) band at 1725 cm-1 
corresponding to acetate groups of an inner mannose unit. At 1606 cm-1, the characteristic band 
of carboxylate of pyruvate group and glucuronic acid appears. Spectra of modified xanthans 
show a shift in the carbonyl band towards 1700 cm-1. These changes may indicate the presence 
of additional ester groups and suggest that palmitoyl groups substituted the hydrogen atoms of 
hydroxyl groups in xanthan. It can also be noted the appearance of two absorption bands at 
2914 and 2846 cm-1, attributed to CH3 and CH2 vibrations from palmitoyl chains. The spectra 
show that the intensity of absorption bands is proportional to the palmitoyl content added during 
modification. 
1H NMR spectroscopy 
1H NMR spectra of palmitoyl xanthans (Figure IV.3.B) show peaks from the protons 
corresponding to the palmitoyl chain at 0.858 ppm (terminal methyl group), 1.062 ppm (13 
methylene groups), 1.234 ppm (-methylene group) and 2.380 ppm (-methylene group) whose 
intensities are proportional to the amount of reacted palmitoyl.  
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Figure IV.3. (A) FTIR and (B) 
1
H NMR spectra of native xanthan and palmitoyl xanthan with various degrees of 
modification [PX(X=0.5P), PX(X=0.75P), PX(X=1.40P) and PX(X=1.70P)]. 
 
WAXS 
To verify possible molecular organization after palmitoylation, we carried out WAXS 
experiments. Diffractograms of xanthan and palmitoyl/xanthan ratios (Figure IV.4.A), show the 
appearance of new peaks after modification, demonstrating that the native structure of xanthan 
has been modified after palmitoylation and this modification has induced a certain molecular 
organization. As expected, the peak intensity of palmitoyl xanthan increased proportionally with 
the feed ratio of palmitoyl chloride reactant (from PX(X=1.7P) to PX(X=0.5P)). This fact may be 
attributed to the higher amount of aliphatic chains (palmitoyl groups) that promotes higher 
hydrophobic interaction and consequently higher organization degree at structural level. 
De Bragg’s law gives the periodic distance, d-spacing values, that may correspond in this 
specific case to the distance for regularly molecular packing. Particularly, if the self-assemblies 
form bilayered structures with a same orientation, the d value should give the relative distance 
for the interdigitated hydrophobic interaction between alkyl chain groups, which is related to the 
hydrophobic interaction. Considering similarities between the main peaks, and comparing peak 
intensities as well as d-spacing, the intensities, as mentioned before, increase with increase of 
the amount of palmitoyl chains due the increase of hydrophobic interactions. Nevertheless, in all 
the samples, the distances between alkyl groups (d-spacing) does not change significantly with 
the amount of reacted palmitoyl chloride indicating that the arrangement of molecular packing 
should be the same independently of the intensity of hydrophobic forces (or amount of palmitoyl 
chains used in such reactions).  
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Figure IV.4. (A) WAXS diffractograms and (B) DSC thermograms of xanthan and palmitoyl xanthan(s). 
 
Table IV.3. Wide angle x-ray diffraction data of palmitoylated xanthan in various conjugation ratios 
Sample designation Angle 2Ɵ 
d-spacing 
Å 
PX(X=0.50P) 
7.48 
12.56 
21.80 
24.32 
31.84 
11.82 
7.09 
4.15 
3.74 
2.92 
PX(X=0.75P) 
7.52 
12.60 
21.84 
24.28 
31.76 
11.84 
7.06 
4.14 
3.74 
2.92 
PX(X=1.40P) 
7.52 
21.80 
24.28 
11.84 
4.15 
3.74 
PX7(X=1.7P) 
7.32 
12.36 
21.60 
24.44 
12.12 
7.19 
4.18 
3.71 
   
Xanthan 31.60 2.94 
The main peaks of conjugate materials were detected at 21.8 and 24.32 2Ɵ values, which 
correspond to 4.15 and 3.74 Å respectively (Table IV.3.). The found d-values indicate that the 
ordered structures are near one and half and two palmitoyl chains length, as Benges et al 
observed in pure nanocrystals of palmitic acid (about 2 Å) 21. As the palmitoylation was 
increased, the relative intensity ratio of 3.74 Å/4.15 Å was higher, showing that the palmitoyl 
chains are interacting more with opposite chains, which may induce stacking between aliphatic 
chains and shortening the packing distance. 
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DSC analysis 
The DSC curves of palmitoyl xanthan (Figure IV.4.B) shows one endothermic phase transition at 
61 ºC which is less intense as the amount of palmitoyl added to reaction is lower. In the DSC 
curve of native xanthan, no relevant transition was observed. These observations are 
corroborating the WAXS results. Such behaviour may be attributed to the increased hydrophobic 
interactions provided by the higher amounts of reacted palmitoyl that will supply a molecular 
rearrangement and consequently induce intermolecular organization. 
Molecular conformation - CD spectroscopy 
CD spectroscopy is suitable technique to predict molecular conformation in liquid state. We used 
CD to investigate changes in molecular structure of xanthan after palmitoylation, CD analyses of 
xanthan and PX(X=1.7P) were performed at 25 ºC in water. The spectrum of both polymers 
(Figure IV.5.A) showed an increase in peak height with maximum absorption wavelength at 196 
nm (ordered state) and a decrease of the minimum with displacement at higher wavelengths at 
220 nm (disordered state). Despite both materials present similar CD signatures, in PX(X=1.7P) 
the difference in absorption of left-hand and right-hand circularly polarized light is more 
accentuated, it can be deduced that the introduction of such hydrophobic tails are promoting a 
soft disruption of the organized structure. Considering that the palmitoylation was performed at 
low temperature (0 ºC), at which an ordered helicoidal structure on native xanthan is present, it 
is more probable that the palmitoyl chains reacted with the hydroxyl groups of the trissaccharide 
side chain due to the difficulty to access to the internal primary structure. Previously, the ordered 
conformation of xanthan was investigated thoroughly and indicated that native xanthan involves 
single or double helix structure and the solid state forms a helical structure with 5-fold symmetry 
22. As a result of conjugation of palmitoyl chains to hydroxyl groups, the disruption of hydrogen 
bonds, which are necessary for helicoidal structure formation, can be expected. 
The native structure of xanthan has been reported in several studies which showed that this 
biopolymer could be stable when assuming helical structure 16, being also temperature 
dependent 13,15. According to Lim and co-workers 23 for concentrations above 1 wt.%, xanthan 
may self-assemble into liquid crystalline regions. However, at around 0.5%, the structure is not 
liquid crystalline in nature but present networks formed by self-organization provided by 
hydrogen bonding. It has been studied before that xanthan forms gels in the presence of salts 
and those have the ability to stabilize the ordered conformation 13,15-16.  
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Dynamic light scattering and zeta potential measurements 
The electrical charge (ζ-potential) of polymers is dependent on several factors such as the pH, 
polymer conformation, and polymer concentration.  
Figure IV.5.B and C presents the zeta potential and particle size of PX(X=1.7P) and native 
xanthan as a function of pH. 
 
Figure IV.5. (A) CD spectra of xanthan and PX(X=1.70P) solutions (0.1 wt%) in distilled water (B) Zeta potential 
measurements and (C) particles size (diameter) of xanthan and PX(X=1.70P) xanthan conjugate aqueous solution as 
a function of pH.  
 
After modification, a decrease in the negative zeta potential is observed when compared with 
native xanthan. At low pH (pH 5), PX(X=1.7P) exhibits a zeta potential value of -26 mV, which 
becomes less negative as the pH increase, reaching the minimum at pH 7 (-17 mV) and then 
increase again at pH 8. Nevertheless, these changes in zeta potential are not as evident as the 
ones observed for native xanthan, where the negatively charged carboxylic groups may be 
positioned without any stereochemical protection and consequently more sensitive to pH 
changes. In the case of PX(X=1.7P), the hydrophobic effect provided by the aliphatic chains of 
palmitoyl is improving the stabilization of molecules, being this maximum peak of stabilization 
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reached at pH 7. At this pH, the hydrophobic interaction between the palmitoyl groups took 
control, occurring the formation of particle aggregate, as can be noticed by the abrupt increase 
in particle size (533 nm) (Figure IV.5.C) while in native xanthan this effect was not observed. 
Given these preliminary results, pH 7 is considered as the transition pH for the self-assembly of 
the amphiphilic conjugate. At pH 7, PX(X=1.7P) was detected in the lowest charged state, in 
which the repulsion between charged groups is expected to be minimum, and this can enhance 
hydrophobic action between alkyl chains. Similarly, a recent study showed that a rapid 
hydrogelation of N-palmitoyl chitosan was occurred through a proper balance between charge 
repulsion and hydrophobic interaction by its environmental pH within a narrow range (pH 6-5-
7.0) 24. 
STEM analysis 
In order to investigate the supramolecular rearrangement of palmitoyl xanthan in physiological 
conditions, namely in an ionic strength of 0.9 % NaCl and at pH 7.4, the casted solutions of 
conjugate was analyzed with scanning transmission electron microscope after negative staining 
with uranyl acetate. The conjugate which was not exposed to any ionic solution and dissolved in 
distilled water showed a random, thin, fibrous network structures as seen by STEM micrographs 
(Figure IV.8.). This fibrous network structure was also evident when the conjugate was dissolved 
in HEPES buffer. In that case, however, the thickness of fibrous structures was increased as 
determined by STEM micrographs at various magnifications. When the palmitoyl xanthan 
solution was incubated in PBS similar to microcapsule preparation, on the other hand, the 
lamellar structures were observed instead of fibrous networks. The magnified STEM images 
clearly show that the assembled structures were formed in an angular and lamellar morphology.  
In addition, the STEM micrographs of native xanthan did not indicate any visible ultra-structures 
which can interact with negative staining as seen in the micrographs. 
Those results may indicate that there were light supromolecular organizations of palmitoyl 
xanthan molecules in aqueous environment without ions. This was even more pronounced in 
HEPES buffer solution by increased size of fibrous structures but still it was not sufficient for a 
major hydrophobic interaction resulting in stable assemblies. The aggregation of PX molecules 
in the ionic and pH milieu provided by PBS and the observation of lamellar structures were 
supporting the hypothesis that major hydrophobic transition occurred in physiological ion 
strength and pH. 
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Figure IV.6. STEM images of palmitoyl-xanthan in 0.1 wt% solution. The samples were negatively stained with 1% 
(w/v) uranyl acetate. 
SEM analysis 
As the first attempt to produce capsules, we tried to extrude 1 and 3 wt% xanthan in PBS. 
Although capsules were able to be formed, they were not stable as they started to dissolve. 
Aiming to improve the stability of xanthan capsules, the procedure described previously was 
performed and successful with PX(X=1.7P), resulting in the hollow capsules showed in SEM 
micrographs (Figure IV.7.A.). SEM analysis of PX(X=1.7P) microcapsules have indicated that 
the external wall structure was constituted of nano-lamels which are overlapping each other with 
a layer thickness of about 52 nm as observed on surface and inside the wall cross-section 
(Figure IV.7.C, D, E and F). 
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Figure IV.7. SEM images showing the overall structure of PX(X=1.70P) capsules performed manually (A), cross-
section of microcapsule membrane (C and the microstructure of the capsule internal (B) and external surface (D). 
Magnified images revealing morphological details of the external surface of PX(X =1.70P) capsules (E and F). 
 
Based on organization of ultra structures revealed by SEM, it can be hypothesized that salt 
addition result in the screening of electrostatic repulsion and the hydrophobic interaction 
between conjugated alkyl chains become the dominating forces leading to molecular packing 
(Figure IV.8.). The internal calcium in gel must diminish repulsion forces between carboxyl 
groups by ionic bridge formation and subsequently, the monovalent cations provided from PBS 
must interact with the polar groups of polysacharide backbone by decreasing their solvation with 
water molecules. As a result of those interactions, the hydrophobic forces between alkyl chains 
become a dominant force and a self organization of molecules resulted in multilayered lamellar 
structures. Those layered structures can further aggregate into piled up structures as polar-
nonpolar repulsion between assembled alky chains and hydrophilic polysaccharide backbone. 
Non-covalent interactions are the main forces that hold supramolecular species together2. 
Despite of its weak nature, relatively to covalent interaction, when these interactions are used 
synergistically, a stable supramolecular complex could be formed. In this specific case, those 
interactions should create a synergistic effect and consequently, able to form and maintain a 
hollow structure with wall thickness of around 16.7 µm that is shown in Figure IV.7.C. We have 
formulated a possible mechanism for the self-assembly of palmitoyl xanthan amphiphile 
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(Figure IV.8.) into hollow capsular structures. The balance between charge repulsion and 
hydrophobic interaction in palmitoyl xanthan is sensitive to environmental pH and presence of 
salts. In absence of salts (water) the charge repulsion between the negatively charge carboxylic 
groups on xanthan is dominating. In PBS, the electrostatic repulsion resulting from the charged 
groups is suppressed by the accumulation of counter ions diffused from the PBS (screening 
effect), thus increasing the hydrophobic interaction. 
 
Figure IV.8. Schematic depiction of microcapsule formation mechanism by PBS induced self assembly of palmitoyl-
xanthan amphiphile molecules (A) and the mechanism of microcapsule formation (B) by hydrophobic forces. 
 
Xanthan-palmitoyl microcapsule formation and cell encapsulation 
When designing materials for cell encapsulation, several properties should be considered for cell 
optimum biological functions. For instance, the amount and the character of functional groups 
contained in monomer units will influence the intermolecular interactions and also the 
interactions that lead to the capsule formation. As mentioned previously, palmitoyl xanthan by 
itself in physiological conditions is able to form self-supporting capsules in the presence of ions 
which are stable in long term. Although appropriate for cell encapsulation purposes, these 
capsules are not physically stable enough to enclosure cells and protect from immunotoxins. For 
this reason, the PX(X=1.7P) microcapsules, which have negatively charged carboxyl groups, 
were coated with cationic poly-l-lysine (PLL). The PLL is well studied in cell encapsulation and 
has showed satisfactory performance in the encapsulation of cells with xanthan based material 
18. 
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Figure IV.9. Bright field light microscopy images of PX(X=1.70P) microcapsules uncoated (A) and coated (B) with 
poly-l-lysine (external layer). 
 
The microcapsules obtained in the present study were spherical and uniform in size with 
diameter size around 450 µm (Figure IV.9.). As it can be observed from the cross-section 
images, there are two distinct layers corresponding to PX(X=1.7P) matrix inside and poly-l-lysine 
cover at outside. 
In vitro viability, proliferation and morphology of ATDC5 cells cultured within 
microcapsules  
To assess the ability of PX(X=1.7P) microcapsules to sustain cell viability, we encapsulated 
ATDC5 cells, an immortalized chondrocytic cell line, within these self-assembled matrices. The 
morphology and viability of encapsulated cells in PX(X=1.7P) microcapsules were investigated. 
Live/dead assay (Figure IV.10.A) shows that encapsulated cells remain viable up to 21 days of 
culture (viable cells depict a green fluorescence color), demonstrating the ability of palmitoyl 
xanthan self-assembled matrix to support cellular viability over prolonged time. Cell viability 
within the microcapsules is also confirmed by the results from the AlamarBlue® assay (Figure 
IV.10. B). Encapsulated cells were observed to reduce AlamarBlue® during 21 days of in vitro 
culture, exhibiting a slight increase in the metabolic activity from day 7 to day 21. 
To validate the results from cell viability studies, cell proliferation was investigated by DNA 
quantification (Figure IV.10.C). A gradual increase of DNA quantity was observed from day 7 
until day 21 as a result of improved cellular proliferation in PX(X=1.7P) microcapsules.  
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Cell viability and proliferation within the microcapsules indicate that palmitoyl xanthan 
microcapsules are permeable as they are able to provide sufficient oxygen and nutrients 
necessary for cell survival and proliferation. SEM images of the microcapsule (Figure IV.11.) 
show two layers with distinct morphologies that can be appreciated.  
 
Figure IV.10. In vitro viability and proliferation of ATDC5 cells cultured in PX(X=1.70P)/PLL microcapsules. (A) 
Fluorescence microscopy images displaying the live/dead assay of encapsulated cells (green cells are live, red cells 
are dead) showing that the cells remain viable in the microcapsules up to 21 days of culture. (B) Metabolic activity and 
(C) proliferation of encapsulated cells determined by AlamarBlue® assay and DNA quantification. Results are 
expressed as means ± standard deviation with n=3. *Indicates a significant difference (p< 0.05) for different time 
points. 
 
Most mammalian cells are anchorage dependent and therefore have to adhere to a surface to 
express their optimum metabolic functionality and viability 25. SEM analysis on cell cultured 
microcapsules after 21 days revealed that the cells were partially entrapped on the internal side 
of the dense microcapsule wall (Figure IV.11.E and F) This may be explained by the fact that 
nutrients and oxygen are more readily available at the capsule surface than in the microcapsule 
core. This core shell type microcapsules, with partial embedding of cells on inner wall, might be 
superior to cell microencapsulation into firm gels, like into alginate beads formed by ionic 
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crosslinking, since the cells immobilized in the center of the gel would present decreased 
metabolic activity and proliferation as the diffusion of nutrients and oxygen would be more 
challenging at this location.  
 
Figure IV.11. SEM images showing the overall PX(X=1.70P)/PLL microcapsule after 21 days of culture (A), the 
external surface (B) and the cross-section demonstrating the interface between PX(X=1.70P) and  poly-l-lysine 
complex (C). Internal surface (D) and morphological characteristics of the cells attached to the microcapsule inner 
surface (E) and (F). 
 
4. CONCLUSIONS 
Palmitoyl xanthan with various conjugation ratios was successfully synthesized to obtain an 
amphiphilic polysaccharide. The amphiphilic character imparted to native xanthan only by certain 
palmitoyl ratio allows the self-assembly into stable hollow capsule structures in cell-friendly 
conditions, i.e., in the presence of physiological ion concentration and pH. Microcapsules with 
long-term stability and ability to support cell viability and proliferation in vitro over prolonged time 
were obtained using this self-assembling system. In summary, we have demonstrated the use of 
self-assembly to provide triggered activation for capsule formation. This approach provides an 
easy and versatile strategy for the construction of synthetic matrices capable of encapsulating 
living cells that could be applied in cell-delivery therapies. 
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Chapter V* 
GUIDED AND MICROFLUIDIC SELF-ASSEMBLY OF PHOSPHOLIPID-XANTHAN 
MICROCAPSULES 
 
ABSTRACT 
We report the synthesis of an amphiphilic polysaccharide, a phospholipid (1,2-dioleoyl-sn-
glycero-phosphoetilamine (DOPE)) conjugated with the anionic xanthan gum, and its ability to 
spontaneously self-assemble into capsular structures under mild aqueous conditions for cell 
encapsulation. Moreover, this work also aimed to apply a microfluidic platform that can precisely 
generate micro-sized and monodispersed capsules. The properties (size, morphology, 
permeability) and performance (stability) of the obtained microcapsules were studied, as well 
their ability to support the viability, function, and proliferation of encapsulated cells. The self-
assembly of the amphiphilic polysaccharide at certain concentrations in physiological ionic 
strength and pH resulted in the formation of stable hollow capsular structures. Using the 
microfluidic device, homogenous microcapsules were fabricated. ATDC5 cells were 
encapsulated within the capsules and shown to remain viable, evidencing an increased cellular 
metabolic activity over 21 days of in vitro culture. By combining self-assembly of xanthan-DOPE 
and microfluidic microencapsulation, we were able to fabricate microcapsules that provided an 
adequate environment for cells to survive and proliferate.  
 
 
 
 
_________________________________________ 
*This chapter is based on the following publication: 
Ana C. Mendes, Erkan T. Baran, Rui L. Reis, Helena S. Azevedo, Guided and microfluidic self-assembly 
of phospholipid-xanthan microcapsules, 2012, submitted 
.
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1. INTRODUCTION 
Hydrophobic interactions have been recognized as one of the driving forces observed on the 
self-organization of biological structures. The cellular membrane, composed of phospholipid 
bilayer1-2, is an example of self-assembled structure driven by hydrophobic effects. The 
phospholipids arrange themselves in such a way that their hydrophobic tails are projecting 
inwards while their polar head groups are projecting on the outside surfaces1,3. This organization 
of phospholipids in the cell membranes makes the latter selectively permeable to ions and 
molecules. Due to its biological importance, phospholipid membranes have been explored for 
preparing biomimetic capsular structures4, mainly vesicles or liposomes, and also as a coating 
for water microdroplets1. In fact, lipids are common self-assembling molecules used by cells to 
compartmentalize biological processes. Liposomes, which are cell mimics lacking the internal 
cellular contents, are good candidates for the encapsulation of biological materials but their high 
sensitivity to osmotic pressure and mechanical stress has limited their application as cell 
encapsulation matrices. Furthermore, the water microdroplets coated with phospholiplips2,5 have 
been investigated in order to overcome such problems and considered as suitable models of 
living cells, since the molecular organization of the phospholipids may be similar to the 
organization of the cytoplasmatic membrane2. Therefore, biomimetic microcapsules have been 
fabricated by applying lipids and proteins as assembly pairs6 for cell encapsulation. Self-
assembling hydrophobized polysaccharides have been considered to provide opportunities in 
molecular design of biomaterials. A hydrophobized polysccharide consists mainly in a water-
soluble main chain, the polysaccharide, carrying a small number of hydrophobic groups. The use 
of these materials is appealing, once the polysaccharide backbone presents numerous favorable 
characteristics such as biodegradability, low toxicity, protein rejecting ability, receptor interaction 
through specific sugar moieties, and abundance of functional groups for modification or 
functionalization7-8. Afterwards, the amphiphilic nature imparted to the polysaccharides after 
hydrophobic modification gives them the ability to self-assemble in cell friendly conditions into 
functional nanostructures 9-13 that can be used in a wide range of biomedical application such as 
emulsion stabilizers, surface modifiers for liposomes and nanoparticles14-15 and as drug delivery 
vehicles16-17. Self-assembly of an amphiphilic polysaccharide into microcapsules in aqueous 
solution for cell encapsulation has been demonstrated in our group as an alternative path to the 
current ion crosslinkable systems18. In this work, we describe the conjugation of the phospholipid 
1,2-dioleoyl -sn-glycero-phosphoetilamine (DOPE) with xanthan (Figure V.1.), a bacterial 
extracellular polysaccharide with a known potential as encapsulating matrix18-19, to obtain an 
amphiphilic system able to form hollow capsules by self-assembly obviating the need of core 
removal, like in the approach of layer-by-layer assembly on colloidal templates. For reproducibly 
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generating capsules with controlled spherical shape and micro-size range, we have employed 
microfluidic technique. The structure and properties of phospholipid xanthan microcapsules are 
described and their potential for application in cell encapsulation.  
 
 
Figure V.1. Chemical structure of xanthan repeating unit (A) and xanthan-DOPE (B) with DOPE molecules (shown in 
red) conjugated in the carboxylic groups of xanthan. 
 
2. MATERIALS AND METHODS 
Materials 
All chemicals, including xanthan gum from Xanthomonas campestris, 1,2-dioleoyl-sn-glycero-3-
phosphoethylenoamine (DOPE) and poly-L-lysine (PLL, 30-70 KDa) were obtained from 
Sigma/Aldrich (USA) unless otherwise indicated, and used as received. Calcium and sodium 
chloride were provided from Merck (Germany) and Carlo Erba (Italy) respectively. Ethanol was 
obtained from Panreac (Spain). 
Synthesis of xanthan-DOPE  
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Xanthan, with an average molecular weight of 152 kDa18, was dissolved in 2-(N-
morpholino)ethanesulfonic acid buffer solution (MES, Sigma), at 55 mM at room temperature. 
The xanthan solution was placed in an ice water bath, under inert atmosphere, and the pH was 
adjusted to 5.5. The N-hydroxysuccinimide (NHS) and ethyl(dimethylaminopropyl)carbodiimide 
(EDC) (NHS/EDC molar ratio = 0.6) was added to xanthan under stirring condition. Equimolar 
amount of EDC was used to activate carboxyl group of xanthan which contains two units per 
repeating pentasaccharide. Later, DOPE was added at the same molarity of carboxyls20 and the 
pH was monitored and maintained at 5.5 during half an hour by adding HCl. The reaction took 
place overnight (15 h) and was stopped by the addition of excess of cold ethanol (70 %). The 
precipitate was washed by ethanol repeatedly on a filter and dried at room temperature until 
constant mass. 
Characterization of xanthan-DOPE 
Fourier transformed infra red (FTIR) spectroscopy 
The structural modification of xanthan-DOPE was followed by FTIR spectroscopy using an IR 
Prestige-21 (SHIMADZU, Japan) spectrophotometer. Prior the analysis, potassium bromide 
pellets were prepared by mixing the native xanthan and xanthan-DOPE powder with KBr (X/KBr 
and X-D/KBr, 1/10, wt/wt). The spectra were taken with the average of 32 scans and a resolution 
of 4 cm-1. 
1H nuclear magnetic resonance (NMR) spectroscopy 
Xanthan and xanthan-DOPE powders were dissolved at a concentration of 1.0 wt% in 
deuterated water (D2O). Fully relaxed 
1H NMR spectra were acquired in a Varian Unity Plus 300 
MHz spectrometer at 25 and 60 ºC. 
Determination of the degree of substitution (DS) 
The DS of the carboxylic groups of native xanthan with DOPE was determined by acid-base 
titration based on the method applied in19,21. Xanthan-DOPE (0.01 g) was dissolved in 40 mL of 
distilled water. The pH of the solution was adjusted to 2 with hydrochloric acid and then xanthan-
DOPE was titrated with 0.02 N NaOH. The volume of added NaOH, as well as the pH values 
were recorded. Three replicates were performed for each sample. DS was calculated as 
following:  
)(
)(
epD
epXru
nMm
nM
DS


       (V.1.) 
Chapter V. Guided and microfluidic self-assembly of phospholipid-xanthan microcapsules 
 
137 
MXru is the molecular weight of xanthan repeating unity (851); nep is the number of mol of 
carboxyll groups at the ending point of the titration; MD is the molecular weight of the reacted 
DOPE molecules grafted in the native structure of xanthan gum. 
Wide angle X-ray scattering (WAXS) 
WAXS technique was employed to obtain the X-ray diffraction patterns of native xanthan and 
xanthan-DOPE. Dry powders were placed in the sample holder and the WAXS patterns were 
obtained in a Bruker AXS NanoStar diffractometer with a HiStar 2D detector with scattering 
angles from 5 to 60º. 
Circular dichroism (CD) spectroscopy 
Xanthan and xanthan-DOPE were dissolved in ultrapure water at concentration of 0.1 wt%. The 
measurements were performed in a Stopped-flow circular dichroism spectrometer (PiStar-180 
spectrometer, Applied Photophysics, UK) at 25 ºC using quartz cells with 0.1 cm path length. 
The spectra were recorded from 300 to 180 nm with scan rate of 100 nm min-1 and are an 
average of five accumulations. 
Polarized light microscopy 
The morphology of xanthan-DOPE assemblies in aqueous conditions was also directly 
examined by polarized light microscopy. Native xanthan and xanthan-DOPE were dissolved in 
distilled water and the solution dropped onto a glass slide The samples were observed in a 
polarized light optical microscope (Olympus type BH-2) and recorded with a Olympus digital 
camera type DFC280. 
Microcapsule preparation 
Xanthan-DOPE was dissolved in HEPES buffer solution (55 mM, pH 7.4) supplemented with 0. 1 
M CaCl2 at concentration of 1 wt% and injected through the polymer microchannel of 
microfluidics device using a syringe pump (Alladdin WPI, England) (Figure V.4.C). 
Simultaneously, the flow of mineral oil was provided to the oil microchannel from an oil reservoir 
by using a peristaltic pump (Ismatec, Switzerland). The operation rate of peristaltic and syringe 
pump was set at 0.35 mL/minute and 20 μL/min, respectively. The xanthan-DOPE microdroplets 
were generated inside the microfluidics device by shear stress when the polymer solution in 
vertical microchannel entered into the stream of mineral oil in larger horizontal microchannel. 
The formed homogenous droplets of the xanthan-DOPE were collected in a collector vessel 
containing PBS solution and about 10 µL of Tween 80 as emulsifying agent. The self-assembly 
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of the amphiphilic xanthan in the aqueous PBS took place with subsequent microcapsule 
formation by gently stirring of droplets for 15 min. Separately, for coating purpose, some batches 
of self assembled microcapsules were transferred into 0.1wt% of poly-L-lysine solution and 
stirred gently for 10 min. Afterwards, the xanthan-DOPE and xanthan-DOPE-PLL microcapsules 
were washed in PBS before transferring them into cell culture plate 12 wells. 
Microcapsule characterization 
Microcapsule morphology by light microscopy analysis 
Microscopic observations of the microcapsules were carried out to examine the microcapsule 
and eventually cell morphology. At predetermined time points, micrographs of microcapsules 
were acquired in a bright field light microscope (AXIOVERT 40 CFL, Germany) equipped with a 
digital camera (Canon Power shot G8, Japan). 
Microcapsule microstructure by scanning electron microscopy (SEM) analysis 
Prior to SEM observation, the capsules were fixed with 3% v/v of glutaraldehyde (Electron 
Microscopy Sciences) in PBS for 1 h. The samples were further dehydrated sequentially by 
immersing microcapsules in graded ethanol series (20, 50, 60, 70, 80, 90 and 100%) for 10 min 
followed by immersion (three times for 10 min) in hexamethyldisilazane (Electron Microscopy 
Sciences). The specimens were transferred and mounted on aluminum stubs and allowed to dry 
at room temperature. Microcapsules were then frozen quickly in liquid nitrogen and cut in half by 
using a razor blade to expose the membrane cross-section and the internal surface of 
microcapsules. Prior to observation, they were sputter coated with Pt/Pd target (80/20) 
generating a thin film with 6 nm of thickness (208 HR High Resolution Sputter Coater, 
Cressington). The microcapsules were imaged on an ultra-high resolution field emission gun 
scanning electron microscope (FEG/SEM, FEI Nova 200 NanoSEM). 
Microcapsule permeability to Imoglobine G (IgG) antibody 
In order to assess IgG (Mw = 146-155 KDa, Abcam, UK) diffusion into the microcapsule interior, 
IgG was labelled with fluorescent dye (fluorescein isothiocyanate, FITC) which allows measuring 
protein sensitively. IgG was dissolved in sodium carbonate buffer (0.1 M, pH 9) at 2 mg/mL 
concentration. The fluorescein dye, dissolved in DMSO (1 mg/mL) was added into protein 
solution (1/1, v/v) and gently mixed for 8 hour at 4 oC in a dark room. Afterwards, the reaction 
was quenched by adding of ammonium chloride to final concentration of 50 mM. The solution 
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was dialyzed against distilled water in the darkness to remove unconjugated FITC. Finally, the 
dialyzed solution was freeze-dried in a light protected vessel. 
Equal volumes of xanthan-DOPE and xanthan-DOPE\PLL microcapsules (400 µL) and IgG-
FITC (400 µL, 15 mg/mL solution in 0.9% NaCl) were shaken in a water-shaker bath at 37 ºC 
and aliquots of 5 µL were collected from 0 to 3h. Concentrations of The fluorescence (485/528 
nm excitation/emission) of IgG-FITC in aliquots were measured on a microplate reader (BIO-
TEK, SYNERGIE HT, USA) and their concentrations were calculated  after constructing a 
standard curve from IgG standards.  
Mechanical stability 
The mechanical strength of xanthan-DOPE microcapsules was evaluated by agitating 100 
microcapsules (uncoated and coated with PLL) in a flat rotator at maximum rate (about 240 rpm, 
DSR-2800V, Digisystem Laboratory Instruments Inc., Taiwan). The microcapsules were 
distributed in 24 well plates (10 per well) with 1 mL of PBS. At various time intervals (1, 2, 3, 6, 
and 24 h) the number of ruptured capsules was counted by observation on a light microscope 
and the percentage of ruptured capsules in function of time was determined. 
Cell culture and encapsulation 
Cell expansion prior to encapsulation 
The murine ATDC5 chondrocyte cells were cultured in basic medium, consisting on Dulbecoo’s 
Modified Eagle’s Medium (DMEM, Sigma-Aldrich) with phenol red, supplemented with 10% fetal 
calf serum (FCS, Biochrom AG), 5 mM L-Glutamine (Sigma) and 1% of antibiotic-antimycotic 
mixture (Sigma) and maintained at 37 °C in a humidified atmosphere of 5% CO2. The medium 
was replaced every two days. At passage 10, cells were detached with trypsin/EDTA and 
counted in a hemacytometer for encapsulation. A cell suspension (5x106 cells/mL, 0.1 mL) was 
mixed with xanthan-DOPE solution (1.9 mL, 1 wt% final concentration). The microcapsules were 
fabricated as described previously for microcapsule preparation. 
Cell viability  
Live/dead cell assay 
Calcein AM (Sigma) solution (2/1000, v/v) was prepared in DMEM medium without FCS and 
phenol red. Propidium iodide (PI, Molecular Probes, Invitrogen) solution was prepared by mixing 
2 µL PI (1 mg/mL) with 20 µL (1 mg/mL) RNAse A (USB corporation) and 2 mL PBS. The 
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microcapsules with encapsulated cells and controls (without cells) were collected from the 
culturing plates and incubated with calcein-AM and propidium iodide solutions at 37 ºC for 10 
min protected from light . Microcapsules were then observed under fluorescent microscopy using 
an Axioplan Imager Z1m (Zeiss, Germany) microscope. 
AlamarBlue® assay 
The metabolic activity of encapsulated cells over time was assessed using the AlamarBlue® 
assay (AbD Serotec). AlamarBlue® was added (10% of the volume of the well) to each well 
containing the encapsulated cells and the plate was incubated at 37 ºC for 20 hours protected 
from light. After incubation, the absorbance was read at 570 and 600 nm on a microplate reader 
(BIO-TEK, SYNERGIE HT, USA). The percentage of reduced AlamarBlue® was calculated 
according the manufacturer instructions. 
Cellular proliferation assay – DNA quantification 
ATDC5 proliferation within the capsules was determined using a fluorimetric dsDNA 
quantification kit (PicoGreen, Molecular Probes, Invitrogen). For this purpose, the microcapsules 
collected at days 1, 7, 14 and 21 were washed twice with sterile PBS (Sigma, USA) solution and 
placed in 1 mL of ultra-pure water. Capsules with and without cells were stored at -80 ºC until 
further analysis. Prior to DNA quantification, samples were thawed and broken by pipetting up 
and down using a syringe with a hypotonic needle (21 G) to disrupt the material and facilitate 
DNA extraction. 28.7 µL of each sample and standards (0-2 mg/mL) were transferred to an 
opaque 96 well plate. Then 71.3 µL of PicoGreen solution and 100 µL of Tris-EDTA buffer were 
added. Standards and samples were prepared in triplicate. The plate was incubated for 10 
minutes in the dark and the fluorescence was measured using an excitation wavelength of 485 
nm and emission of 528 nm. DNA amounts were calculated from the calibration curve obtained 
by dsDNA standards (Molecular Probes, Invitrogen). 
Statistical analysis 
The results of DNA quantification and cell viability are expressed as a mean ± standard deviation 
with n=3 for each group. Statistical significance of differences was determined using unpaired 
student’s t-test multiple comparison procedure at a confidence level of 95 % (p<0.05). 
3. RESULTS AND DISCUSSION 
This study addresses the use of a phospholipid polysaccharide that spontaneously self-
assembles into capsular structures for the encapsulation of cells in a microfluidic device. To 
Chapter V. Guided and microfluidic self-assembly of phospholipid-xanthan microcapsules 
 
141 
obtain an amphiphilic polysaccharide, DOPE  phospholipid was conjugated to the anionic and 
pH sensitive xanthan macromolecule (Figure V.1.A) so that hydrophobic forces can be engaged 
in the self-assembly process upon charge screening of xanthan by pH changes or electrolyte 
addition. Xanthan has hydroxyl and carboxyl groups available for chemical modification for 
obtaining xanthan derivatives. The chemical modification performed in this study is represented 
in Figure V.1.B and the obtained derivative was characterized by spectroscopy and microscopy 
techniques. 
Fourier Transformed Infra Red spectroscopy  
FTIR spectrum of xanthan-DOPE (Figure V.2.A) shows an increase in the intensity of the bands 
at 1735 and 1624 cm-1 assigned to the carbonyl groups. These bands derive from the acetate 
and pyruvate groups present in xanthan in addition to carbonyl from DOPE. Bands at 2935 and 
2856 cm-1 indicated the presence of the aliphatic DOPE chains (-CH3 and -CH2 respectively). In 
addition, the appearance of bands at 1166, 1081and 977 cm-1, representative of the stretch 
vibrations of P=O, P-OH and P-O of phosphate group, respectively, was also observed. Taken 
together, these observations indicate that DOPE was successfully grafted into xanthan. 
 
Figure V.2. FTIR (A) and 
1
H NMR at 60 ºC (B) spectra of native xanthan and xanthan-DOPE. 
 
1H Nuclear Magnetic Ressonance spectroscopy 
1H NMR spectrum of xanthan-DOPE (Figure V.2.B) shows the appearance of new signals in the 
range of 1-1.5 ppm attributed to aliphatic protons from DOPE. Moreover, it displays new signals 
in the range of 3.3-3.7 ppm and also the increase on the intensity of the protons from pyruvate 
and acetate groups, demonstrating the changes in the native structure of xanthan. 
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Degree of substitution 
As determined by potentiometric titration, a degree of substitution (DS) about 1.16 ± 0.024 was 
obtained considering the two carboxylic acid groups present in the xanthan repeating unit. 
Wide Angle X-ray Scattering  
To determine whether there were any ordered structures after phospholipid conjugation, we 
carried out WAXS experiments. Comparing the diffractograms of xanthan and xanthan-DOPE 
(Figure V.3.A) the appearance of new peaks on xanthan-DOPE pattern at 17.7, 20.66, 21.51, 
24.11 and 25.84º suggests the presence of ordered molecular arrangement.  
When comparing with X-ray diffraction of palmitoyl xanthan measurements described in our 
recent study18, it is apparent that xanthan-DOPE presents more diffraction points with higher 
intensities. It can be deduced that the hydrophobic effect in xanthan-DOPE is stronger and 
consequently the intermolecular interactions resulted from the self-assembly could expected to 
be higher due to the higher degree of substitution and higher number of hydrophobic chains (two 
alkyl chains per unit of DOPE grafted). 
Molecular conformation – Circular Dichroism spectroscopy 
CD spectroscopy is a suitable technique to predict molecular conformation in liquid state. We 
used CD to investigate changes in molecular structure of xanthan after the hydrophobization of 
xanthan with DOPE.  
The spectrum of both polymers (Figure V.3.B) showed an increase in peak height with maximum 
absorption wavelength at 196 nm (ordered state) and a decrease of the minimum with 
displacement at higher wavelengths at 220 nm (disordered state)18. Despite both polymers 
present similar CD signatures, for xanthan-DOPE the difference in absorption of left-hand and 
right-hand circularly of polarized light is less accentuated, suggesting that introduction of such 
hydrophobic tails are improving stability of the native structure of xanthan. 
Polarized light microscopy 
By polarized light microscopy, the birefringence dispersion in xanthan-DOPE (Figure V.3.C) 
allows the detection of organized structures disposed with same orientation as a result of the 
hydrophobic self-assembly of the xanthan amphiphile, while in native xanthan for the same 
conditions this scenario cannot be visualized. 
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Figure V.3. Characterization of native xanthan and xanthan-DOPE by WAXS (A), CD at 0.1 wt% (B) and polarized 
light microscopy in the aqueous state (C). 
 
Polarized light microscopy in combination with WAXS and CD analyses revealed the presence 
of organized structures. It is believed that the hydrophobic nature imparted to native xanthan 
after phospholipd conjugation is the main driving force for the observed molecular organization. 
A key challenge in cell encapsulation consists in obtaining reproducible monodisperse 
microcapsules with a minimum number of fabrication steps. After investigating the 
physicochemical properties of xanthan-DOPE, we used microfluidic technology (Figure V.4) to 
realize the self-assembly of the lipid-polymer (xanthan-DOPE) into microcapsules for cell 
encapsulation. 
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Figure V.4. Schematic representation of the set-up for cell encapsulation (A) showing details of the microfluidics 
assembly (B) and copper chip device (C). 
 
The morphology and microstructure of the developed microcapsules were investigated using 
optical and electron microscopy. Their permeability, mechanical resistance and ability to 
encapsulate cells was also assessed. 
Bright Field Microscopy 
Figure V.5.A displays images of the obtained microcapsules (uncoated and coated with PLL) 
observed by bright field microscopy showing their spherical shape and uniform size. The shape 
and size of both microcapsules remained constant over time, confirming their stability. Uncoated 
microcapsules present a diameter size around 530 μm, but when coated with PLL the diameter 
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size decreased for 350 μm. This could be a consequence of polyelectrolyte complexation at 
which the electrostatic forces may lead to stronger gel formation, thereby less swelling22 in 
aqueous media as compared to self-assembled gel that is based on relatively weaker 
hydrophobic forces.  
 
Figure V.5. (A) Bright field light microscopy images of xanthan-DOPE and xanthan-DOPE microcapsules coated with 
PLL. (B) Permeability of xanthan-DOPE and xanthan-DOPE/PLL microcapsules, assessed by IgG (Mw=146-155 KDa) 
diffusion, where C is the IgG concentration at different time points and Co initial concentration. (C) SEM images 
showing the overall structure of xanthan-DOPE/PLL microcapsules (C1), external surface (C2), cross-section (C3) 
and inner wall with morphological feature of a cell attached to the microcapsules surface (C4). 
 
Microcapsule permeability and stability 
The permeability of the microcapsules to oxygen and nutrients and its impermeability to immune 
cells and antibodies is one of the crucial criteria to be considered when developing 
microcapsules for cell encapsulation purposes23-24. The required immunoisolation for a 
successful transplantation of encapsulated cells depends on the selective permeability property 
of the microcapsules23,25. 
The permeability of xanthan-DOPE and xanthan-DOPE/PLL microcapsules was assessed by 
immersing microcapsules in a labeled IgG solution and the diffusion of the protein from 
surrounding medium to the microcapsule interior was evaluated. Both microcapsules are 
permeable to IgG (Figure V.5.B), but as expected, the PLL coated microcapsules are more 
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effective on protecting encapsulated cells from immunotoxins, since the diffusion of the antibody 
is lower when compared with the uncoated ones.  
To ensure that the developed microcapsules maintain their structural integrity when dispersed in 
aqueous media, we have performed mechanical stability tests26. Both types of microcapsules 
demonstrated to be resistant to rupture, when subjected to strong agitation in PBS (data not 
shown). This result showed the efficiency of self-assembly process by phospholipid-conjugated 
polysaccharide in preserving microcapsule structure for prolonged periods in vitro. Nevertheless, 
PLL coated xanthan-DOPE microcapsules are expected  to have higher mechanical strength 
since it was demonstrated before in literature that PLL coating improved the mechanical strength 
of alginate microcapsules26 
Scanning Electron Microscopy 
SEM images of the microcapsules coated with PLL (Figure V.5.C) confirmed the spherical shape 
and revealed a porous outer layer and a denser inner layer. The cross-section evidences a 
porous and fibrillar structure as a result of the self-assembly of xanthan-DOPE and further 
interactions with PLL. SEM analysis on cell cultured microcapsules after 21 days revealed that 
the cells were partially entrapped on the internal side of the dense microcapsule wall. This may 
be explained by the fact that nutrients and oxygen are more readily available at the capsule 
surface than in the microcapsule core. 
Live/dead assay 
The fluorescence microscopy images displaying the live/dead assay of encapsulated cells 
showed that the cells remained viable and well distributed within the microcapsules during the 
21 days of in vitro culture (Figure V.6.A). While most cells appear to be viable, in the PLL coated 
microcapsules few non-viable cells (red cells) were also observed.  
AlamarBlue® assay 
In order to quantify the cellular metabolic activity of encapsulated cells, the AlamarBlue® assay 
was performed. Figure V.6.B shows that the encapsulated ATDC5 cells were able to reduce 
AlamarBlue® during 21 days of in vitro culture with slight increase over time. Furthermore, 
ATDC5 cells encapsulated in uncoated xanthan-DOPE microcapsules exhibited significantly 
higher metabolic activity (p<0.05) for the initial time points than in those coated with PLL. 
Nevertheless, at the end of 21 days the cells encapsulated in xanthan-DOPE/PLL presented 
higher metabolic activity than the uncoated ones, but not statistically significant. 
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Figure V.6. In vitro viability and proliferation of ATDC5 cells cultured in xanthan-DOPE and xanthan-DOPE-PLL 
microcapsules. (A) Fluorescence microscopy images displaying the live/dead assay of encapsulated cells (green cells 
are live, red cells are dead) showing that the cells remain viable in the microcapsules up to 21 days of culture. (B) 
Metabolic activity and (C) proliferation of encapsulated cells determined by AlamarBlue® assay and DNA 
quantification. Results are expressed as means ± standard deviation with n=3. *Indicates a significant difference (p< 
0.05) between xanthan-DOPE and xanthan-DOPE/PLL microcapsules for different time points. 
 
When comparing ATDC5 cells within xanthan-DOPE/PLL microcapsules with the same cells 
encapsulated in palmitoyl xanthan/PLL18, although the methodology for fabricating 
microcapsules was different (microfluidics and micro-droplet generator, respectively) the cellular 
metabolic activity seems to be apparently higher when cells are encapsulated in Xanthan-DOPE 
matrix. These observations are evincing the potential of phospholipids to be used to form unique 
and organized structures, the microcapsules in this specific case, through the spontaneous self-
assembly, simultaneously with its advantage of the inherent biocompatibility of the lipids as a 
component of the cytoplasmatic membrane in biomimetic systems1. However, regarding the 
permeability results, the uncoated microcapsules were more permeable to antibodies than those 
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containing PLL, suggesting that those within PLL are more effective for prolonged time periods 
in terms of immunoisolation and able to maintain or even enhance the cellular viability. 
Proliferation assay: DNA quantification  
The quantification of DNA over the culture time revealed (Figure V.6.C) a gradual and significant 
increase of DNA (p<0.05) as a result of improved cellular proliferation in both microcapsule 
types (uncoated and PLL-coated microcapsules). Curiously, the cells within xanthan-DOPE-PLL 
are expressing significantly (p<0.05) lower cellularity comparatively to the uncoated ones. We 
believe that the lower cellularity observed in the coated microcapsules may be related with the 
higher rigidity of the wall membrane and decreased permeability to nutrients provided by the 
interactions between PLL and xanthan-DOPE. The cells were found to be entrapped in the 
microcapsule wall (Figure V.5.C) that may result in a decreased mobility and ability to proliferate. 
Additionally, in previous works27, it was demonstrated that the cell growth may be inhibited by 
the reduced volume inside microcapsules as it may happen in the case of coated capsules with 
PLL. 
The use of PLL as coating matrix in alginate microcapsules containing transplanted islets has 
shown to cause inflammatory responses when transplanted28 which poses concerns for their 
application in vivo. Even low concentrations of PLL29, necrosis effect was observed on islet 
transplants26. 
4. CONCLUSIONS 
An amphiphilic xanthan derivative (xanthan-DOPE) was successfully synthesized which allowed 
its self-assembly into stable hollow capsular structures when subjected to physiological pH and 
ion concentrations. We have demonstrated that using a microfluidic device, stable self-
assembled and size-controlled spherical microcapsules were obtained, and cells could be 
encapsulated within the xanthan-DOPE microcapsules with enhanced metabolic activity for 
prolonged time, without the need of any external coat such as the potential immunogenic poly-L-
lysine. In summary, these results suggest that xanthan-DOPE microcapsules might provide a 
biomimetic environment for cells to grow and thus be useful in cell-based transplantation 
therapies. 
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Chapter VI* 
MICROFLUIDICS FABRICATION OF SELF-ASSEMBLED PEPTIDE-POLYSSACCHARIDE 
MICROCAPSULES AS 3D ENVIRONMENTS FOR CELL CULTURE  
 
ABSTRACT 
We report a mild cell encapsulation method based on self-assembly and microfluidics 
technology. Xanthan gum, an anionic polysaccharide, was used to trigger the self-assembly of a 
positively charged multidomain peptide. The self-assembly results in the formation of a 
nanofibrous matrix and using a microfluidic device, microcapsules with homogenous size were 
fabricated. The properties and performance of xanthan-peptide microcapsules were optimized 
by changing peptide/polysaccharide ratio and their effects on the microcapsule permeability and 
mechanical stability were analyzed. The effect of microcapsule formulation on viability and 
proliferation of encapsulated chondrocytic (ATDC5) cells were also investigated. The 
encapsulated cells were metabolically active, showing an increased viability and proliferation 
over 21 days of in vitro culture, demonstrating the long-term stability of the self-assembled 
microcapsules and their ability to support and enhance the survival of encapsulated cells over 
prolonged time. Self-assembling materials combined with microfluidics demonstrated to be an 
innovative approach in the fabrication of cytocompatible matrix for cell micro-encapsulation and 
delivery. 
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*This chapter is based on the following publication:  
Ana C. Mendes, Erkan T. Baran, Patrícia Lisboa, Rui L. Reis, Helena S. Azevedo, Microfluidics fabrication 
of self-assembled peptide-polysaccharide microcapsules as 3D environments for cell culture, 2012, 
submitted. 
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1. INTRODUCTION 
Molecular self-assembly relies on the design of molecular segments that interact with each other 
in a coordinated way to form large and more complex supramolecular assemblies1 with defined 
morphologies (tubes, spheres, fibrils) and can occur through a change in temperature, pH or ion 
concentration, or triggered by radiation2. Self-assembling is, therefore, an appealing 
methodology for the bottom-up fabrication of new biomaterials allowing to achieve very high 
accuracy in positioning small components (nanometer resolution) with signaling functionality. In 
spite of its importance in the bottom-up fabrication of functional nanomaterials, the use of self-
assembly processes has been limited by a lack of temporal and spatial control3. Most self-
assembling materials are macroscopically disordered which can limit their bulk properties and 
consequently their functionality/performance. Alignment of nanostructures provides a strategy to 
control materials properties and macro-scale behavior by tuning the directionally of interactions 
at the nano-scale. Different strategies have been investigated to control order in materials and 
several factors may play a significant role on the dynamics and kinetics of self-assembly, 
including, concentration gradients, diffusion/mobility of molecules and supramolecular 
aggregates that can be generated under specific processing environments (temperature, 
mechanical agitation, electrical fields, spatial confinement)4-5. Some of these techniques are 
based on the effects that spatial confinement has on the behavior of materials to guide micro- or 
nano-scale ordering. There is a growing recognition that the physical properties of materials can 
also regulate biological responses. For example, the in vivo performance of particle materials 
are dependent on their size and shape6. It is known that particle size controls their transport and 
adhesion in specific body regions such as in blood vessels and airways6-7. In addition, shape 
assumes an important role in the regulation/modulation of cellular responses6,8. Although there 
are numerous techniques and methods for microcapsule formation, the integration of self-
assembly nanofabrication into existing microtechnologies can still offer new possibilities to 
fabricate complex capsular structures with increased level of bioactivity. Microfluidic devices 
have been recognized as a potential tools for the fabrication of micro-engineered hydrogels9-10. 
This fabrication process allows the generation of hydrogels with controlled size and shape by 
changing viscosity of polymer solution, flow rate and dimensions of micro-channels. Small 
amounts of fluids can be manipulated using channels with dimensions of tens to hundred 
of micrometers. Manipulation of multiphase flows in microfluidics, where the viscous and surface 
tension forces are used to create homogeneous structures and operating under laminar flow 
without turbulence, is an appealing technology to be used with self-assembling materials for 
encapsulation of delicate biological agents and cells9-11. Moreover, it can provide a miniature and 
Chapter VI. Microfluidics fabrication of self-assembled peptide-polysaccharide microcapsules 
 
155 
sterile platform without the need of a clean room making this fabrication process suited for cell 
encapsulation.  
Biomaterials that can undergo self-assembly in conditions that are cell-compatible and be 
injected into the body in a minimally invasive way can find numerous applications, including 
controlled growth of cell populations for cell therapies or to promote regenerative processes in 
vivo12-13. In this context, peptides are excellent building blocks to form complex nanostructures 
by self-assembly processes. They can self-assemble into fibril nanostructures, thus recreating 
some of the architectural features of the natural extracellular matrix14. Another intrinsic 
advantage of using peptides as structural units is the ability to incorporate into their structure 
known biological signals that are recognized by cell receptors and thus mediate cell specific 
functions15 (e.g. adhesion, proliferation, differentiation).  
Hartgerink’s group has proposed multi-domain peptides based on ABA block motif16-17 in which 
forces favoring self-assembly into a nanofiber versus those favoring disassembly could be easily 
modified by balancing the forces of block A against B. These peptides consist of a central block 
of glutamine-leucine repeats (B block, with ability to induce the assembly into β-sheets) and two 
flanking positively charged lysine (A blocks). They have shown that for example the K2(QL)6K2 
peptide (Figure VI.1.B) has the ability to self-assemble into organized nanostructures (e.g. 
nanofibers) and form self-supporting gels when the charge is screened (e.g. in presence of 
multivalent anions such as phosphate)16.  
 
Figure VI.1. Chemical structure of xanthan repeating unit (A) and K2(QL)6K2 peptide (B). Zeta potential of both 
component solutions (0.1 wt%) was measured at different pHs to demonstrate the nature of ionizable groups in the 
self-assembling components. 
  
 
156 
Our group has been investigating xanthan gum (Figure VI.1.A), an anionic extracellular bacterial 
polysaccharide, as a potential cell encapsulation matrix. We have used different strategies, 
carboxymethylation18 and palmitoylation19 of xanthan, to drive the assembly of this 
polysaccharide into capsular structures with controlled properties. Following these studies, we 
thought on using xanthan gum to drive the self-assembly of the K2(QL)6K2 multi-domain peptide, 
proposed by Hartgerink group, and microfluidic technology to convert the self-assembled 
structures into spherical microcapsules for cell encapsulation. 
The self-assembly between peptide amphiphiles and polysaccharides has been reported 
previously20-21, showing the formation macroscopic structures with highly organized architecture 
at the nanoscale. In this work, the properties and microcapsule performance of xanthan-peptide 
microcapsules were optimized by changing peptide/polysaccharide ratio and their effects on the 
membrane permeability, microcapsule stability and cell function (viability and proliferation) of 
encapsulated chondrogenic cell line were investigated. 
2. MATERIALS AND METHODS 
Materials 
All chemicals, including xanthan gum from Xanthomonas campestris, were obtained from 
Sigma/Aldrich (USA) unless otherwise indicated. The chemicals were used as received. The 
average molecular weight (Mw) of xanthan was estimated by size-exclusion chromatography as 
152 KDa22. 
Peptide synthesis and purification 
All amino acids and Rink MBHA resin were purchased from Novabiochem Corporation (USA). 
K2(QL)6K2 peptide was synthesized by solid-phase peptide synthesis in a automated peptide 
synthesizer (CS Bio, USA) using Fmoc strategy. After synthesis, the peptide was cleaved from 
the resin using a cocktail of trifluoroacetic acid (TFA), triisopropylsilane, and water (95:2.5:2.5). 
The mass of the peptide (Mw = 1977.44 g.mol-1) was confirmed by mass spectrometry (see 
supplementary information) and its isolation from impurities was achieved by purification of the 
crude product in a 2545 Binary Gradient preparative high-performance liquid chromatography 
(Waters, USA) with 2489 UV/Visible Detector (Waters, USA) using C18 column (Atlantis Prep 
OBD T3 Column, Waters, USA) and a water/acetonitrile (0.1% trifluoroacetic acid) gradient. TFA 
counter-ions were exchanged by sublimation from 0.1 M hydrochloric acid. Finally, the peptides 
were dialyzed against deionized water using 500 MWCO dialysis tubing (Spectrum Europe B.V., 
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The Netherlands) to remove salts, lyophilized, to obtain a fluffy powder, and stored in closed 
containers at -20 ºC until use. 
Characterization of peptide-xanthan interactions 
Zeta potential 
Zeta potential measurements of polymer and peptide solutions were performed at 25 ºC using a 
Zetasizer NanoZS Instrument (ZEN 3600, Malvern Instruments, Worcestershire, UK). Xanthan 
and K2(QL)6K2 solutions were prepared at a concentration of 0.1 wt% with ultrapure water and its 
pH adjusted to the desired value by adding HCl (0.1 M) and NH4OH (0.1 M). 
Quartz crystal microbalance (QCM) with dissipation monitoring 
QCM measurements were performed with an instrument with dissipation monitoring (QCM-D) 
from Q-Sense (Göteborg, Sweden). The experiments were performed at 24 ºC with 50 L/min 
flow rate using gold coated crystals (model QSX301, Q-Sense, Göteborg, Sweden) previously 
cleaned with H2O2(30%)/NH3(25%)/H2O (1:1:5) during 10 minutes at 75 ºC. The system was 
initially equilibrated with phosphate buffered saline (PBS) solution (10 mM, pH7.4) to obtain a 
stable frequency and dissipation baseline signal. Once the signals were stable, the buffer was 
replaced by a solution of xanthan (0.25 wt% in PBS) during 25 minutes. Then, the buffer was 
again introduced to remove weakly bound material. This step was followed by the introduction of 
the peptide solution (0.0025; 0.0625 or 0.125 wt% in H2O) or BSA solution (0.5 mg/mL in PBS). 
Finally the system was rinsed with PBS solution. 
Thickness was calculated by the Voigt model23 incorporated in Q-Sense software using different 
overtones (7th; 9th, 11th,13th). The layer viscosity values used in the model were between 0.001 
and 0.01 kg.ms-1, the layer shear modulus between 10 and 105 Pa, and layer thickness values 
were between 10-10 a 10-6 m. For xanthan, a fluid density of 1000 kg.m-3, fluid viscosity of 0.001 
kg.ms-1 and layer density of 850 kg.m-3 were used. For the peptide modeling, a fluid density of 
1300 kg.m-3, fluid viscosity of 0.003 kg.ms-1 and layer density of 1600 kg.m-3 were used. For 
BSA modeling, a fluid density of 1000 kg.m-3, fluid viscosity of 0.001 kg.ms-1 and layer density of 
1500 kg.m-3 were used.  
Microfluidic device fabrication 
The device design was made by CAD software and printed onto a transparency sheet by using a 
desk top laser printer. This pattern subsequently served as a mask for copper etching. The laser 
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toner has been successfully exploited previously for applications as an etch mask for metal 
plates intended for microfluidics application24. A copper plate (1.5x1.5 cm, 0.675 mm thick, 
0.99% annealed, Alfa Aesar, USA) was used as a substrate for developing microfluidic 
channels.  
 
Figure VI.2. Schematic representation of the set-up for cell encapsulation (A) showing details of the micro-fluidics 
apparatus (B- view of disasembled microfluidics device which consists of a metal chip, silicone seal and TEFLON 
case). Side views of combined microfluidic device enabling fluid flows by backside adapters (B, C). 
 
The melted toner adheres to the copper and is insoluble in ferric chloride solution, allowing it to 
serve as an etch mask for microchannel fabrication. Initially, the copper plate surface was 
cleaned by rubbing thoroughly with a fine steel wool. The plate was then sonicated 5 min in a 
solution of acetone-water (50%). The cleaned plate was transferred onto a hot plate at 200 oC 
and incubated for 2 min. The heated plate was then transferred immediately to printed-face of 
transparency and a metal block weighing approximately 10 kg was placed onto copper plate to 
facilitate toner transfer. After 2 min, the copper plate and transparency was placed to a freezer (-
20 oC) and incubated for 5 min. After cooling, the transparency was carefully peeled off from 
copper plate. The back and front surface of plate, where there is no toner, was covered with 
plastic duct tape to protect unmasked region from etching process. The plate was etched in 
FeCl3 solution (35%, 50 mL) in a glass beaker for 30 min at room temperature by manual 
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shaking of the solution. The etching was stopped by removing the plate and washing it under 
running water. After removing duct tapes from the etched plate, the plate was placed into 
acetone-water solution (50%) and sonicated for 10 min to remove toner from the surface. 
Beside, a poly(dimethyl siloxane) (PDMS) seal was prepared at 1/10 crosslinker/monomer ratio 
(w/w) (SYLGARD® 184 silicone elastomer kit, Dow Corning, USA) and the mixture was cured for 
2 days at 37 oC in a rectangular mould. The seal was perforated at inlets and outlets of vertical 
and horizontal channels reserved for polymer-cell and oil flow, respectively (Figure VI.2.). 
A piece of poly(tetrafluoro ethylene) (TEFLON) block was also machined for securing and 
precise positioning of the perforated silicone seal and allowing the transfer of fluids by providing 
4 adopters at the backside for connecting silicone tubing from peristaltic and syringe pump 
(Figure VI.2.B-D). 
Microcapsule preparation 
Xanthan (1 wt%) was dissolved in PBS. The xanthan solution was injected into the microfluidics 
device using a syringe pump. The polymer microdroplets were generated inside the microfluidics 
device by shear stress when entered into a stream of mineral oil. The formed homogenous 
microdroplets were collected in a collector vessel containing K2(QL)6K2 solution at different 
concentration (0.1, 0.25 and 0.5 wt%). About 10 µL of Tween 80 was added as emulsifying 
agent. The self-assembly of xanthan-peptide into microcapsules took place in the collector 
vessel by gently stirring of the polymer droplets over 15 minutes on a magnetic stirrer.  
Microcapsule characterization 
Light microscopy analysis. 
Microscopic observations of the microcapsules were carried in a bright field light microscope 
(AXIOVERT 40 CFL, Germany) equipped with a digital camera (Canon Power shot G8, Japan). 
Scanning Electron Microscopy (SEM) analysis 
Prior to the SEM observations, the microcapsules were fixed with glutaraldehyde (Electron 
Microscopy Sciences, USA) solution (3%, v/v in PBS) at 4 ºC for 1 h. The samples were further 
dehydrated in a graded ethanol series (20, 50, 60, 70, 80, 90 and 100%) followed by immersion 
in 100% hexamethyldisilazane (HMDS, Electron Microscopy Sciences, USA). Microcapsules 
were cut into half to expose the membrane cross-section and the internal surface of 
microcapsules. The specimens were mounted on aluminum stubs and sputter coated with Pt/Pd 
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target (80/20) generating a thin film with 6 nm of thickness (208 HR High Resolution Sputter 
Coater, Cressington). The microcapsules were imaged on an ultra-high resolution field emission 
gun scanning electron microscope (FEG/SEM, FEI Nova 200 NanoSEM). 
Microcapsules permeability to Immunoglobulin G (IgG) antibody 
IgG (Mw = 146-155 KDa, Abcam, UK) was labeled with fluorescein isothiocyanide (FITC) in 
order to determine the diffusion of the protein into the microcapsules using a highly sensitive 
techniques such as fluorescence spectroscopy. The IgG was dissolved in sodium carbonate 
buffer (0.1 M, pH 9) at 2 mg/mL concentration. The fluorescein dye, dissolved in DMSO (1 
mg/mL) was added per mL of protein solution and gentle mixed for 8 hours at 4 oC in the dark. 
Afterwards, the reaction was quenched by adding ammonium chloride to a final concentration of 
50 mM. The solution was placed into dialysis tubing and dialyzed against distilled water in the 
dark to remove unconjugated FITC. Finally, the dialyzed solution was freeze-dried in a light 
protected vessel. For permeability studies, equal volumes of microcapsules and IgG-FITC (15 
mg/mL solution in NaCl 0.9%) were shaken in a water-shaker bath at 37 ºC and samples of 5 µL 
were collected from 0 to 3 h. Concentrations of IgG-FITC were measured by fluorescence 
(485/528 nm) on a microplate reader (BIO-TEK, SYNERGIE HT, USA). 
Mechanical stability 
The mechanical testing used in this study were adapted from the work described for Darrabie 
and co-authors25. 
Induction of mechanical stress using osmotic pressure 
Aliquots of xanthan-peptide  microcapsules were placed in 10 mL of water and incubated for 24 
h at 37 ºC in a water shaker bath. At various time intervals, the capsules were collected and 
observed in a bright field light microscope (AXIOVERT 40 CFL, Germany) equipped with a 
digital camera (Canon Power shot G8, Japan) and the number of ruptured capsules counted.  
Induction of mechanical stress using bead agitation 
Xanthan-peptide microcapsules were placed in flasks containing 20 glass beads (3 mm 
diameter, VWR Scientific Products Corporation) and 30 mL of PBS solution in a flat rotator 
shaking at maximum rate (about 300 rpm) (DSR-2800V, Digisystem Laboratory Instruments Inc, 
Taiwan). At various time intervals (2, 5, 7, 24 h) the number of ruptured capsules was counted 
by observation in a bright field light microscope (AXIOVERT 40 CFL, Germany) equipped with a 
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digital camera (Canon Power shot G8, Japan). The percentage of ruptured capsules in function 
of time was determined.  
Cell culture and encapsulation 
The murine ATDC5 chondrocyte cells were cultured in basic medium, consisted of Dulbecoo’s 
Modified Eagle’s Medium (DMEM) with phenol red, supplemented with 10% fetal calf serum 
(FCS, Biochrom AG, Germany), 5 mM L-Glutamine and 1% of antibiotic-antimycotic mixture and 
maintained at 37°C in a humidified atmosphere of 5% CO2. The medium was replaced every two 
days. At passage 8, cells were detached with trypsin/EDTA and counted in a hemacytometer for 
encapsulation. The production of the xanthan-peptide microcapsules and the encapsulation of 
the ATDC5 cells were done in the developed microfluidics device which was connected to 
syringe and peristaltic pump for transferring xanthan-cell and mineral oil, respectively (Figure 2). 
Xanthan (1 wt%), previously sterilized in an autoclave (10 min, 121 ºC) was dissolved in PBS 
and mixed subsequently with a cell suspension (5x106 cells/mL). Xanthan solution and cell 
suspension in xanthan solution were injected by syringe pump (Alladdin WPI, England) into the 
polymer microchannel of microfluidics device (Figure 2). Simultaneously, the flow of mineral oil 
was provided from an oil reservoir by using a peristaltic pump (Ismatec, Switzerland). The 
operation rate of peristaltic and syringe pump was set at 0.35 mL/minute and 20 μL/min, 
respectively. The xanthan microdroplets were generated inside the microfluidics device by shear 
stress when the polymer-cell suspension in vertical microchannel entered into the stream of 
mineral oil in larger horizontal microchannel. The formed homogenous droplets of 
polysaccharide-cell were collected in a collector vessel containing K2(QL)6K2 solutions at 
different percentages (0.1, 0.25 and 0.5 wt%) and about 10 µL of Tween 80 as emulsifying 
agent. The self-assembly of the polysaccharide with peptide, and the subsequent microcapsule 
formation took place after the contact between both components by gently stirring the polymer 
droplets for 20 min on a magnetic stirrer. Afterwards, the xanthan-peptide microcapsules were 
washed in PBS and transferred to tissue culture plate containing DMEM for further cellular 
studies. The encapsulated cells (n=3) were maintained in vitro culture for a period of 3 weeks in 
DMEM with media exchange every 2 days. Empty microcapsules were also maintained 
throughout the culture period to serve as controls. 
Viability and proliferation of microencapsulated cells 
To investigate the ability of the xanthan-peptide microcapsules to support cell viability and 
proliferation in respect to various peptide concentrations, the live/dead and AlamarBlue® assays 
(viability) and DNA quantification (proliferation) were performed. 
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Metabolic activity assay 
AlamarBlue® (AbD Serotec,UK) was added (10% of the volume of the well) to each well 
containing the encapsulated cells and the plate was incubated at 37 ºC for 20 hours protected 
from light. After incubation, 100 µL of solution was taken from each well and placed in a 96 well 
plate. The absorbance was read at 570 and 600 nm on a microplate reader (BIO-TEK, SYNERGIE 
HT, USA). The percentage of reduced AlamarBlue® was calculated according the manufacturer 
instructions. 
Live/dead cell assay 
Calcein AM (Sigma, USA) solution (2/1000, v/v) was prepared in DMEM without FCS and phenol 
red. Propidium iodide (PI, Molecular Probes, Invitrogen, USA) solution was prepared by mixing 2 
µL PI (1 mg/mL) with 20 µL (1 mg/mL) RNAse A (USB corporation, USA) and 2 mL PBS. The 
microcapsules with encapsulated cells and controls were collected from the culturing plates and 
incubated with calcein-AM and propidium iodide solutions at 37 ºC for 10 min protected from 
light. Samples were then observed under fluorescent microscopy using an Axio (Zeiss HAL 
100/HBO 100; Axiocam MRc5 (Zeiss).  
DNA quantification assay 
ATDC5 proliferation within the microcapsules was determined using a fluorimetric DNA 
quantification kit (PicoGreen, Molecular Probes, Invitrogen, USA). For this purpose, the samples 
collected at days 1, 7, 14 and 21 were washed twice with sterile PBS (Sigma, USA) solution and 
transferred into 1.5 mL microtubes containing 1 mL of ultra-pure water. Capsules with and 
without cells were stored at -80 ºC until further analysis. Prior to DNA quantification, samples 
were thawed and broken by pipetting up and down using a syringe with a needle and crushed 
with a glass tube to cause material disruption and facilitate DNA extraction. 28.7 µL of each 
sample and standards (0-2 mg/mL) were transferred to an opaque 96 well plate. Then 71.3 µL of 
PicoGreen solution and 100 µL of Tris-EDTA buffer were added. Standards and samples were 
prepared in triplicate. The plate was incubated for 10 minutes in the dark and the fluorescence 
was measured using an excitation wavelength of 485 nm and emission of 528 nm. DNA 
amounts were calculated from the calibration curve.  
Statistical analysis 
The results of DNA quantification and cell viability are expressed as a mean ± standard deviation 
with n=3 for each group. 
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Statistical significance of differences was  determined using unpaired student’s t-test multiple 
comparison procedure at a confidence level of 95 % (p<0.05). 
3. RESULTS AND DISCUSSION 
We have hypothesized that the presence of anionic groups in the xanthan chain at pH 7 (Figure 
VI.1.A) could trigger the self-assembly of a positively charged multidomain peptide (Figure 
VI.1.B) into macroscopic assemblies by electrostatic interactions, as reported in previous studies 
using hyaluronic acid 20or alginate21 combined with a different peptide molecule. Moreover, we 
thought on using microfluidics (Figure VI.2.) to precisely generate micro-sized and 
monodispersed capsules for cell encapsulation in physiological conditions. To test our 
hypotheses, we have analyzed the peptide-xanthan interactions, as well the structures formed 
from these interactions in certain assembling conditions. 
Peptide-xanthan interaction studied by QCM 
 
QCM detection principle is based on the resonance frequency shifts due to addition or removal 
of mass on a piezoelectric material (typically quartz crystal)26. In this study, QCM measurements 
were performed with an instrument with dissipation monitoring (QCM-D). Dissipation monitoring 
allows analyzing the viscoelastic properties of the adhered layers and their interaction with 
layers previously deposited on the crystal surface27. In order to verify the specificity of the 
interactions between the peptide and xanthan, the interaction of BSA with xanthan was also 
analyzed as a control test. Figure VI.3.A shows that the change in the frequency related with the 
BSA interaction is lower than the one obtained for all peptide concentrations.  
The frequency signal (Figure VI.3.A) in the initial stage for all the peptide concentrations 
presents a similar behavior: a fast decrease as a result of the fast and high interaction of the 
peptide with xanthan. After the fast decrease, the frequency signal presented an instable 
behavior probably due to rearrangements between the two layers and finally the signal 
stabilized, indicating that the interaction reached the equilibrium. 
After the addition of PBS (about 102 min) the frequency of signal decreased. PBS is more 
viscous than water, thus it is expected to induce an increase in dissipation, as it was observed in 
Figure VI.3.B and at the same time a decrease in the frequency (Figure VI.3.A). It can be noticed 
that the layer created by the interactions between peptide and xanthan was stable in PBS, since 
no increase in frequency signal was observed, indicating no mass loss. The final frequency 
change indicates, as expected, that the total mass adsorbed was higher for the higher peptide 
concentrations (Figure VI.3.A). 
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Figure VI.3.B shows that the dissipation changes associated with the peptide-xanthan 
interactions present a parallel behavior with the frequency change. For the higher peptide 
concentration, a fast increase in the dissipation followed by a slower decrease was observed. 
This behavior is indicative of the formation of a highly viscoelastic layer during the beginning of 
the interaction, that slowly reorganizes and becomes less viscous with the time. For the lowest 
peptide concentration, the dissipation initially increases, then presents some instability and 
finally increases slowly until a stable signal. This behavior indicates that the interaction initially 
increases highly the viscosity, passes through a rearrangement step that decreases the viscosity 
and finally stabilizes increasing again the viscosity (Figure VI.3.B). The final dissipation for the 
two lower concentrations is similar indicating similar structural character. 
 
 
Figure VI.3. Visco-elastic properties, frequency (A) and dissipation (B) from the 9
th
 overtone and thickness (C) of the 
films of xanthan-K2(QL)6K2 monitored by QCM. 
 
The thickness of the xanthan-peptide layer was determined by applying the viscoelastic model 
(based on Voigt model) incorporated in Q-Sense software. For all the different peptide 
concentrations there was an increase in the thickness as compared to the xanthan initial 
thickness, being this increase proportional to the peptide concentration as it is demonstrated in 
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Figure VI.3.C. The highest peptide concentration presents a thickness of about 60 nm, two times 
higher than the thickness revealed by the lowest peptide concentration (30 nm). 
Microcapsule morphology and microstructure 
The morphology and microstructure of the microcapsules were analysed using bright field and 
scanning electron microscopy (Figure VI.4. and 5.). From these observations, it can be noticed 
that size and morphologies are dependent on the peptide concentration. 
 
Figure VI.4. Bright field light microscopy photographs of xanthan-K2(QL)6K2 microcapsules prepared with three 
peptide concentrations (0.1, 0.25 and 0.5 wt%). 
Nevertheless, all the obtained capsules are hollow, as noticed by microscopy analyses, present 
spherical shape and their diameter varies from 390 ± 8 µm when 0.1 wt% of peptide was used to 
585 ±18 µm for 0.5 wt% peptide (Table VI.1.). 
 
Table VI.1. Effect of peptide concentration on the size and membrane thickness of peptide-xanthan microcapsules. 
Peptide / wt% d-Size/µm Membrane thickness / µm 
0.1 390± 8 5.6± 0.5 
0.25 417± 8 - 
0.5 585± 18 10.7± 0.33 
Additionally, the microcapsule external surface appears to be quite smooth in the case of the 
capsules fabricated with the lowest peptide concentration (0.1 wt%), while for the highest 
concentrations the surface morphology appears to be rougher (Figure VI.4.).  
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SEM images of the microcapsule cross-sections (Figure VI.5.A and C) reveal an amorphous and 
dense membrane with thickness ranging from 5.6 µm to 10.7 µm for the microcapsules prepared 
with 0.1 and 0.5 wt% of peptide, respectively. Those results are corroborating the differences in 
the thickness found in QCM results (Figure VI.3.C), that increasing the peptide concentration five 
times, the thickness of the resulted complex would duplicate. Moreover, nanofibrilar structures 
are observed in the in internal side of the microcapsules (Figure VI.5.D) as a result of the self-
assembly of the peptide with xanthan. 
 
Figure VI.5. SEM micrographs showing the cross-section of xanthan-peptide microcapsule membrane (A and C) and 
the interior of microcapsules (B and D). 
 
Stupp and co-workers21 have reported the formation of uniform microcapsules with an average 
diameter of 25 µm using capillary picospray and interfacial self-assembly between alginate and 
a peptide amphiphile molecule. The microcapsules exhibited a nanofibrous surface and a liquid 
core (alginate) that could be gelled upon addition of Ca2+ ions to increase their mechanical 
resistance. They have shown that the thickness of the microcapsule membrane was dependent 
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on the incubation time of the alginate microcapsules in the peptide solution. Here we showed 
that the microcapsule diameter and membrane thickness (Table VI.1.) can be controlled by 
varying the peptide concentration.  
Permeability to IgG. 
The mass transport properties through an encapsulation membrane are crucial for the success 
of the encapsulating process. The influx of essential molecules, such as oxygen and nutrients, 
are critical for cell survival. On the other hand, the efflux rate of therapeutic product and wastes 
would determine the extent of the encapsulated cell viability. Additionally, the encapsulation 
membrane may avoid the influx of immune cells and antibodies, which might destroy the 
enclosed cells28-29. 
Microcapsules were placed into the IgG solution and the protein diffused from the dispersing 
medium, outside the peptide-xanthan microcapsules, to the inner part of the microcapsules was 
measured. In Figure VI.6.A it can be noticed that although IgG was able to diffuse in the 
microcapsules, this permeability was lower for those microcapsules prepared with the highest 
peptide concentration. This fact may be related with the membrane thickness, which is higher for 
the microcapsules prepared with 0.5 wt% peptide. It has been shown that higher membrane 
thickness result in higher resistance to protein diffusion30-31.  
Mechanical stability 
Microcapsule resistance is another important criterion for the success of cell 
microencapsulation25,28,30. A microcapsule should be resistant enough to be durable during its 
production and handling and to resist to the mechanical stress without the loss of its membrane 
integrity32. Moreover, by increasing the strength and resistance of the capsules, the durability of 
the transplant will also increase in vivo30. Initially, in order to understand the effect of peptide 
concentration in the mechanical strength of the xanthan-peptide microcapsules, the 
microcapsules were immersed into a hypotonic environment. This assay was carried out by 
incubating the microcapsules in water under shaking over 24 h. At the end of the assay, none of 
microcapsules were observed broken by osmotic pressure. The low susceptibility of the 
microcapsules to collapse and burst under these conditions is quite unusual having into account 
their hollow structure. This may be related with the dense microcapsule wall observed in Figure 
VI.5. and with the stable visco-elastic interactions (Figure VI.3.B) that may cause reduced 
swelling of the microcapsules and consequently increased mechanical strength. The capsules 
with reduced swelling rate are less prone to rupture and to induce inflammatory responses which 
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may result in an enhanced mechanical strength and biocompatibility25. Nevertheless, in order to 
resemble in vivo shear stress, the microcapsules were exposed to PBS solution and agitated 
with glass micro beads over 24 h. Although in the initial time points the capsules with the lowest 
peptide concentration were showed to be more resistant (Figure VI.6.B) at 24 h less breakage 
rate was found for the microcapsules prepared with 0.5 wt% of peptide. This was an expected 
result, considering the differences in the membrane thickness found (in QCM and SEM 
measurements) for the distinct peptide concentrations and from the literature which reported that 
the membrane thickness is an significant indicator of the strength and permeability33. 
Figure VI.6. (A) Microcapsule permeability, assessed by IgG (Mw=146-155 KDa) diffusion, and (B) mechanical 
resistance of the xanthan-peptide microcapsules as function of peptide concentration. 
 
In vitro viability and proliferation of ATDC5 cells cultured within microcapsules 
The potential of xanthan-peptide microcapsules and the effects of peptide concentration in the 
cellular metabolic activity of encapsulated ATDC5 cells were investigated by using 
AlamarBlue®, live/dead and DNA quantification assays (Figure VI.7.). 
The results showed that ATDC5 cells encapsulated in xanthan-peptide microcapsules were able 
to reduce AlamarBlue® over the 21 days of in vitro culture (Figure VI.7.A), with a slight increase 
as a result of the increased cellular viability. Additionally, it can be noticed that the ATDC5 cells 
within the capsules prepared with the highest peptide concentration were expressing 
significantly (p<0.05) higher viability than those encapsulated in the microcapsules with the 
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lowest peptide concentration. The highest viability of encapsulated cells in xanthan-peptide 
microcapsules was also confirmed by the live/dead assay (Figure VI.7.B) which showed that 
encapsulated cells remained viable up to 21 days of culture (viable cells depict a green 
fluorescence color), demonstrating the ability of this self-assembled matrix to support cellular 
viability over prolonged time. Moreover it can be noticed that the cells are well distributed within 
the microcapsule. 
Figure VI.7. In vitro viability and proliferation of ATDC5 cells cultured within the xanthan- peptide microcapsules. 
Metabolic activity (A) and fluorescence microscopy image (B) displaying the live/dead assay of encapsulated cells 
(green cells are live, red cells are dead) showing that the cells remain viable in the microcapsules (0.5 wt% peptide) 
up to 21 days of culture. Proliferation of encapsulated cells determined by DNA quantification (C). Results are 
expressed as means ± standard deviation. * indicates significant difference (p< 0.05) between different time points for 
xanthan-peptide with different peptide concentrations. 
 
To assess cell proliferation within the microcapsules, the DNA of encapsulated cells was 
quantified along the culture time (Figure VI.7.C). A gradual increase in the DNA concentration 
was observed for all xanthan-peptide microcapsules as a result of cell proliferation. Although the 
cells in the capsules prepared with 0.1 wt% peptide showed lower metabolic activity (Figure 
VI.7.A) the number of cells in these capsules at day 21 was found to be higher than those in the 
capsules of higher peptide concentration (Figure VI.7.C). This might be related with the available 
space within the hollow capsules and the distribution of cells in the microcapsule interior. These 
factors are expected to influence cell-cell contact and cell-matrix interactions and thus cell 
activities, including their metabolism and proliferation. 
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While in this study a non-bioactive peptide was used, the possibility to incorporate biological 
epitopes into the peptide sequence is diverse and several examples of peptide-based matrices 
used for cell encapsulation have been reported in the literature. In an early study on chondrocyte 
encapsulation, ionic self-complementary peptide gels were found to support cell survival and 
maintain chondrogenic phenotype expression and increased production of glycosaminoglycans 
and type II collagen34. Increased gene expression of chondrogenic markers was also reported in 
peptide gels as compared to agarose gels, and expression of osteogenic and adipogenic 
markers were found constant or decreased during 15 days in culture in a study with bone 
marrow stromal cells35. Furthermore, in a recent study, peptide amphiphile molecules designed 
to form nanofibers for cartilage regeneration by displaying a high density of binding epitopes to 
transforming growth factor beta-1 (TGF beta-1) showed that these materials can promote 
regeneration of articular cartilage in a full thickness chondral defect with or even without the 
addition of exogenous growth factor36. 
4. CONCLUSIONS 
Combining self-assembling materials with microfluidic technology appears to be a promising 
alternative to the conventional biomaterials employed in cell encapsulation due the simplicity 
and size-control property of fabrication. We were able to develop robust microcapsules using an 
alternative to the conventional gelation methods, by employing a negatively charged 
polysaccharide to screen and drive the self-assembly of a positively charged peptide. The 
control of the properties of xanthan-peptide microcapsules can be achieved by changing peptide 
concentration, once the concentration plays an important role in the morphology, size, and 
permeability of the microcapsules. The optimized processing conditions enabled generating 
homogenous-size microcapsules with long-term stability and the ability to support the survival 
and function of encapsulated cells over prolonged time. 
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Chapter VII* 
CO-ASSEMBLED AND MICROFABRICATED BIOACTIVE MEMBRANES 
 
ABSTRACT 
We report on the fabrication of hierarchical and bioactive self-supporting membranes, integrating 
physical and biomolecular elements, in a single-step process that combines molecular self-
assembly with soft lithography. A positively charged multi-domain peptide (with or without the 
cell-adhesive sequence RGDS) self-assembles with hyaluronic acid (HA), an anionic 
biopolymer. Optimization of the assembling conditions enable the realization of membranes with 
well-controlled and easily tunable features at multiple size scales including peptide sequence, 
building-block co-assembly, membrane thickness, bioactive epitope availability, and 
topographical pattern morphology. Membrane structure, morphology, and bioactivity are 
investigated according to temperature and assembly time as well as experimental setup 
variations. Furthermore, in order to evaluate the physical and biomolecular signaling of the self-
assembled microfabricated membranes, rat mesenchymal stem cells are cultured on 
membranes exhibiting various densities of RGDS and different topographical patterns. Cell 
adhesion, spreading, and morphology are significantly affected by the surface topographical 
patterns and the different concentrations of RGDS. The versatility of the combined bottom-up 
and top-down fabrication processes described here may permit the development of hierarchical 
macrostructures with precise biomolecular and physical properties and the opportunity to fine 
tune them with spatio-temporal control. 
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*This chapter is based on the following publication:  
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1. INTRODUCTION 
As a bottom-up fabrication technique, self-assembly facilitates the development of new 
biomaterials with molecular resolution by precisely controlling the positioning of high quantities of 
small building-blocks 1. This level of precision enables the capacity to generate 
nanoarchitectures similar to those found in the natural extracellular matrix (ECM) that 
additionally exhibit biomolecular ligands capable of controlling biological processes 2. However, 
a major limitation of current self-assembling systems is the lack of structural and functional 
control at the micro and macroscopic levels, which significantly limits the bulk properties of the 
material and consequently its practicality, functionality, and overall performance. 
In order to overcome this limitation, a number of groups are focusing efforts on developing 
strategies that facilitate molecular assembly at higher size-scales. One approach relies on 
molecules that incorporate by design the “code” to guide their assembly across scales. For 
example, Hartgerink et al. have developed a strategy that employs electrostatic interactions to 
guide the self-assembly of heterotrimeric triple helices designed to replicate the self-assembly of 
collagen, from peptide chain to triple helix formation to nanofiber and finally to a hydrogel 3. 
Stupp and co-workers have reported the formation of hierarchically structured macroscopic sacs 
and membranes obtained by the co-assembly of positively charged small peptide molecules 
(peptide amphiphiles) and a large negatively charged polymer (hyaluronic acid) with a millimeter 
size scale 4-6. Another example of hierarchical organization was provided by Chung et al. who 
used self-templating assembly of chiral colloidal particles (phage particles) to produce long-
range ordered supramolecular films 7. While these mechanisms are highly biomimetic and 
generate materials with improved macroscopic properties, there is still a great need to develop 
novel fabrication schemes that reproducibly control molecular assembly at higher scales. On the 
other hand, controlled multiscale self-assembly has been investigated by incorporating top-down 
methods that offer high reproducibility, micro/nano precision over large areas, and batch 
fabrication capabilities8. For example, building on the work of Zhang and colleagues9, soft 
lithography techniques have been widely used to fabricate material surfaces with molecular 
patterns at various scales10. However, limited biocompatibility and capacity to generate three-
dimensional structures has hampered the practicality of this approach in applications such as 
tissue engineering and regenerative medicine. The present work aims to integrate both of these 
approaches to provide an additional level of hierarchical order and a higher degree of 
functionality. 
Soft lithography has been used to precisely manipulate and localize cells, control cell–cell and 
cell–substrate interactions, guide cell behavior, and facilitate the fundamental study of many 
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biological processes11-15. These studies have thoroughly demonstrated the possibility to 
modulate cell morphology16-17, adhesion18, migration19, proliferation14,20, and differentiation21-22 
through precise nano- and microstructures using large variety of biocompatible materials such 
as polydimethylsiloxane14,20, polylactic acid23, hyaluronic acid24, or poly-ε-caprolactone25. 
Generating self-assembling materials with such well-controlled topographical features would not 
only improve hierarchical order, but would also provide a higher level of bioactivity by enabling 
the opportunity for cell interaction on various size scales. For example, Mata et al13, reported on 
the possibility to enhance osteoblastic differentiation when presenting cells with a combination of 
bioactive self-assembling nanofibers and well-defined 40 µm diameter, 4 µm deep holes. The 
possibility to fabricate materials with such well-defined topographical patterns using increasingly 
complex self-assembling systems represents an attractive approach to generate biomimetic and 
easily tunable materials with improved spatio-temporal control of bioactive signals. 
Synthetic membranes would benefit significantly from this kind of top-down/bottom-up approach. 
In the human body, membranes play critical roles supporting cell attachment and function, 
regulating nutrient and waste transfer, and providing boundaries between tissues and organs 26. 
The possibility of using artificial membranes as in vitro or in vivo scaffolds capable of exhibiting 
specific signals, tunable properties, and cell guiding features would be broadly useful in tissue 
engineering and regenerative medicine applications. For example, membranes have been 
investigated for bone and cartilage regeneration27, cornea repair28, skin engineering29, 
reconstruction of the abdominal wall30 and cardiac tissue replacement31. Natural (e.g. OSSIX™ 
PLUS™, Tutodent®, Bio-Gide® and Chondro-Gide®)32, and synthetic materials have been 
used, isolated or in combination, to fabricate membranes using methods such as solvent 
casting, electrospinning, polyelectrolyte complexation, or compression molding33. Although 
intense research efforts have been devoted to develop functional membranes as scaffolds for 
tissue engineering, limited work has been focused on developing membranes that exhibit a level 
of biomimetic complexity more similar to the in vivo environment. 
The formation of membranes at the interface between two aqueous solutions, one containing a 
megadalton polymer and the other small self-assembling molecules bearing opposite charge, 
was previously demonstrated4 The structure-property relationship of these kinds of membranes 
has been studied5 and the effect of electric fields on the self-assembly process forming the 
membranes has been recently investigated34. Inspired by this remarkable self-assembling 
system, we propose here a single-step bottom-up (self-assembly) and top-down (soft 
lithography) fabrication technique to create hybrid multifunctional membranes that, in addition to 
displaying biomimetic nanofibers and biomolecular elements, exhibit specific surface 
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topographies that can be easily modified to elicit desirable biological responses. We have 
selected the natural polymer hyaluronic acid (HA), an anionic polysaccharide typically found in 
the connective tissues of vertebrates, to drive the self-assembly of a multi-domain peptide, 
previously proposed by Hartgerink and co-workers35. The resulting peptide/HA co-assembled 
membranes exhibited a hierarchical structure of nanofibers and surface microtopographies with 
various densities of RGDS. Furthermore, we investigate the effect of temperature, time, and 
experimental setup on the structural characteristics of the membranes. 
2. MATERIALS AND METHODS 
Peptide synthesis and purification 
Two similar peptides were synthesized in this study, having the following amino acid sequences: 
K2(QL)6K2 and K2(QL)6K2RGDS. The structure of K2(QL)6K2 is shown in Figure VII.1.A.  
 
Figure VII.1. Chemical structure of the self-assembling components used in this study: multidomain K2(QL)6K2 
peptide (A) incorporating alternating hydrophilic/hydrophobic amino acid residues (QL) and two flanking positively 
charged lysines (K) required for self-assembly in presence of negatively charged high molecular weight polymer 
hyaluronic acid (B). Zeta potential of both component solutions (0.1 wt%) was measured at different temperatures (pH 
7) and pHs (21 ºC) to demonstrate the nature of ionizable groups in the self-assembling components (* indicates a 
significant difference (p < 0.05) between conditions). 
Chapter VII. Co-assembled and Microfabricated Bioactive Membranes 
 
179 
The peptides were produced by solid-phase peptide synthesis using standard 9-
fluorenylmethoxycarbonyl (Fmoc) chemistry on an automated peptide synthesizer (CS Bio, USA) 
at 1 mmol scale on a 4-methylbenzhydrylamine (MBHA) rink amide resin. Fmoc-protected amino 
acids and MBHA rink amide resin were purchased from Novabiochem (USA) and O-
(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium (HBTU) from Carbosynth (UK). N-N-
diisopropylethylamine (DIEA), piperidine and all other reagents were obtained from Sigma-
Aldrich (USA). 
Once synthesized, cleavage of the peptide from the resin and deprotection of the protecting 
groups was carried out with a mixture of trifluoroacetic acid (TFA)/ triisopropylsilane (TIS)/ water 
(95/2.5/2.5) for 3 h at room temperature. After filtration of the cleavage mixture, excess TFA was 
removed by rotary evaporation. The resulting viscous peptide solution was triturated with cold 
diethylether. The white precipitate was collected by filtration, washed with cold ether, and 
allowed to dry under vacuum overnight. The peptide mass was confirmed by electrospray 
ionization mass spectrometry (ESI-MS, Finnigan LXQ, USA). The peptide was then purified on a 
Waters 2545 Binary Gradient high-performance liquid chromatography (HPLC) system using a 
preparative reverse-phase C18 column (Atlantis Prep OBD T3 Column, Waters) and a 
water/acetonitrile (0.1% TFA) gradient. TFA counter-ions were exchanged by sublimation from 
hydrochloric acid (0.1 M). Finally, the peptides were dialyzed against deionized water using 
dialysis tubing (500 MWCO, Spectrum Europe B.V., The Netherlands) to remove salts, 
lyophilized, to obtain a fluffy powder, and stored in closed containers at -20 ºC until use. The 
purity and accurate mass of each peptide were verified using liquid chromatography/MS and the 
HPLC. 
Zeta potential analysis 
Zeta potential measurements of the peptide and hyaluronic acid (2 MDa, Lifecore Biomedical, 
Inc, USA) solutions (0.1 wt%) were performed at distinct pHs (T = 21 ºC) and different 
temperatures (pH 7) using a Zetasizer Instrument (NANO-ZS ZEN3600, Malvern Instruments, 
UK). 
Membrane fabrication 
Smooth membranes were fabricated by casting hyaluronic acid solution (2 MDa, 1 wt% in water) 
on a polydimethylsiloxane (PDMS, Sylgard 184, Dow Corning, USA) substrate. The PDMS 
substrate was prepared by mixing the prepolymer and crosslinker at a 10:1 ratio, degassing for 
10 min under vacuum and curing for 2 h at 65 ºC. The PDMS was oxygen plasma treated in a 
plasma cleaner (PDC-002, Harrick Cientific Corporation, USA), in order to increase the 
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wettability of the surface. The K2(QL)6K2 peptide (1 wt% in water) was next added on top of the 
HA, generating a membrane upon contact between the solutions. The membrane was allowed to 
age for either 4 or 24 h at 4, 21 and 50 ºC. The membranes were also prepared inverting the 
positions of the HA and peptide: peptide solution was cast onto the PDMS substrate with the HA 
added on top. The effects of time and temperature on the membranes were also analyzed. 
Membranes containing different amounts of the RGDS motif were prepared by mixing the 
K2(QL)6K2 and K2(QL)6K2RGDS peptides in different ratios (1:10 and 3:10) prior to the co-
assembly with HA. 
Topographically patterned membrane fabrication 
Fabrication of topographic PDMS molds 
Molds comprising several micro topographical patterns were fabricated using a soft lithography 
process. The patterns were generated in SU8-10 photoresist (Microchem Corporation, USA) 
using conventional contact mode UV photolithography (Mask Aligner MJB4, SUSS Microtec, 
Germany) with a rigid chrome mask as follows. SU8-10 photoresist was spin coated onto a 
(111)-oriented silicon wafer (Siltronix) at 500 rpm for 5 s followed by 4000 rpm for 30 s, 
achieving a layer approximately 8 µm thick. The sample was baked at 65 ºC for 2 min and 95 ºC 
for 5 min prior to UV exposure (3.3 s at 30 mW.cm-2 ) and baked post-exposure at 65 ºC for 1 
min followed by 95 ºC for 5 min. The topographical patterns were then developed with SU8 
developer (Microchem, USA). The resulting samples were silanized with trichloro(1H,1H,2H,2H-
perfluorooctyl)silane (Sigma-Aldrich, USA) before being used as molds for the production of 
patterned PDMS substrates (Figure VII.4.A). The patterns were comprised of different 
geometries, channels (10 µm wide, 10 µm in separation, and 8 µm in height), posts (10 µm wide, 
10 µm in separation, and 8 µm in height), and holes (10 µm wide, 10 µm in separation, and 8 µm 
deep), and posts and holes (20 µm wide, 20 µm in separation, and 8 µm in height). 
Fabrication of topographic membranes 
Topographically patterned membranes were fabricated by casting the peptide solution onto the 
hydrophilic PDMS molds followed by the addition of the HA on the top of peptide solution (Figure 
VII.4.B). The membranes were aged for 24 h at room temperature. The self-assembled 
membranes were removed from the patterned PDMS molds by immersion in ethanol (70%) and 
then characterized. 
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Membrane characterization 
Scanning Electron Microscopy (SEM): The morphology and uniformity of membrane surface and 
cross-section were investigated by SEM. Prior to the SEM observations; the membranes were 
fixed with glutaraldehyde (Electron Microscopy Sciences, Spain) solution (2.5%, v/v in 0.1 M 
phosphate buffer solution, pH 7.4) for 1 h. The samples were then dehydrated in a graded 
ethanol series (50, 70, 90, 96 and 100%) followed by immersion in hexamethyldisilazane 
(HMDS, Sigma-Aldrich, Spain). The membranes were sputter-coated with 20 nm of gold and 
then visualized using a Nova nano SEM (FEI, Netherlands). 
Confocal microscopy: To get better insight into the self-assembly process, namely on the 
mixture of the components during membrane formation, HA was labeled with 5-
(aminoacetamido) Fluorescein (Life Technologies, USA) according to a procedure described 
elsewhere36. The membranes were prepared as described previously, with variations in time, 
temperature and positioning of peptide and fluorescent HA. They were then imaged using an 
SP2 confocal microscope (Leica Microsystems, Germany). 
Biological assessment  
Cell seeding and culture on the fabricated membranes 
Rat mesenchymal stem cells (rMSCs) isolated from bone marrow of rat tibia and femur, were 
provided by the Animal Research Center (SEA) of the Parc Científic Barcelona. Cells were 
expanded in Dulbecco’s modified Eagle’s medium (DMEM; Life Technologies, Spain) 
supplemented with fetal bovine serum (10%, FBS; Attendbio Research, Spain), L-glutamine (0.2 
mM), penicillin (100 units ml-1) and streptomycin (0.1 mg ml-1) (Sigma-Aldrich, Spain). rMSCs of 
passage 3–6 were suspended in serum-free DMEM and seeded at 12 500 cells cm-2 onto 
smooth and patterned membranes with and without the RGDS sequence. After 4 h of culture, all 
medium was replaced with DMEM containing 10% FBS to allow cell proliferation. 
Cell adhesion 
After 18 h, the culture medium was removed and the samples were washed twice with PBS to 
remove any non-adherent cells. Cells were fixed with formaldehyde (4%, v/v, Sigma-Aldrich, 
Spain) in PBS for 30 min at RT. To visualize the actin cytoskeleton, cells were stained with 
phalloidin-fluorescein isothiocyanate (phalloidin–FITC, Sigma-Aldrich, Spain) at a 1:500 dilution 
in PBS for 1 h at room temperature. They were then counterstained with 4’,6-diamidino-2-
phenylindole dihydrochloride (DAPI; Sigma-Aldrich, Spain) for observation of the nuclei. Finally, 
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the samples were mounted on glass slides with a drop of Fluoro-Gel mountant (Aname, Spain). 
The cells were visualized using an SPE confocal microscope (Leica Microsystems, Germany). 
SEM observations 
Cells cultured on the membranes were examined under SEM to analyze cell morphology and its 
interactions with the membranes at the nano and microscale. Samples were fixed and 
dehydrated as described above.  
Statistical analysis 
The results of zeta potential and membrane thickness are expressed as a mean  standard 
deviation with n = 3 for each condition. Statistical significance of differences was determined 
using the unpaired Student’s t-test multiple comparison procedure at a confidence level of 95% 
(p < 0.05). 
3. RESULTS AND DISCUSSION 
The self-assembling building blocks used in this study were a positively charged multidomain 
peptide, with or without the RGDS cell-adhesive peptide sequence, and a high molecular weight 
(2 MDa) negatively charged biopolymer. The peptides, K2(QL)6K2 and K2(QL)6K2RGDS, were 
synthesized and purified successfully (MS and HPLC spectra provided in the supporting 
information). The multidomain K2(QL)6K2 peptide (Figure VI.1.A) consists of an ABA block motif
35 
comprising a central block of glutamine-leucine (QL) repeats and two flanking positively charged 
lysines (K). Different variations of these multidomain peptides37-38 have been previously 
synthesized and demonstrated to self-assemble into well-defined nanofibers35 with various 
bioactive epitopes.38-39 On the other hand, HA (Figure VII.1.B) was selected due to its intrinsic 
polyanionic nature, linear unbranched random-coil structure, biocompatibility, low 
immunogenicity, and large size40. Furthermore, its presence in the natural ECM of many tissues 
and role in cellular signaling and wound healing makes it a highly attractive molecule to serve as 
a building block of a self-assembled biomimetic scaffold. 
Fabrication of Smooth Membranes 
When the K2(QL)6K2 peptide solution (1 wt%) was added at a 1:1 ratio (v/v) to the high molecular 
weight hyaluronic acid solution (1 wt%), a membrane was obtained at the interface between the 
two solutions. However, the order in which the two solutions were combined (HA over the 
peptide or vice-versa) resulted in strikingly different types of membranes (Figures VII.2. and .3.). 
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Furthermore, time and temperature variations during the self-assembly and incubation of the 
membranes were also investigated and resulted in significant variations.  
As expected, combining the viscous HA solution with the peptide solution enabled the 
continuous growth of a self-assembled membrane, with its thickness increasing over time from 4 
to 24 h after initial contact (Figure VII.2).  
 
Figure VII.2. SEM images of membranes fabricated with peptide on top of hyaluronic acid solution showing the 
membrane cross-sections at 4 ºC (A1, A2) and 21 ºC (A5, A6) after 4 and 24 h of incubation and surface morphology 
on the HA side (A3, A7) and peptide side (A4, A8). Graph in B shows the increase in membrane thickness, measured 
by SEM, with increasing time and temperature (* indicates a significant difference p < 0.05) between conditions). C 
are confocal microscopy images of the membranes with fluorescein-HA formed after 4 h of incubation showing the 
distribution of fluorescent labeled HA over the membrane as well as the increase in the membrane thickness with 
temperature. 
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This time-dependency is consistent with that reported by Capito et al., when mixing HA with a 
different self-assembling peptide4. When the HA solution was positioned on top of the peptide, 4 
h after initial contact, the membranes exhibited an increase in thickness from 4 ºC (9.37 ± 0.064 
µm) up to 21 ºC (15.55 ± 0.70 µm) to 50 ºC (16.34 ± 1.40 µm) (Figure VII.2.B). A similar increase 
was observed 24 h after contact from 4 ºC (13.06 ± 2.99 µm) to 21 ºC (26.84 ± 11.48 µm), but 
not from 21 ºC to 50 ºC (22.82 ± 11.21 µm). In addition, SEM observations revealed distinct 
surface morphologies on both sides of the membrane depending on the temperature. The 
surface of the HA-side at 4 ºC (Figure VII.2.A3) exhibited a higher heterogeneity associated with 
the presence of HA aggregates compared to the HA-side of membranes at 21 ºC (Figure 
VII.2.A7). This increase in surface homogeneity of the HA side and membrane thickness from 4 
ºC to 21 ºC may be a result of better diffusion and consequent enhanced interaction between HA 
and peptide molecules owing to the higher temperature during the self-assembly. Furthermore, 
confocal microscopy of membranes assembled with a fluorescently tagged HA enabled 
visualization of the distribution of HA through the membrane cross-section. The images in Figure 
VII.2.C show that membranes assembled at 4 ºC exhibited less fluorescence, suggesting an 
incomplete mixing of the components due to restricted mobility of the HA at lower temperatures. 
At 50 ºC (data not shown), the membranes presented similar surface morphology and 
statistically similar thickness to those obtained at 21 ºC, supporting our hypothesis. 
Assuming the significance of electrostatic interactions on the self-assembly of the K2(QL)6K2 
peptide, we investigated the zeta potential of HA and peptide solutions at the different 
temperatures. It was found that at neutral pH the zeta potential of the peptide tended to 
decrease with an increase in temperature from 4 ºC to 21 ºC (Figure VII.1.A, from 21 to 50 ºC no 
significant change was observed), while the value for hyaluronic acid increased considerably 
across the whole temperature range (Figure VII.1.B). The zeta potential is associated with the 
stability of charged aggregates in solution, and in this case should correlate to the total 
electrostatic charge of the molecules4. The greater values of the zeta potential obtained at 
higher temperatures, may indicate that at 21 ºC and 50 ºC the mobility of the HA chains is 
increased, allowing better diffusion of the two components into each other, resulting in thicker 
and more robust membranes. Similarly, Capito and co-workers4 found that their self-assembled 
sacs were formed with greater physical integrity when both solutions had strong zeta potentials 
of opposite charge. 
In addition to temperature and time, the experimental setup (e.g. peptide solution cast on top of 
HA solution or vice-versa), played a crucial role in the surface and cross-section morphology of 
the assembled membranes. When the peptide solution was positioned on top of the more 
viscous HA solution, a thin film was initially formed at the interface between the components, 
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due to limited diffusion of the peptide into the viscous HA solution. This phenomenon would be 
accentuated at 4 oC because of the reduction in mobility of the molecules, resulting in a 
membrane with two distinct layers (Figure VII.3.A1). 
 
Figure VII.3. SEM images of membranes fabricated with hyaluronic acid on top of the peptide solution showing the 
membrane cross-sections at 4 ºC (A1, A2) and 21 ºC (A5, A6) after 4 and 24 h of incubation and surface morphology 
on the HA side (A3, A7) and peptide side (A4, A8). Graph in B shows the increase in membrane thickness, measured 
by SEM, with increasing time and temperature (* indicates a significant difference, p < 0.05) between conditions). C 
are confocal microscopy images of the membranes with fluorescein-HA formed after 4 h of incubation showing the 
distribution of fluorescent labeled HA over the membrane as well as the increase in membrane thickness with 
temperature. 
 
The bilayer membrane obtained at 4 ºC was confirmed by confocal microscopy, where a dense, 
green layer of fluorescent HA can be distinguished from a darker region attributed to the peptide 
layer (Figure VII.3.C). When the temperature was increased to 21 ºC, although the presence of 
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nano-fibers was observed, confirming a degree of self-assembly occurred; HA fragments could 
still be seen on one side of the membrane (Figure VII.3.A7).  
Based on these findings, it was hypothesized that by applying the more viscous HA solution over 
the less viscous peptide, faster and more efficient diffusion of the HA into the peptide would 
occur. This would result in membranes with a more homogenous structure. Figure VII.2. shows 
SEM and confocal images of the cross-sections of membranes formed in this manner. As 
expected, the membranes consist of a single uniform layer made up of densely packed nano-
fibers. 
The optimum time and temperature for the membrane fabrication process were therefore 
considered to be 24 h, 21 ºC, respectively, with the addition of the HA solution to the top of the 
peptide solution used as the experimental setup. These conditions were subsequently selected 
for the preparation of membranes for further studies.  
Topographically Patterned Membranes 
The two-dimensional (2D) patterning of self-assembling peptides has been previously described 
in the literature41-42, Mata et al13, proposed a three-dimensional (3D) patterning method applied 
to peptide amphiphiles that resulted in substrates capable of enhancing osteoblastic 
differentiation of MSCs. However, this fabrication process required further chemical modification 
of the peptide to enable photo-crosslinking in order to form the desired patterns. More recently, 
we reported on a drop casting/evaporation technique to create thin bioactive membranes based 
on recombinant elastin-like polymers15. While this process allowed the generation of self-
supporting structures and the incorporation of both physical and biomolecular signals, it also 
required chemical cross-linking and lacked the biomimetic nanofibrous architecture. The present 
study aimed to overcome these limitations by relying solely on molecular co-assembly and soft 
lithography, resulting in precise biomimetic nanofibers, bioactive microtopographies, and self-
supporting macroscopic membranes. Considering the lower resistance provided by the peptide 
solution (less viscous) to the diffusion of the HA molecules, we decided to cast first the peptide 
solution onto the hydrophilic patterned PDMS in order to guarantee that the solution would fill all 
the spaces in the molds, which in turn can guide their self-assembly, resulting in effective 
transference of the patterns (Figure VII.4.C).  
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Figure VII.4. (A) SU8-10 photoresist-coated Si wafer patterned by photolithography and the following steps of the 
microfabrication process; (B) Membrane fabrication over the patterned PDMS mold; (C) Images obtained by bright 
field microscopy of the patterned PDMS mold and patterned peptide–HA membrane after removal from the mold 
confirming the success of the transference of the patterns; (D) SEM images and zoom-in of the patterned membrane 
surface demonstrating the fibrilar network resulting from the self-assembly of the K2(QL)6K2 peptide triggered by HA. 
 
Using this approach, membranes displaying posts (Figure VII.5.A and D), holes (Figure VII.4.-D 
and Figure VII.5.E), channels (Figure VII.5.C), and pores (Figure VII.5.F) ranging from 10 to 20 
µm in lateral dimension were successfully produced. Figure VII.5. (B) shows an image of the 
cross section of a membrane demonstrating the absence of distinct regions. The fabrication of 
patterned membranes with the peptide cast on top of the HA was also attempted, however the 
structures exhibited distortions and the quality was considerably inferior. In this case, the use of 
a top mold to press the setup from above may be necessary to improve the lithographic process.  
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Figure VII.5. SEM micrographs showing membranes with different patterned geometries: posts 10 (A) and 20 (D) µm 
in diameter, channels (C), pores 5 µm in diameter (F), B displays an image of a membrane cross-section confirming 
the absence of distinct regions, E is a high magnification image of a post and (inset) the nanofibrilar membrane 
structure. 
 
Control of membrane thickness is recognized as being of extreme importance in the application 
of bioengineered scaffolds for tissue engineering applications43. We show here that it is possible 
to vary membrane thickness by changing the time and/or temperature during the molecular co-
assembly process. Moreover, the membrane complexity can be increased by the combination of 
top-down and bottom-up methodologies. Examples of this have previously been reported in the 
literature13,15, however, for the membranes presented in this work, the topographical patterns are 
incorporated into the membrane structure during the self-assembly process. The versatility of 
these membranes to incorporate a variety of geometrical shapes is of extreme relevance, as it 
opens up the possibility to include specific physical signals that can be tailored to the specific 
application and designed to interact with cells on different length scales. Reproducible patterns 
were obtained over large regions of the membranes, which is a major criterion in the 
development of tissue engineered scaffolds, where sizeable surface areas are desirable for 
enhancing cell interactions15. 
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Biological Assessment 
In order to investigate the effects of the physical guidance provided by topographies and the 
biomolecular signaling by the incorporated RGDS, rat mesenchymal stem cells (rMSCs) were 
cultured on the membranes. The difference in cell adhesion on the HA side versus the peptide 
side for smooth membranes was analyzed. In addition, the effect of different proportions of the 
RGDS sequence within the peptide component of the membranes was assessed, as well as, the 
effect of the topographical patterns. 
Rat MSCs were observed to adhere to both sides of the membrane, as well as to interact with 
the RGDS-containing peptide nanofibers, as shown in Figure VII.6.. 
 
Figure VII.6. Confocal microscopy images showing the actin cytoskeleton (green) and nuclei (blue) of rMSCs cultured 
for 18 h on the surface of smooth membranes with different percentages of RGDS: (A-C) peptide side, (D-F) 
hyaluronic acid side. (A,D) no RGDS, (B,E) 10% RGDS and, (C,F) 30% RGDS. 
 
Without the RGDS cell binding sequence, the cells remained round without a well-defined actin 
cytoskeleton, appearing similar on both sides of the membrane. However, for the membranes 
containing the RGDS motif rMSCs tended to attach and spread when cultured on the peptide 
side, exhibiting a well defined actin cytoskeleton (Figure VII.6.A). In contrast, on the HA side 
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they maintained a rounded morphology (Figure VII.6.B) and a lower number of attached cells 
were evident. Interestingly, for the membranes prepared with 30% RGDS, there was a slight 
increase in the degree of spreading of the cells cultured on the HA side. It is possible that a 
small quantity of the peptide solution diffused completely through the HA during the assembly 
process, and due to the high RGDS concentration in this instance, a proportion of the adhesion 
motif was displayed on the HA surface.  
Although hyaluronic acid has previously been considered as a mediator of cell adhesion44, it is 
clearly not as effective as the RGDS sequence. It has been demonstrated that a number of cell-
surface integrins have the ability to recognize the RGD peptide sequence45-47, and there is a 
great deal of evidence showing strong cell adhesion to substrates displaying this peptide motif 
as has been demonstrated in the present study. This particular peptide motif was used in this 
work as a proof of principle. However, owing to the peptide molecular design, it would be 
extremely easy to incorporate an alternative signaling sequence in order to elicit more specific 
cellular responses.  
 
Figure VII.7. SEM micrographs showing differences in cell morphology when cultured on smooth membranes and 
those patterned with different topographies: (A) posts 10 µm in diameter, (B,C) smooth, (D) holes 20 µm in diameter 
and (E,F) channels 10 µm across. 
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It is well known that cell morphology can not only be modulated by epitope availability, but that 
physical signaling provided by topographical surface patterns can also have a noticeable effect. 
In this work, rMSCs were cultured on smooth and patterned membranes and their morphologies 
were assessed. In Figure VII.7., SEM images show that cells on the smooth membrane were 
randomly oriented. In contrast, when cells were seeded on membranes patterned with channels, 
they tended to align and spread along them, growing both on the ridges and within the channels. 
Cells also adapted their morphology when cultured on posts or holes. Similar behavior was 
observed by Tejeda and co-workers when culturing rMSCs on elastin like-polymer (ELP) 
membranes15 with patterned channels. Figure VII.7 also contains high magnification images 
showing the cell filopodia attached to the membrane fibers. 
These results confirm the potential of combining both biomolecular and physical features to act 
synergistically to elicit specific biological responses, such as cell proliferation or differentiation. 
Moreover, we have produced a membrane intrinsically containing these properties: fibrilar 
nanostructure (as a result of self-assembly), epitope availability (biomolecular signals), and 
micro-patterns (topographic signals). The fabrication process for producing these membranes 
enables each of these features to be incorporated in a single step, without the need for 
additional chemical modifications of the molecules or post-assembly treatments. 
4. CONCLUSIONS 
In summary, a self-supporting bioactive membrane was produced through the self-assembly of a 
positively charged multidomain peptide triggered by a negatively charged high molecular weight 
polymer. The growth and structure of the membranes were seen to be affected by assembly 
time and temperature in addition to the positioning of components (peptide on top or bottom of 
HA). A biomolecular signaling motif was incorporated into the membranes, and the proportion of 
this could be easily controlled by varying the composition of the peptide solution prior to 
assembly. Topographical features could be incorporated into the membrane structure during its 
formation, removing the requirement for post-assembly fabrication steps. Rat MSCs were 
observed to recognize the RGDS cell adhesion sequence and the topographical patterns, 
varying their morphology depending on the concentration of binding motif or specific physical 
features that were cultured on. The simultaneous integration of bottom-up and top-down 
fabrication processes described here permit the development of hierarchical macrostructures 
made from well-defined nanofibers and microtopographies that together provide precise 
biomolecular and physical properties. The numerous possibilities to better tune them with spatio-
temporal and biomimetic control provide a broad spectrum of potential applications in tissue 
engineering and regenerative medicine. 
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Chapter VIII  
GENERAL CONCLUSIONS AND FUTURE PERSPECTIVES  
 
Cell encapsulation technology holds promise in various areas of medicine and some important 
applications are, for example, treatment of diabetes and production of biologically important 
therapeutics. The hope that encapsulated cells might be used as a therapeutic strategy is 
increasingly being recognized and is expected to have enormous potential in medicine in the 
near future. However, to be a viable complement to the current methods of cell transplantation 
therapy, encapsulation technology has to fulfill the strict requirements necessary to these types 
of therapeutic strategies, like performance, biosafety, biocompatibility, stability, availability, 
purity, characterization and cost. It is widely understood that in order to encapsulate living cells 
within an artificial matrix, the encapsulating conditions must not damage the living cells and the 
matrix material must be biocompatible and at the same time provide a natural microenvironment 
for cells to sustain their viability, function, and growth. The mechanical strength of the 
encapsulating matrix is also critical, particularly when long-term implantation is envisaged. The 
mechanical strength is essential for maintaining the matrix integrity and to withstand 
manipulations associated with in vitro culture, implantation and in vivo existence. Moreover, it is 
essential that the matrix should be permeable to ensure sufficient diffusion of nutrients and the 
removal of secreted metabolic waste products, to sustain the survival and function of 
encapsulated cells. Thus, there is a need for relatively mild cell encapsulation methods, which 
offers control over properties of the encapsulating matrix. An exciting approach for cell delivery 
is the use of materials that can self-assemble in conditions that are cell-compatible and into 
structures that can be injected into the body (e.g. microcapsules). Self-assembly can occur 
through a change in temperature, pH or ion concentration or be triggered by radiation. This 
approach enables the clinician to transplant the cell and material combination in a minimally 
invasive way.  
Although xanthan gum has been widely used in food and pharmaceutical industry, because of 
the encouraging reports on xanthan biosafety, the use of this polysaccharide has not been fully 
explored as a biomaterial. We have, thus, hypothesized that its unique chemical structure could 
offer very interesting rheological and functional properties in cell encapsulatitechnology. The 
overall goal of the work presented in this thesis was to develop novel biomaterial systems, 
microcapsules and membranes, for cell encapsulation and culture, respectively. Bottom-up and 
top-down approaches, based on self-assembly and microfabrication methods, were combined 
and explored to develop the proposed systems. 
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To obtain stable microcapsules, we have investigated the potential of xanthan gum and its 
derivatives to form encapsulating matrices in physiological conditions, and capsule-forming 
devices (micro-droplet generator and micro-fluidics) for reproducibly generating capsules with 
controlled shape and micro-size range. The materials and microcapsules were characterized 
and evaluated for their biological response in vitro. The results of these studies show that cells 
can be encapsulated, remaining viable within the developed microcapsules. To the best of our 
knowledge, this dissertation is the first work to report the use of xanthan gum as cell 
encapsulating matrix. It was also hypothesized that microscale features, incorporated on self-
assembled membranes exhibiting simultaneously biomolecular signals (RGDS cell-adhesive 
sequence), could provide instructive cues to cells. Cell adhesion, spreading, and morphology 
were significantly affected by the surface topographical patterns and the different densities of 
RGDS. 
It is object of the present chapter to summarize the significant findings in the experiments 
presented in the preceding chapters and describe how the conclusions address the 
aforementioned hypotheses.  
Xanthan is able to form self-supporting gels in the presence of ions, although they are not stable 
in the long term when placed in aqueous solutions. In the present PhD investigation, we have 
performed chemical modification of xanthan to evaluate its potential as a cell encapsulation 
matrix. In a first attempt, xanthan was carboxymethylated (carboxymethyl xanthan, CMX) to 
increase the number of carboxylic groups available for ionic crosslinking. Simultaneously, a 
simple micro-droplet generator (as alternative to the common sophisticated microfluidic systems) 
was developed to produce CMX microcapsules with reduced size (comparatively to capsules 
obtained manually) and spherical shape. The microcapsules generated from xanthan in its 
carboxymethylated form were shown to be stable in the long-term and able to encapsulate 
chondrocytic cells. Encapsulated cells showed enhanced viability, proliferation and retained the 
property of forming cell aggregates comparatively to the ones encapsulated in alginate 
microcapsules produced in similar conditions. In conclusion, these studies suggest that CMX 
can be an alternative to the current cell encapsulating materials, but in vivo studies are 
necessary to confirm our hypothesis. 
Most of the biological systems found in the Nature are hierarchically structured and organized at 
nano, micro and meso scale, presenting unique and multi-functional properties. Molecular self-
assembly provides the opportunity to design reproducible biomimetic materials with known and 
controllable chemistry, organized at nano-scale, being an appellative approach for cell 
encapsulation. In that respect, xanthan based amphiphilic systems were developed to self-
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assemble into hollow capsular structures in physiological conditions and encapsulate cells. In 
one attempt, the hydrophilic xanthan was reacted with hydrophobic palmitoyl chloride in a single 
step. The amphiphilic character imparted to native xanthan only by certain palmitoyl ratio 
allowed the supramolecular rearrangement of palmitoyl xanthan into nano-fibrilar structures 
when placed in aqueous media. Palmitoyl xanthan was able to form stable and robust hollow 
capsules by self-assembly in physiological ion concentration and pH. The capsule morphology 
was revealed to be highly organized in lamellar nanostructures. Capsules with uniform spherical 
shape and micro-size were then obtained using the micro-droplet generator previously 
developed. Cells encapsulated in the palmitoyl xanthan microcapsules were shown to remain 
viable and proliferate for longer periods of time. The developed micro-droplet generator 
demonstrated high versatility to be used as microcapsule generator device allowing working with 
a variety of polymer systems and the generation of microcapsules by different processes (ionic 
cross-linking, self-assembly) in physiological conditions for encapsulation of cells. Knowing the 
amphipathic nature  of phospholipids and their role in biological membranes, the second attempt 
consisted on using a similar strategy to attach 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine 
(DOPE) phospholipid to xanthan through the standard carbodiimide chemistry. Xanthan-DOPE 
amphiphile was successfully synthesized with ability to self-assemble into stable hollow capsular 
structures when subjected to physiological ion concentrations. In this case, the self-assembled 
phospholipid-xanthan structures were converted into spherical microcapsules by means of 
microfluidics technology. Stable microcapsules were obtained with ability to support and 
enhance cellular metabolic activity in vitro. A particular advantage of this system relies on the 
fact that the phospholipid-xanthan microcapsules did not require an external coat with poly-L-
Lysine, as described for the CMX and palmitoyl xanthan microcapsules, avoiding potential 
immunological problems. The successful self-assembly of amphiphilic xanthan and their 
conversion into stable microcapsules using microfluidics encouraged us to explore new self-
assembling systems. Following this approach, robust microcapsules were developed when 
combining the negatively charged xanthan with a positively charged self-assembling peptide. 
The properties of the self-assembled microcapsules, generated by microfluidics technology, 
were controlled by changing peptide concentration. It was demonstrated that the concentration 
played an important role in the morphology, size, and permeability of the microcapsules. The 
optimized processing conditions enabled generating homogenous-size microcapsules with long-
term stability and the ability to support the survival and function of encapsulated cells over 
prolonged time. This set of experiments and data show that several aims proposed in this thesis 
were satisfactorily achieved, namely i) the use of xanthan gum as potential cell encapsulation 
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matrix and ii) production of microcapsules with homogeneous size distribution and micrometer 
size favorable for mass transfer and easy injects for cell therapy, mentioned in Chapter II. 
Still within the same strategy, a bioactive membrane was developed through self-assembly of a 
positively charged multidomain peptide triggered by the negatively charged hyaluronic acid. The 
growth and structure of the membranes were seen to be affected by assembly time and 
temperature in addition to the positioning of components (peptide on top or bottom of HA). A 
biomolecular signaling motif was incorporated into the membranes, and the proportion of this 
could be easily controlled by varying the composition of the peptide solution prior to assembly. 
Topographical features could be incorporated into the membrane structure during its formation, 
removing the requirement for post-assembly fabrication steps. Rat MSCs were observed to 
recognize the RGDS cell adhesion sequence and the topographical patterns, varying their 
morphology depending on the concentration of binding motif or specific physical features that 
were cultured on. The simultaneous integration of bottom-up and top-down fabrication 
processes described here permit the development of hierarchical macrostructures made from 
well-defined nanofibers and microtopographies that together provide precise biomolecular and 
physical properties. The numerous possibilities to better tune them with spatio-temporal and 
biomimetic control provide a broad spectrum of potential applications in tissue engineering and 
regenerative medicine. 
The present thesis incrementally expanded the current scientific knowledge on considering the 
use of xanthan gum polysaccharide as a biomaterial. We have proposed several chemical 
modifications on xanthan (carboxymethylation, palmitoylation and conjugation with 
phospholipids) and its combination with self-assembling peptides to obtain distinct assembling 
pathways (ionic crosslinking, self-assembly) for the formation of stable capsules indented for cell 
encapsulation. In the process of developing these systems, an attempt was made to better 
understand the fundamental aspects of their design on their resulting functionality and 
performance in vitro. The obtained results are promising and can enhance the applicability of 
xanthan gum in the biomaterial field. The same approaches, described herein, can also be 
applied for other polysaccharides in general. Self-assembly was used in this PhD project as a 
nanofabrication technique. Self-assembly allows the spontaneous organization of individual 
building blocks into ordered and stable nanostructures by noncovalent interactions. We have 
used negatively charged polysaccharides with self-assembling peptides of opposite charge to 
direct their self-assembly into cylindrical nanostructures (nanofibers). The nanofibers had 
diameters as small as 10 nm (significantly smaller that those obtained by electrospinning, a top-
down fabrication technique). Furthermore, the peptide structures were designed to display 
bioactive sequences to foster the adhesion of cells. Nevertheless, since most of the self-
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assembling materials are macroscopically disordered and this may limit their performance, 
micro-fabrication methods were applied within the scope of this PhD work to fabricate 
biomaterial systems with well-defined features at micro-scale. Several examples presented in 
this thesis proved that combining self-assembling materials with microfabrication technologies 
can be an effective approach to fabricate microcapsules and membranes with increased level of 
control over their structure, shape, bioactivity and overall performance. 
A number of valuable results were obtained in this research project which will hopefully be of 
utility in future investigations. The development of amphiphilic xanthan systems is one the most 
significant contributions of this thesis. The combination of polysaccharides with self-assembling 
peptides of opposite charge has also contributed to the understanding on the self-assembly 
between large and small molecules and revealed new potential applications. In addition, the 
results reported in this thesis provide a deeper understanding on the properties of xanthan 
derivatives and their use as encapsulating matrix. While extensive work has been presented in 
this thesis, further studies must be performed to confirm the potential of the developed 
biomaterial systems, including: 
- Study the in vitro degradation of the developed systems (microcapsules and membranes); 
- Perform cell encapsulation studies with primary cells (e.g. human articular chondrocytes, stem 
cells) to validate the performance of the developed microcapsules; 
- Undertake in vivo studies to assess the biocompatibility, stability and performance of the 
developed microcapsule systems; 
- Evaluate the mechanical properties of the micropatterned self-assembled membranes and 
perform advanced cell culture studies to investigate in detail cell-membrane interactions, cell 
spreading and differentiation; 
- Increase the level of biochemical complexity of the fabricated patterned membranes, such as 
including mineral-attracting sequences for inducing biomineralization and/or growth-factor 
binding sequences for directing cell differentiation, to develop truly biomimetic synthetic 
periosteum membranes, for example.  
 
 
 
  
 
 
